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Abstract 
 
Expression quantitative trait loci (eQTLs) are generated by the combined use of 
microarray technology to measure gene expression and genetic linkage analysis to 
map the expression traits to the genome.  
 
This thesis describes co-expression and quantitative trait transcript (QTT) analysis 
carried out on a dataset consisting of thousands of cis- and trans-eQTLs. These were 
mapped in 29 rat Recombinant Inbred strains derived from a cross between the 
Spontaneously Hypertensive Rat (SHR), a widely used model of the human metabolic 
syndrome, and the normotensive Brown Norway (BN). Gene expression data from 
four tissues relevant to the metabolic syndrome and cardiovascular disease were 
analysed: fat, kidney, adrenal gland and left ventricle. 
 
By systematically applying a rigorous statistical methodology to the eQTL dataset, a 
consistent, distinct correlation structure was observed. Co-expression of groups of 
transcripts linked to a common region of the genome, referred to as trans-eQTL 
clusters, was investigated. Some of these cluster-forming groups were found to 
remain significantly correlated after the effect of genotype was accounted for, and 
functionally enriched. 
 
An example of successful application of QTT analysis to the dataset is described. 
This contributed to the identification of Ogn as a regulator of left ventricular mass in 
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rodents and subsequent implication of the homologue of Ogn in a related role in 
humans. Correlation of a further 103 physiological traits with cis-eQTLs in each of 
the four tissues was also carried out; analysis which potentially informs a wide range 
of hypotheses concerning relevant phenotypes. 
 
Together, the findings described here demonstrate the utility of a systematic 
computational approach using correlation-based methodologies in combination with 
appropriate statistical techniques to inform the genetic analysis of complex traits. 
These findings indicate the importance of understanding potential confounding 
factors in eQTL analysis, as well as the potential of the eQTL approach to stimulate 
gene discovery. 
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Chapter 1:  Introduction  
 
 
1.1 Complex traits 
Many of the commonest and costliest diseases, particularly in the Western world, are 
at least partially genetically determined, but cannot be explained by the inheritance of 
a single locus (i.e. they are not monogenic). Instead, the development and progression 
of such diseases as cancer, cardiovascular disease and diabetes are influenced by the 
interaction between genetic, developmental and environmental factors (Churchill et 
al., 2004). Therefore, these conditions are referred to as ‘complex traits’. 
 
The discovery of genes underlying complex traits is one of the biggest challenges 
facing researchers in the post-genomic era, and success in this area promises 
considerable improvements in medical knowledge and correspondingly in human 
health. However, the aetiologic complexity of these traits is such that progress in this 
area has, up until recently, been very slow (Yagil and Yagil, 2006). 
 
1.1.1 The Metabolic Syndrome 
A relationship between complex metabolic and physiological disorders including 
hypertension, dyslipidaemia, and insulin resistance was identified by Gerald Reaven 
in 1988, and termed Syndrome X (Reaven, 1988), or the ‘Insulin Resistance 
Syndrome’ (IRS). As described then, in its original form Syndrome X included (1) 
resistance to insulin-stimulated glucose uptake; (2) glucose intolerance; (3) 
19 
 
hyperinsulinemia; (4) increased very-low-density lipoprotein (VLDL) triglyceride; 
(5) decreased high-density lipoprotein (HDL) cholesterol; and (6) hypertension 
(McLaren, 1997). It was suggested that the presence of this syndrome in an individual 
is a significant risk factor for cardiovascular disease (CVD), and by the 1990s the 
name ‘metabolic syndrome’ was adopted to describe the condition (Ferrannini, 2007). 
Reaven did not include central obesity as part of his original definition of Syndrome 
X. Later, modified definitions such as the NCEP:ATP III and WHO definitions 
(Lakka et al., 2002), and the American Heart Association criteria (Grundy et al., 
2004) provided new descriptions of the metabolic syndrome that included abdominal 
obesity in addition to increasing the specificity of definitions of components in 
Reaven’s original criteria. 
 
Although there is substantial evidence for links between the components of the 
metabolic syndrome and increased risk of CVD, there is some debate over the utility 
of the designation of the described combination of risk factors as a syndrome 
(Grundy, 2006; Kahn et al., 2005; Reaven, 2005). The facts that the described 
symptoms cluster together within individuals, and that they are associated with CVD, 
are however not in dispute – nor is the utility of rodent models which replicate 
features of the human metabolic syndrome, such as the Spontaneously Hypertensive 
Rat (SHR) (Aitman et al., 1997).  
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1.1.2 Hypertension 
Hypertension can be defined operationally as an adult individual with a blood 
pressure of 140/90 mmHg or greater (Binder, 2007). As well as forming part of the 
criteria for diagnosis of the metabolic syndrome, hypertension is in and of itself a 
serious public health problem, with a prevalence of up to 40% in western populations 
(Zhu and Cooper, 2007). It arises as a consequence of a complex interplay between 
genetic and environmental factors. Estimates suggest that around 30% of the 
population variance can be accounted for by genetic variation (Zhu and Cooper, 
2007). However, due to the numbers of different genes and pathways involved, the 
heterogeneity of the condition’s aetiology, the high frequency of hypertension in the 
population, and the small effect size of causative genes, the identification of genetic 
variants involved in increasing risk of hypertension is not straightforward (Wellcome 
Trust Case Control Consortium, 2007) 
 
In particular, because hypertension is so prevalent and the relative importance of 
genetic and environmental factors, such as diet and physical activity, is unclear and 
itself variable, the study of the genetics of hypertension in humans has proven 
refractory to even modern genetic strategies (Wellcome Trust Case Control 
Consortium, 2007). The use of animal models in laboratory conditions – i.e. a 
controlled environment – simplifies the investigation somewhat by minimising non-
genetic variation. Rodent models such as the SHR, which is an inbred strain in which, 
as the name suggests, almost 100% of individuals spontaneously develop high blood 
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pressure (Okamoto and Aoki, 1963), are a valuable resource for the study of the 
genetics of hypertension and related disorders. 
 
1.1.3 Insulin Resistance 
The term ‘insulin resistance’ refers to the defects in insulin action that are observed in 
the metabolic syndrome and other disorders, specifically defects in insulin action on 
carbohydrate and fat metabolism, such as glucose uptake and suppression of lipolysis 
(McLaren, 1997; Reaven, 1988). A common accompaniment of insulin resistance is 
hyperinsulinaemia, which has frequently been assumed to be a compensatory 
response, to maintain homeostasis of carbohydrate and fat metabolism. The aetiology 
and pathology of insulin resistance are still quite poorly understood, but the syndrome 
has been linked to numerous serious diseases including cardiovascular disease, type 2 
diabetes and neurodegenerative disorders (Biddinger and Kahn, 2006).  
 
The direct link between insulin resistance and type 2 diabetes, a disorder which is 
becoming increasingly prevalent across the world (Stumvoll et al., 2005), is of 
particular interest in the context of the metabolic syndrome since it suggests an inter-
relationship between these conditions, obesity and cardiovascular disease. Links 
between insulin resistance syndromes and cardiovascular disease have been identified 
in 40-60% of coronary heart disease (CHD) patients (Aitman, 2001; Nathan et al., 
1997). This means that genetic risk factors identified for insulin resistance syndromes 
may hold the key to improving our understanding of the causes not just of type 2 
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diabetes, but of cardiovascular diseases as well; in the context of the metabolic 
syndrome. 
 
Type 2 diabetes, also referred to as non-insulin dependent diabetes, is diagnosed by 
the presence of high-levels of glucose in the bloodstream (hyperglycaemia) (Stumvoll 
et al., 2005). The occurrence of hyperglycaemia is a consequence of decreased insulin 
sensitivity as well as defects of β-cell function (Monnier et al., 2008). 
 
1.1.4 Cardiac Hypertrophy 
Hypertrophic enlargement of the ventricular wall through growth of individual 
myocytes is the heart’s primary response to stressful physiological stimuli (Lorell and 
Carabello, 2000). Such enlargement, particularly of the left ventricle, occurs 
beneficially to health as a result of athletic exertion (Hill and Olson, 2008), but also 
pathologically as a response to increased blood pressure (Wilkins et al., 2004). It is a 
powerful predictor of cardiovascular disease, independent of other risk factors 
including the metabolic syndrome (Wagner et al., 2004). In particular, compensatory 
cardiac hypertrophy is part of a well-characterised path to heart failure (Liew and 
Dzau, 2004), as part of a process called ‘left ventricular remodelling’.  
 
It is hoped that gaining an improved understanding of the processes that occur during 
the early stages of heart failure will lead to progress in the development of new 
treatments. This incorporates the study of genetic variation that influences 
23 
 
hemodynamic hypertrophy (e.g. (Cerutti et al., 2006)), and variation in left 
ventricular mass (LVM) that occurs independent of hypertension (Petretto et al., 
2008) 
 
 
1.2 Genetic Analysis of Complex Traits 
The genes responsible for most of the more common monogenic diseases have been 
identified. However, because complex traits come about as a result of an interplay 
between multiple genetic and environmental factors, and each genetic locus involved 
explains only a small part of that interplay (Mott, 2006), studies aiming to identify 
contributory genes have often drawn a blank. The need for very large sample sizes 
and stringent case-control study design, and the difficulty of controlling for lifestyle 
factors, has made the discovery of complex trait genes in humans a formidable 
proposition (Glazier et al., 2002; Risch and Merikangas, 1996).  
 
The approaches used in the effort to elucidate the genetic basis of complex traits have 
undergone many changes in the recent past and will continue to do so. The 
foundation upon which the varied methodologies are built is, however, consistent – 
the relating of region(s) of the genome with phenotypic variation. The two widely 
used methods of doing so are linkage analysis, used to generate quantitative trait loci 
(QTLs), and association analysis. 
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1.2.1 Genetic Markers 
Genetic markers are regions of the genome that are variable, or polymorphic, between 
the populations under investigation. There are several types of genetic marker; the 
two that are most commonly used for linkage analysis are microsatellites (also known 
as simple sequence repeats (SSRs)) and single nucleotide polymorphisms (SNPs). A 
variation on SNP markers is the single functional polymorphism (SFP). Microsatellite 
markers are variable in length between strains or individuals, whereas SNPs and SFPs 
are variable in sequence. The genetic markers used in the study described in this 
thesis are microsatellite markers. 
 
1.2.2 Quantitative Trait Loci (QTLs) 
A quantitative trait is a phenotypic characteristic that varies in a quantifiable manner, 
such as blood pressure, waist circumference and left ventricular mass. The mapping 
of quantitative traits to the genome in the form of QTLs by linkage analysis has been 
performed in humans and in model organisms for many years. QTL mapping was 
carried out in the SHR and BN parental strains prior to the commencement of the 
work described in this thesis (Hubner et al., 2005); these QTLs are henceforth 
referred to as the physiological QTLs (pQTLs). As of 2005, almost two thousand 
QTLs had been mapped to the mouse genome (Flaherty et al., 2005), 708 QTLs had 
been mapped in the rat, and just over one thousand in humans (de la Cruz et al., 
2005). QTL mapping has formed the first stage of the process of identification of 
numerous complex trait genetic loci (Cervino et al., 2005). Recombinant Inbred (RI) 
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strains (described in detail in 1.4), in particular, have enabled large numbers of QTLs 
to be localised (Flaherty et al., 2005). However, having identified a QTL interval, the 
next step - the isolation of the contributory gene has proven to be much more 
challenging. By 2005, only around 20 genes were identified from the thousands of 
rodent QTLs that had been mapped (Flint et al., 2005).   
 
1.2.3 Genome-wide Association Studies (GWAS) 
Genetic association analysis makes use of historical recombination to compare two 
groups (for instance, cases and controls) for the relative frequency of occurrence of a 
genetic trait such as a SNP. Typically, a p-value is found to assess the significance of 
the association of the phenotype with each SNP, although Bayesian methods that can 
quantify the probability of association are also suitable for use (Stephens and 
Balding, 2009).  
 
The increased availability of sequencing has enabled the frequencies of genetic 
variants to be compared across the whole genome between large samples of cases and 
controls, an approach referred to as a Genome-wide Association Study (GWAS) 
(Kruglyak, 2008). The advent of GWAS has increased the rate of gene identification 
in higher mammalian complex traits dramatically. As of May 2008, almost 100 
contributory loci for nearly 40 complex traits have been identified (Manolio et al., 
2008). This has been made possible thanks to the availability of the International 
HapMap resource (Morton, 2008); large, well-characterised sets of clinical samples; 
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and the ability to genotype hundreds of thousands of markers, usually single 
nucleotide polymorphisms (SNPs) in samples classified according to a trait of interest 
(Wellcome Trust Case Control Consortium, 2007).  
 
Although GWAS is an important innovation and has enabled several novel complex 
trait loci to be identified, the importance of the contribution to disease research made 
by rodent models has not diminished. GWAS have succeeded in identifying genomic 
regions – which can be large as a consequence of linkage disequilibrium (Lusis et al., 
2008) – explaining only a small part of the observed phenotypic variation (Sarwar 
and Cook, 2009). It cannot detect rare variants and those that are too complex to 
associate with a SNP locus (Nathan and Orkin, 2009). Additionally, replication of 
GWAS findings in different populations has proven problematic in some cases 
(Frayling et al., 2007; Vogel et al., 2009). Animal models; particularly recombinant 
inbred strains and congenic and consomic strains are expected to continue to be 
valuable resources for geneticists (Aitman et al., 2008). 
 
 
1.3 Genetic Analysis of Model Organisms 
                                                             
1.3.1 The Use of Model Organisms 
The study of model organisms has facilitated the identification of complex trait 
susceptibility genes and pathways, by genetic linkage approaches and by positional 
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cloning (Krinke, 2000). The use of inbred rodent models such as the spontaneously 
hypertensive rat (SHR) and recombinant inbred (RI) strains generated using it in 
genetic analysis eliminates the problem of genetic heterogeneity and allows almost 
complete control over environmental factors. It is possible to set up precise, 
controlled experimental crosses, making possible a wider scope of experimentation. It 
also enables larger sample sizes to be utilised. The most significant downside of using 
model organisms is that there are of course substantial developmental, physiological 
and genetic differences between rodents and humans. 
 
The prioritisation of candidate genes in animal models, particularly rodents, is an 
approach that has been successfully applied to the study of a wide variety of complex 
traits (Glazier et al., 2002). Typically, the methods of analysis used in rodent models 
have entailed genome-wide linkage and gene expression analysis (Clee, 2005). 
Strategies integrating these two approaches were first used in the identification of a 
gene underlying a complex trait in (Aitman et al., 1999) and have been applied in 
rodent models to predict candidate loci for hypertension (Hubner et al., 2006; Soler et 
al., 2006), obesity (Mehrabian et al., 2005), and cardiac mass (Petretto et al., 2008) 
among others. 
                                                               
1.3.2 Rodents as Model Organisms for Complex Traits 
The utility of rodent models for disease research has been established for almost a 
century, and has provided insights into the physiological and genetic basis of a wide 
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range of disorders (Editorial, 2008). Of the two rodent species that are widely used as 
model organisms, the mouse (Mus musculus) became established as the geneticist’s 
mammalian model of choice early on (Jacob, 1999), and was the first rodent genome 
to be sequenced (Waterston et al., 2002). As of 2005, almost three times as many 
QTLs had been identified in mouse as in rat (Flint et al., 2005). Comprehensive QTL 
databases exist for mice (Eppig et al., 2005) and rats (de la Cruz et al., 2005).  
 
The rat (Rattus norvegicus) has been at the centre of disease research since the middle 
of the 19
th
 century, and inbred strains have been in development since 1909 (Jacob, 
1999). Although geneticists have historically favoured the mouse, the rat has always 
been preferred by physiologists because it is more amenable to laboratory 
experimentation. Over 500 inbred rat strains have been created in order to study 
common diseases (Lazar et al., 2005). As rat genetic and genomic resources continue 
to develop and become increasingly competitive with those available for mouse 
(Twigger et al., 2008), insights into rat physiology and biochemistry can be used to 
inform the findings of genetic analysis in the rat.   
 
1.3.3 The Spontaneously Hypertensive Rat (SHR) 
In terms of research into the metabolic syndrome and associated disorders, the most 
important of the inbred rat strains in terms of the volume of research carried out using 
it is the Spontaneously Hypertensive Rat (SHR). 
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The SHR inbred strain was created in 1962 from an outbred strain of Rattus 
norvegicus, the Wistar strain. The rats to be bred were selected for high blood 
pressure until occurrence of spontaneous hypertension approached 100% (Okamoto 
and Aoki, 1963).  
 
It has since been established that, alongside displaying the consistently raised blood 
pressures described by Okamoto and Aoki, the SHR also models other aspects of the 
metabolic syndrome (Pravenec et al., 2004; Pravenec et al., 2002), including insulin 
resistance, dyslipidaemia and disturbances of  lipid and carbohydrate metabolism. 
Several QTLs for metabolic syndrome-associated physiological traits have been 
mapped in the SHR (e.g. (Kren et al., 1997)), along with QTLs for other disorders 
including cardiac hypertrophy (Cerutti et al., 2006; Inomata et al., 2005; Pravenec et 
al., 1995) and neuro-behavioural traits such as attention deficit hyperactivity disorder 
(ADHD) (Vendruscolo et al., 2006). 
 
Several other inbred lines modelling some aspects of the metabolic syndrome have 
also been developed. These include the Dahl salt-sensitive rat, the Lyon hypertensive 
rat and the Milan hypertensive rat, all of which are hypertensive (Channa et al., 2004; 
Pravenec et al., 2002). 
 
1.4 Recombinant Inbred Strains 
The development of rodent recombinant inbred (RI) strain panels was pioneered in 
the early 1970s by Donald Bailey, who by repeatedly interbreeding the same two 
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inbred strains was able to produce a genetically distinct but fixed set of strains that 
are homozygous at all genetic loci (Bailey, 1971) The first ‘RI panel’, of 7 mouse RI 
strains – the first time this had been achieved in mammalian species – was used to 
study histocompatibility genes using linkage analysis.  
 
The use of RI strains is also an established methodology in research in other species, 
such as the plant model organisms Arabidopsis thaliana, tomato and maize, the 
nematode C. elegans, and the insect model organism Drosophila melanogaster 
(Peirce et al., 2004). For obvious reasons, research into complex traits like the 
metabolic syndrome requires the use of a mammalian model. 
 
RI strains provide a cumulative and permanent resource for model organism genetic 
research. They are of particular value, therefore, in the mapping of complex traits, 
because unlimited phenotypic measurements may be obtained for each line – further 
animals can be bred according to demand. Multiple genetically identical individuals 
from each line can be assayed, e.g. in gene expression studies, to reduce individual 
environmental and measurement variation, increasing expression trait heritability. 
They provide a greater resolution for genetic mapping than do intercrosses, as the 
breakpoints on RI chromosomes are denser (Broman, 2005). Investigation of 
statistical power to detect QTL has found that the number of RI strains required to 
achieve a given power to detect QTL is half that required in an F2 population (de 
Koning et al., 2005).  
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1.4.1 The BXH/HXB Recombinant Inbred Panel 
The 29 strains making up the BXH/HXB recombinant inbred panel were created by 
systematic inbreeding for around 60 generations between members of the F2 
generation resulting from an initial intercross of membes of the hypertensive 
SHR/Ola and normotensive BN.lx/Cub inbred strains (Pravenec et al., 1989). The 
breeding process used in the generation of this panel is illustrated in Figure 1.1.  
 
 
Figure 1.1: Generation of the BXH/HXB panel of recombinant inbred strains (Van Zant and 
de Haan, 2004) 
 
The BXH/HXB panel was, at the time of its completion, the largest rat RI panel in the 
world (Pravenec et al., 1995). The genetic map derived from this panel of RI strains 
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(Jirout et al., 2003) has facilitated the mapping of physiological traits within the panel 
(Jaworski et al., 2002), and provides the basis for large-scale analysis of the genetic 
basis of the complex traits modelled by the SHR (Hubner et al., 2006). 
 
1.5 Tissue Selection 
The large-scale combined genetic and gene expression analysis described here was 
carried out on samples of four tissues that were chosen for use in the investigation 
because of their relevance to the complex traits manifested in the SHR and in order to 
build on previous findings.  
 
As discussed previously in 1.3.3, the SHR was long prior to the development of the 
BXH/HXB RI strains a widely used model of spontaneous hypertension, defective 
insulin action and other aspects of the human metabolic syndrome (1.1.1). Adipose 
tissue (fat) samples and kidneys were used for gene expression analysis in the initial 
analysis described in (Hubner et al., 2005). Adrenal glands and left ventricles were 
subsequently analysed in the same way; this is described in  (Petretto et al., 2006a). 
 
1.5.1 Fat 
The role played by the adipose tissue in the development of the metabolic syndrome 
is discussed in (Eckel et al., 2005). Perhaps counterintuitively, adipocytes are now 
recognised as a significant endocrine organ (Biddinger and Kahn, 2006), secreting 
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factors such as adiponectin which have been linked to metabolic syndrome and also 
heart disease (Eckel et al., 2005).  
 
One gene that is highly expressed in adipose tissue and whose variation has been 
shown to play an important role in development of the insulin resistance syndrome in 
the SHR is Cd36 (Aitman et al., 1999), which was found to underlie a QTL for 
hypertension in rodents.  
 
1.5.2 Kidney 
The kidney is key to the regulation of blood pressure, through the renin-angiotensin-
aldosterone system (Binder, 2007; Delles et al., 2008), which regulates levels of salt 
reabsorption in the kidneys’ tubules. Components of the system have previously been 
identified through genetic analysis and linked to essential hypertension (Binder, 
2007). Genetic variation in the kidney has also been linked to the development of 
pathologies in other tissues including left ventricular hypertrophy (Ortlepp et al., 
2001) and new-onset heart failure (Schocken et al., 2008).  
 
The central role of the kidney in the development of hypertension has been 
demonstrated through rodent renal grafts, whereby transplantation of kidneys from 
genetically hypertensive donors has produced essential hypertension in previously 
normotensive individuals (Rettig and Grisk, 2005).  
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Cd36, which as previously discussed has been shown to play an important role in the 
development of insulin resistance, has also recently been implicated in renal 
regulation of blood pressure (Pravenec et al., 2008). 
 
1.5.3 Adrenal Gland 
The contribution of the adrenal gland to the development of hypertension and the 
metabolic syndrome is far from fully understood. It is known that rare tumours of the 
adrenal gland, such as pheochromocytoma, can directly produce pathologically high 
blood pressure (Young, 2007) by affecting levels of secreted factors such as 
catecholamines. At the same time, catecholamine deficiencies have previously been 
associated with dyslipidaemia and insulin resistance  (Landsberg, 1999) 
  
Aldosterone, a hormone produced by the adrenal cortex, forms part of the 
aforementioned renin-angiotensin-aldosterone system of blood pressure regulation. 
Levels of aldosterone are regulated primarily by angiotensin, but are also influenced 
by the sympathetic nervous system (SNS). Increased activity of the SNS has been 
associated with insulin resistance (Reynisdottir et al., 1994) as well as hypertension 
(Landsberg, 1999).  
 
1.5.4 Left Ventricle 
The SHR is of interest as a model of Left Ventricular Hypertrophy (LVH) as well as 
the metabolic syndrome. A QTL for blood pressure-independent variation in cardiac 
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mass was identified in the BXH/HXB RI strains in 1995 (Pravenec et al., 1995), 
suggesting that analysis of the relationship between this phenotype and gene 
expression in the LV has the potential to be informative  
 
 
1.6 Gene Expression Analysis 
The quantity of the messenger RNA (mRNA) intermediate that is produced when a 
region of the genome is transcribed can be referred to as the ‘transcript abundance’. 
The measurement of the transcript abundance and therefore of gene expression can be 
undertaken on a genome-wide basis through the application of microarray technology 
(Chee et al., 1996). 
 
Since the advent of microarray technology, the study of differential gene expression 
levels as a consequence of genetic variation has made possible advances across the 
whole of the field of biology. Variation between individuals in gene regulation has 
been considered by some authors to be at least as significant as structure in terms of 
explaining phenotypic differences (Cotsapas et al., 2006; Whitehead and Crawford, 
2006). The study of expression variation is therefore critical if we are to gain an 
understanding of the genetic basis of complex traits. 
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1.6.1 Measurement of Gene Expression 
DNA microarrays can be used to measure simultaneously the expression levels of 
thousands of genes; this is referred to as gene expression profiling. Among other 
applications of this technology are comparative genomic hybridization (for assessing 
copy number variation) and chromatin immunoprecipitation (for investigating 
interactions between DNA and proteins). Microarrays can be used to measure levels 
of DNA as well as mRNA.   
 
Expression profiling can be carried out using several different types of expression 
array which, although they vary in their design specifications, all perform essentially 
the same function. The two main types of DNA microarray are oligonucleotide arrays 
and spotted arrays (Efron et al., 2001). Both consist of ‘probes’ – short sequence 
fragments (usually either oligonucleotides or cDNAs) that complement the targets 
(e.g. mRNAs) whose abundance is to be measured.  
 
The specific hybridization of complementary mRNAs to the probes on the array 
produces a signal whose intensity is measured to provide a quantitative assessment of 
the abundance of the transcript (Whitehead and Crawford, 2006). Due to the need to 
quantify the intensity and because of the large numbers of simultaneous tests 
performed, the downstream analysis and the interpretation of the data so obtained are 
a considerable computational and statistical challenge.  
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1.6.2 The Affymetrix GeneChip 
The microarray system that was used to generate the rodent gene expression profile 
data described in this thesis is the Affymetrix GeneChip®. The GeneChip is an 
oligonucleotide microarray, whose design incorporates pairs of ‘perfect match’ (PM) 
and ‘mismatch’ (MM) probes. Probes consist of complementary oligonucleotides, 25 
bases in length – the MM probes contain one mismatch (non-complementary base) at 
the 13
th
 position. Each probeset normally consists of 11 probe pairs. It is intended that 
all probes within a probeset should map to the same gene, but sometimes this is not 
the case (Harbig et al., 2005).  
 
1.6.3 Validation 
The microarray is an extremely efficient, high-throughput method of measuring gene 
expression that allows analysis to be performed simultaneously on a genome-wide 
scale – something that would be utterly impractical were only single-gene techniques 
available for use.   
 
That said, laboratory techniques such as the Quantitative Real Time Polymerase 
Chain Reaction (qRT-PCR) and Northern blotting still play an important role in gene 
expression studies, as a means of independently validating the data obtained through 
the microarray analysis. This is an integral part of the quality control process for 
microarray experiments (Chuaqui et al., 2002). 
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1.6.4 Sequence Analysis 
The annotation of microarray probesets to genes, and downstream functional 
annotation (e.g. Gene Ontology annotation) depends on the initial mapping of a 
probeset to a specified transcript. This is contingent on the probeset hybridizing with 
the mRNA with which it is expected to hybridize.  
 
“Part of the problem is that the probes on an array are identified based on 
what [Affymetrix] was hoping to detect, not based on what they actually 
detect.” (Harbig et al., 2005) 
 
Because of this, it was considered necessary to cross-reference the probeset 
annotations provided by Affymetrix with those in the EnsEMBL annotation database 
using SCAMPA (Dickens, 2006)(2.2.2.1). This has made it possible for us to use in 
our analysis only probesets that hybridize with the gene indicated in the probeset 
annotation provided by NetAffx. 
 
Another consideration related to the probeset sequence pertains to the sequence of the 
region of DNA to which the probeset is intended to bind. Polymorphisms within the 
mRNA region that is targeted by a probe can result in hybridization differences 
(between two sample populations) that are not caused by differential gene expression 
(Alberts et al., 2005; Alberts et al., 2007b). This can lead to misinterpretations of the 
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data later on in the analysis. 
 
 
1.7 Expression Quantitative Trait Loci (eQTLs) 
The eQTL study design utilises expression traits measured by DNA microarray 
whose genetic control points are then mapped to the genome through linkage 
analysis, enabling the basis of quantitative variation in gene expression to be studied.  
The technique, applied on a genome-wide basis, is also known as ‘genetical 
genomics’ and was first proposed by Ritsert Jansen and Jan-Peter Nap in 2001 
(Jansen and Nap, 2001). Since then, the genetical genomics methodology has been 
applied in budding yeast (Brem et al., 2002), nematodes (Li et al., 2006), plant 
models (Hansen et al., 2008; West et al., 2007), rodent models (Hubner et al., 2005; 
Lum et al., 2006), and in humans (Goring et al., 2007; Hansen et al., 2008).  
 
eQTL analysis can be carried out in the segregating progeny of a backcross or 
intercross, in recombinant inbred lines, or (typically in humans) in pairs of siblings 
(e.g. (Goring et al., 2007)). The methodology is similar to that used to map 
physiological quantitative trait loci (pQTLs), except the quantitative traits that are to 
be mapped are expression levels of thousands of genes. As with the mapping of 
pQTLs, eQTL analysis requires a genetic map, and the genotyping of genetic markers 
across the genome (Kendziorski and Wang, 2006).   
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1.7.1 The Strain Distribution Pattern (SDP) 
The set of genotypes of a given genetic marker across a panel of recombinant inbred 
strains is referred to as that marker’s Strain Distribution Pattern (SDP). Ideally, the 
SDP consists of a complete set of known genotypes of a vector corresponding to the 
number of strains in the panel. However, in practice, genotype data is often missing 
from the SDP. It was necessary during the generation of our eQTL dataset to take into 
account the statistical and computational implications of the presence in the marker 
data of missing genotypes (3.1).   
 
1.7.2 Mapping eQTLs 
There are several factors that must be taken into account when mapping eQTLs to the 
genome in order for the data to be meaningful and suitable for downstream analysis 
(Kendziorski and Wang, 2006). Summarisation, using a pre-processing algorithm 
such as Robust Multichip Average (RMA), and the genomic locations of all of the 
markers used in mapping must be verified as far as possible (e.g. (Hubner et al., 
2005)). In the process of mapping itself, the number of transcripts and therefore of 
possible linkages means that there is a substantial problem of multiple testing. The 
computational methods used to generate eQTL datasets have to take these into 
account. 
 
The eQTL dataset described here, in the BXH/HXB RI strain panel, was generated 
using a map consisting of 1,011 microsatellite markers (Hubner et al., 2005). These 
were genotyped in each of the 29 strains using the methods described in (Jirout et al., 
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2003), contiguously covering almost all of the genome and providing a clear 
indication of the segregation of the parental genotypes (SHR and BN) across the 
strains following genotyping.  
 
Mapping of the eQTLs to the genome was carried out using QTL Reaper (Manly, 
2006). Markers for which 10 or more strains lacked genotype data were excluded 
from the analysis. Interpolation of missing genotype data was not carried out for 
reasons of time. 
 
QTL Reaper carries out genome-wide linkage analysis for each expression trait, and 
generates a likelihood ratio statistic (LRS) as a measure of the significance of each 
possible eQTL. The statistical significance of the LRS is assessed empirically by 
permutation, and the false discovery rate (FDR) evaluated in order to control for 
multiple testing (2.5.2), to provide a genome-wide corrected p-value for each 
probeset-marker combination. Typically, an eQTL would be used in downstream 
analysis if it was found to have genome-wide p<0.05 following correction for 
multiple testing (Hubner et al., 2005).  
 
The LRS technique used by QTL Reaper, and its predecessor Map Manager QTX 
(Manly et al., 2001), is a weighted regression-based method of assessing linkage 
based on methods first described by (Haley and Knott, 1992). 
 
SNPs, which can provide a denser marker map (STAR Consortium, 2008), became 
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available later in the course of the project, and were available for use in fine-mapping 
of specific quantitative traits (Petretto et al., 2008). However, the eQTLs were not re-
created using the new markers for use in this project due to a combination of 
statistical considerations and time constraints. 
 
1.7.3 Visualising eQTLs 
eQTL Explorer (Mueller et al., 2006) is a database-driven software application that 
was developed in order to facilitate the handling and interpretation, and in particular 
the use by non-bioinformaticians, of the eQTL dataset. eQTL Explorer enables cis- 
and trans-eQTLs to be visualised by the map location of the peak of linkage, and 
pQTLs by the locations of the flanking markers. Examples of eQTL Explorer’s 
display of the BXH/HXB database are provided in Figures 1.3 and 1.4.  
 
 
1.8 Cis- and Trans- Expression Quantitative Trait Loci (eQTLs) 
One of the strongest aspects of the eQTL study design is its ability to delineate 
eQTLs into two classes, cis- and trans-, depending on the location of the expression 
trait compared to that of the genotyped marker.  
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 Figure 1.2: Illustration of the genetic basis of cis- and trans-acting expression Quantitative 
Trait Loci (eQTLs) (Petretto, E., personal communication). 
 
As illustrated by Figure 1.2, cis-eQTLs are defined, as detailed in 1.8.1 and in 
(Hubner et al., 2005), so as to encompass those genes in which variation in transcript 
abundance is caused by genetic variation in the same gene (Doss et al., 2005). Trans-
eQTLs (1.8.2) are of interest as potential remote regulators of one or more 
downstream genes (Petretto et al., 2006b), which may or may not be on the same 
chromosome as the gene in which the genetic variation giving rise to the trans-eQTL 
occurs. 
 
This delineation is therefore biologically significant. The identification of an eQTL 
implies the presence of a genetic sequence variation that influences the levels of the 
transcript concerned (Drake et al., 2006). Whether that influence is local or remote 
has important implications for the likely biological basis of the transcript variation.  
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1.8.1 Cis-eQTLs  
Cis-eQTLs are typically defined in such a way that the transcript whose abundance is 
being measured is, as often as possible, the result of genetic variation in the same 
gene, perhaps in the promoter or regulatory regions (Yvert et al., 2003). The most 
suitable definition of the ‘window’ region of the cis-eQTL depends on the inherent 
margin of error in QTL mapping and the recombination rate across the genome 
(Hubner et al., 2005). A cis-eQTL is defined here as one in which the marker and the 
transcript are no more than 10Mbp apart (20Mbp total window size), as selected to 
capture as many positional candidate genes for physiological QTLs as possible 
(Figure S3, (Hubner et al., 2005)). Where a substantially greater mapping precision 
can be achieved, such as in eQTL studies using yeast (e.g. (Yvert et al., 2003)), 
‘window’ regions as small as 20kb have been used in the definition of a cis-eQTL. 
The guiding principle underlying the cis-trans delineation remains as described. 
 
Because cis-eQTLs are indicative of genetic variation that has a statistically 
significant influence on gene expression levels, it follows that the same genetic 
variation may also influence physiological phenotypes. For this reason, the 
identification of cis-eQTLs that colocalise with pQTLs for a trait of interest is 
considered to be of particular value to geneticists (Doss et al., 2005; Flaherty et al., 
2005; Wang et al., 2007). This principle underlies the analysis described in chapter 5. 
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1.8.2 Trans-eQTLs 
Trans-eQTLs are those in which variation in expression levels is controlled remotely. 
The eQTL (sequence variant) may be on the same chromosome as the transcript but 
outside the window region used to define cis-eQTLs, or it may be on a different 
chromosome.  
 
Because the presence of trans-eQTLs implies that genetic variation in one gene 
significantly affects the expression of another, it has been hypothesised (Yvert et al., 
2003) that trans-eQTLs are likely to represent polymorphisms in transcription factors 
– DNA-binding proteins that regulate gene expression (Pabo and Sauer, 1992). 
However, it has been observed that trans-eQTLs often do not map to regions of the 
genome containing any transcription factors (Tu et al., 2006), suggesting the 
involvement of trans-eQTL genes in more complex regulatory mechanisms. One 
reason for this, suggested by (Kliebenstein, 2009), may be that the pleiotropic effects 
of transcription factor mutations are so large as to impact the viability of organisms in 
which they occur. 
 
Trans-eQTLs typically show smaller effects than cis-eQTLs, suggesting that they 
represent a lesser degree of biological variability than do cis-eQTLs (Petretto et al., 
2006a). This finding is consistent with the aforementioned explanation of the 
biological basis of trans-eQTLs, and has been observed in other studies also (e.g. 
(Sladek and Hudson, 2006)).  
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1.8.2.1   Trans-eQTL Clusters 
One feature of trans-eQTL datasets that has been the subject of much study and no 
little controversy is the tendency, first noted in yeast by (Yvert et al., 2003), for tens 
or even hundreds of expression traits across multiple chromosomes to be linked to the 
same genetic marker. Such groups of trans-eQTLs are variously referred to as trans-
eQTL clusters, trans-eQTL ‘hotspots’, or trans-bands (the term ‘trans-eQTL cluster’ 
is used to refer to them in this thesis).  
 
Trans-eQTL clusters have been observed in eQTL studies in several species (Kirst et 
al., 2005; Morley et al., 2004; Petretto et al., 2006b). A trans-eQTL cluster identified 
on chromosome 4 in the BXH/HXB RI panel (Hubner et al., 2005), as visualised by 
eQTL Explorer (1.7.3), is illustrated in Figure 1.3, overleaf.  
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Figure 1.3: A trans-eQTL cluster mapped to chromosome 4 in the RI panel in kidney, as 
visualized by eQTL Explorer (Mueller et al., 2006)  
 
Because trans-eQTL clusters consist of multiple eQTLs that all map to the same 
location but affect transcript levels across the genome, it has been suggested that all 
of these transcripts may be under the control of a single regulatory gene (Yvert et al., 
2003), often referred to as a hypothetical ‘master regulator’ (Pastinen et al., 2006). 
This hypothesis is however disputed; it has been suggested that the observations of 
trans-eQTL clusters and corresponding hypothesized master regulators may be a 
consequence of systematic artefacts in microarray data (Kang et al., 2008), 
particularly since when real expression data has been combined with simulated SNP 
marker genotypes, ‘eQTL hotspots’ have arisen in the resulting dataset (Pérez-Enciso 
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et al., 2003) suggesting that clusters observed in eQTL experiments may arise from 
chance linkage of a group of correlated transcripts with a region of the genome. As 
discussed in 1.8.3, trans-eQTL clusters consist of expression traits with low effect 
sizes, a high proportion of which are mapped to the genome with a high probability of 
them being false positives, as evaluated by the expected FDR (2.5.2) (Petretto et al., 
2006a). The statistical significance of the eQTLs forming trans-eQTL clusters was 
investigated as part of this study and found, in general, to be low (4.2.2). 
 
1.8.3 Statistical power to detect cis- and trans-eQTLs 
Statistical power is the power of a statistical test to reject the null hypothesis given 
that it is false. The statistical power to detect QTL is dependent on the sample size of 
the experimental population used for mapping. However, as previously mentioned 
(1.4), because RI strains are homozygous across the genome they offer a statistical 
power twice that achieved in F2 crosses for an equivalent number of strains in the RI 
panel to that of individuals in the F2 cross. 
 
Cis-eQTLs are, on average, easier to detect because they explain a larger proportion 
of the variation in gene expression (their effect size is larger) than do trans-eQTLs 
(Hubner et al., 2005). Calculations of the power to detect cis- and trans-eQTLs in 
four tissues from the BXH/HXB panel of 29 RI strains were carried out by colleagues 
and the outcome of this analysis is described in (Petretto et al., 2006a). The statistical 
power and median expected FDR for cis- and trans-eQTLs in each of the four tissues 
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were calculated. For cis-eQTLs with high (h
2
 > 0.25) trait heritability, the statistical 
power was found to be ~100% in all tissues. For similarly heritable trans-eQTLs, the 
power ranges from ~10% (in adrenal) to ~60% (for the most heritable expression 
traits in fat). The median expected FDR for cis-eQTLs ranges from 4% to 8% across 
the four tissues, whereas for trans-eQTLs it ranges from ~26% (in fat and left 
ventricle) to ~35% (in kidney and adrenal) (Figure 4, (Petretto et al., 2006a)).  
 
 
1.9 Investigating Relationships between Expression Traits 
In the study of complex traits, it is important to realise that the understanding that can 
be obtained by studying genes in isolation is limited. The analysis of gene 
interactions and functional modules can provide a much more complete picture of the 
factors underlying phenotypic variation. 
 
Several studies have ‘integrated’ gene expression measurements with associated data 
(e.g. heritability), genotype information and phenotypic measurements to predict gene 
interactions (Brem et al., 2005) and modules (Li et al., 2005), and build gene 
networks (Sieberts and Schadt, 2007). Such analyses typically make use of 
mathematical models; some relatively simple, others highly complex; in silico to 
generate hypotheses regarding genetic interactions. The foundations that these 
analysis are built on are the relationships between gene expression traits – commonly 
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considered in terms of correlation of expression profiles across a population – and 
between these traits and the genetic loci that influence their genetic variation. 
 
1.9.1 Co-expression Analysis 
Correlation in gene expression is commonly used to identify pairs or groups of genes 
that may share functional and/or regulatory relationships. Typically, pairwise 
correlation is carried out by finding the Pearson (or alternatively Spearman’s rank) 
correlation coefficient (2.4.1). The evaluation of the Pearson correlation coefficient 
across a set of genes is often the first stage in the construction of  a gene network. 
 
1.9.2 Partial Correlation Analysis 
Straightforward methods of assessing the correlation of two variables (e.g. expression 
profiles), such as Pearson correlation, do not distinguish between direct associations 
between the two variables and those that arise indirectly through the effects of 
intermediate traits (Rockman, 2008), or between causal and responsive factors 
(Opgen-Rhein and Strimmer, 2007).  
 
One method of testing whether or not a relationship between two variables of interest 
is direct is by carrying out partial correlation analysis, conditional on a potential 
confounding variable, such as the genotype (SDP) of the marker at the shared peak of 
linkage of two eQTLs (Mozhui et al., 2008). The partial correlation coefficient 
(2.4.5), as applied to such a pair of expression traits conditional on genotype, 
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quantifies the correlation between between the parts of the expression profiles that are 
uncorrelated with the genotype. 
 
Partial correlation analysis can thus be used to distinguish between pairwise 
correlations that are due to direct causal relationships, and those that arise due in 
whole or in part to the potential confounding variable(s) on which the correlation is 
conditioned (De La Fuente et al., 2004). However, it does not provide unequivocal 
evidence that there is a direct relationship, as it is possible that a variable not taken 
into account in the partial correlation model is influential (De La Fuente et al., 2004). 
 
1.9.3 Biological Relationships Between Genes 
Two main types of relationship are studied using the methods described here: 
Functional relationships and regulatory relationships.  
 
Examples of functional relationships are studies in which functionally related genes 
are predicted based on the observation of co-ordinated expression followed by 
relation to functional annotation (e.g. (Fuller et al., 2007))  and analyses predicated on 
prior biological knowledge, such as gene set enrichment analysis (GSEA) (e.g. 
(Subramanian et al., 2005)). The use of such methods to elucidate pathways and 
networks has the potential to provide a level of insight into biological processes that 
is not visible at the level of individual genes (Wentzell et al., 2007). eQTL studies 
seeking to elucidate functional relationships typically focus on cis-eQTLs, as these 
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represent polymorphisms which affect local gene expression and are therefore less 
likely to represent regulatory effects than are trans-eQTLs (Petretto et al., 2006a), in 
which the genetic variation underlying the eQTL is in a different gene to that whose 
expression has been observed to vary. 
 
Investigations into regulatory relationships have been carried out using cis- and trans-
eQTLs. In some studies, the distinction is not made prior to the analysis of expression 
data, while in others cis- and trans-eQTLs are considered separately. In the latter (e.g. 
(Ghazalpour et al., 2006; Sun et al., 2007)), the observation of trans-eQTL clusters 
(hot-spots) perhaps under the control of a ‘master regulator’ (Yvert et al., 2003) can 
be incorporated into large-scale network analysis in aid of the prediction of regulatory 
relationships.   
 
Some studies combine elements of functional and regulatory investigations in pursuit 
of the elucidation of biological systems (e.g. (Lan et al., 2006)). The use of these 
methods to predict networks of genes acting on a complex trait such as obesity in 
rodents (Fuller et al., 2007; Lum et al., 2006) or flowering time in Arabidopsis 
(Keurentjes et al., 2007) has led to the testing of regulatory hypotheses and the 
characterisation of new pathways. It is anticipated that quantitative ‘systems’ (Hall, 
2004)  approaches to the understanding of complex traits like obesity and the 
metabolic syndrome will grow in importance as the sophistication of the analyses that 
are possible – both in terms of biology and in computational power – increases (Wu 
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et al., 2009).  
 
1.9.4 Gene Networks 
The construction of gene networks is often an intermediate stage in the elucidation of 
functional and/or regulatory relationships between genes. Networks consist of nodes, 
usually representing genes or proteins, linked by edges, indicating associations 
between the nodes (Sieberts and Schadt, 2007).  
 
Methods of network reconstruction used in the analysis of gene expression data range 
from relatively straightforward co-expression networks built on correlations (defined 
mathematically in a variety of ways) between expression profiles (e.g. (Schadt et al., 
2005; Zhang and Horvath, 2005)). In some cases, these analyses take into account the 
effects of linkage disequlibrium (Doss et al., 2005) and/or long-range allelic 
association (non-independence of genetic markers) (Cervino et al., 2005). More 
sophisticated methods of co-expression network modelling, such as the construction 
of Graphical Gaussian Models (GGM), use partial correlations to produce models that 
include only direct linear associations between nodes (Opgen-Rhein and Strimmer, 
2007).  
 
Networks that use gene expression data can be roughly divided into two groups: ‘a 
priori’ network analysis and ‘a posteriori’ (Hansen et al., 2008). The ‘a priori’ 
approach, exemplified by (Wentzell et al., 2007)’s study of glucosinolate biosynthetic 
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pathways in Arabidopsis, makes use of prior knowledge of biological relationships. 
The ‘a posteriori’ approach, of which the aforementioned GGM network inference 
methodology is an example, does not require prior biological information but begins 
with uninformed correlations. As such, ‘a posteriori’ methods have the potential to 
identify truly novel networks and processes – but are somewhat more sensitive to the 
assumptions made in their construction (Drake et al., 2006) and the interpretation of 
the findings – for instance the implications for the network of trans-eQTL clusters 
(‘hot-spots’) (Tu et al., 2006).   
 
Some studies have made use of still more complex mathematical models, such as 
Bayesian network reconstruction, a probabilistic method which provides the option of 
weighting of the expression profiles (Li et al., 2005; Zhu et al., 2004). This and other 
techniques enable factors related to the original linkage analysis (e.g. LOD score) 
and/or functional information to be made use of in the construction of the network. 
This increases the flexibility of the technique, but can also make the interpretation of 
the output more challenging. 
 
1.9.5 Modules 
Many integrated studies make use of the concept of ‘modules’ – groups of highly 
correlated genes identified following co-expression analysis (Ghazalpour et al., 
2006). The definition of a module used varies in its specifics from study to study, but 
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the aim is the same: to find groups of genes which relate to a common biological 
function and may combine to form pathways (Sieberts and Schadt, 2007).  
 
The study of the patterns of co-expression has subsequently been applied to the 
modules identified – often following network construction - to predict structures 
within these modules (Lum et al., 2006), allowing relationships between component 
genes to be inferred. A separate study (Sun et al., 2007) investigated expression 
profiles of cis- and trans-eQTLs forming modules to analyse the transcriptional 
regulation of the networks identified.  
 
These modules can related to physiology through the use of functional annotation 
methods such as Gene Ontology (GO) (2.6.1), e.g. (Lum et al., 2006). Although 
ontological analysis is not without its limitations (Khatri and Draghici, 2005), it 
remains a well-established and useful method of identification of functionally related 
genes in a large set, such as biological pathways from modules identified through ‘a 
posteriori’ network analysis (Ghazalpour et al., 2005).  
 
 
1.10 From eQTLs to Genes  
eQTL datasets have been generated in a wide range of different species, making use 
of various experimental designs (de Koning and Haley, 2005). One of the commonest 
motivations for generating eQTLs is to serve as a potential resource for gene 
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discovery and/or the investigation of interactions between genes, particularly in the 
study of complex traits (Drake et al., 2006). The aforementioned delineation of 
eQTLs into cis- and trans-regulated categories is a precursor to more function-
focused downstream analysis.  
 
Cis-eQTLs are assumed to arise as a consequence of genetic variation within a small 
region, specifically the genomic region containing the gene giving rise to the eQTL. 
Hence, somewhat more success has been achieved in the identification of genes 
underlying cis-eQTLs than in the study of trans-regulation which typically, 
necessarily focuses more on identifying pathways and interactions between genes (Tu 
et al., 2006). Candidate genes for disease traits have been prioritised and in some 
cases validated following the mapping of cis-eQTLs in many model organisms (e.g. 
(Brem et al., 2005; Meng et al., 2007; Petretto et al., 2008)) and in humans (Goring et 
al., 2007).  
 
1.10.1 Prioritisation of Candidate Genes 
The mapping of eQTLs in related populations (such as an intercross of inbred strains) 
that differ with regard to a complex trait provides an opportunity to scour the entire 
genome for expression variants that may relate to that trait.  
 
One way of doing so that we have made use of in our analysis is to make use of 
previously mapped (Hubner et al., 2005) and new (Petretto et al., 2008) physiological 
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QTLs (pQTLs) . Cis-eQTLs that coincide with pQTLs, as illustrated by the eQTL 
Explorer visualisation shown in Figure 1.4, are considered to be particularly strong 
candidates for the gene that underlies the pQTL and therefore directly influences the 
phenotypic component concerned (Doss et al., 2005; Flaherty et al., 2005).   
 
As can be observed in the illustrative figure (Figure 1.4), the pQTL intervals are often 
wide, encompassing many eQTLs and even more genes. The prioritisation of 
potential candidate genes can begin in silico, including through the use of functional 
analyses and comparative genomics (Wang et al., 2005), and by making use of 
higher-density SNP data to map QTLs with a substantially higher degree of precision 
(Cervino et al., 2005).  The development of these techniques and associated network 
resources, such as EnsEMBL (Hubbard et al., 2002), has the net effect of reducing the 
amount of laboratory work entailed in gene discovery and decreasing the total time it 
takes and money it costs to do so.  
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Figure 1.4: Cis-eQTLs, mapped to chromosome 17 in the RI panel in left ventricle, that are 
coincident with pQTLs for heart weight and kidney weight (Kw), as visualized by eQTL 
Explorer (Mueller et al., 2006)  
 
 
1.10.1.1 Quantitative Trait Transcripts 
Quantitative Trait Transcript (QTT) analysis, first described in (Passador-Gurgel et 
al., 2007), is a means of directly relating quantitative phenotypic variation with 
variation in gene expression across a population such as an RI panel using correlation 
analysis. Where the expression profiles of cis-eQTL transcripts are used in QTT 
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analysis, the method effectively combines conventional QTL mapping (as by 
definition their expression profiles correlate with the genotype of a local marker) with 
correlation of the expression and physiological traits. The QTT method is however 
not limited to cis-eQTLs and can be applied to any transcripts for which expression 
profiles have been generated in the same population as the quantitative physiological 
trait has been measured, as was performed in humans and described in (Emilsson et 
al., 2008).  
 
1.10.2 Validation of Candidate Genes 
Although computational genomic methods have revolutionised the prioritisation of 
candidate genes for complex traits, there is a limit to the level of evidence of gene 
function that can be gathered in silico. The gold standard for validation of genes 
hypothesized to underly QTLs remains to take place in the laboratory, using strategies 
such as transgenic expression of the candidate gene (e.g. (Meng et al., 2007; Schadt et 
al., 2005)) and/or gene knockouts (e.g. (Mehrabian et al., 2005; Petretto et al., 2008)) 
in combination with physiological and biochemical assessments. 
 
1.10.3 Moving from Model Organisms to Humans 
Applying genetical genomics in model organisms, particularly rodents, has enabled 
discoveries to be made that have directly contributed to our understanding of the 
biology of complex traits in humans, as well as that of the model organisms 
themselves. Comparative genomics and studies of homology, aided by resources such 
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as EnsEMBL’s Compara species comparison database (Flicek et al., 2008), facilitate 
the translation of rodent study outcomes to humans. The investigation of species 
concordance of QTLs (Wang et al., 2005) and identification of orthologous human 
genes to those whose functions have been investigated in rodents (Petretto et al., 
2008) have enabled genes underlying atherosclerosis and cardiac mass to be 
characterised. 
 
One of the most significant rationales for the continued use of animal models in 
biomedical research is, as discussed in 1.3, the relative ease (compared to working 
with human subjects) with which a wide variety of physiological traits can be 
characterised. Before physiological QTLs can be mapped, it is necessary to identify 
and quantify the phenotype concerned. Inbred and recombinant inbred strains 
facilitate this by providing a genetically homogeneous sample population, minimising 
individual variation and increasing statistical power to detect QTLs. They can also be 
kept in a much more controlled environment than can human subjects (although this 
is less of a problem with cell-lines, there are only some physiological traits that can 
be studied using cell-lines). This increases the reliability of the QTLs that are then 
generated.     
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1.11 Aims of This Work 
The eQTL dataset that has been used for this computational genetics study was 
generated in multiple tissues from the BXH/HXB panel of RI strains, the generation 
of which from SHR and BN is described in (Hubner et al., 2005; Petretto et al., 
2006b) and which provides a platform for the study of the genetic basis of the 
metabolic syndrome in the rat model organism. 
 
The availability for analysis of this dataset, along with extensive prior physiological 
characterisation of the RI panel, provides an opportunity to analyse in detail the 
relationships between expression traits, and between gene expression and 
physiological phenotypes. The ‘genetical genomics’ study design, integrating 
genetics and gene expression enables cis- and trans-eQTLs to be differentiated, and 
informed hypotheses relating to the processes underlying the observed expression 
variation to be generated. 
 
The prior mapping of pQTLs for a variety of phenotypic traits in the SHR and BN 
strain combination enabled functional analysis of the dataset to be performed. Further 
physiological measurements were obtained in the parental strains and in the RI strains 
during the course of this study, and these were used in combination with the eQTL 
data to generate more specific functional hypotheses. 
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The specific aims presented in this thesis are to: 
1. Verify the quality of the eQTL data in the RI strains that is the main material 
for the study described in the remainder of this thesis, including validation of 
the method used by the linkage software that mapped the eQTLs.  
2. Assess a statistical model that aims to predict potential ‘false cis-eQTLs’. 
3. Investigate the correlation structure of the eQTL dataset, and the relationship 
between pairwise co-expression of eQTLs and the genotypes at the eQTLs’ 
peaks of linkage in cis- and trans-eQTLs. 
4. Assess the consistency or otherwise of the relationships observed in Specific 
Aim 3 across the four tissues of study. 
5. Analyse the patterns of co-expression observed in trans-eQTL clusters (hot-
spots), thereby testing the hypothesis that clusters represent co-ordinately 
regulated groups of genes. 
6. Use computational methods to prioritise candidate ‘master regulators’ of 
trans-eQTL clusters, i.e. the cis-eQTLs in the vicinity of the cluster’s peak of 
linkage. 
7.  Perform quantitative trait transcript (QTT) analysis using physiological traits 
that have been measured in the RI strains, in order to generate hypotheses 
regarding the genetic basis of these traits. 
8. For one candidate gene in particular that was identified in part through QTT 
analysis, Ogn, perform further statistical analysis in the RI strains and on data 
from humans.  
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Chapter 2 describes the materials and methods that are used in the results chapters of 
the thesis (chapters 3-5), including the statistical approaches used. 
 
Chapter 3 describes quality control and statistical validation of the methods of 
linkage analysis used to generate the eQTL dataset in four tissues from the 
BXH/HXB RI panel. The investigations that resulted in the discovery and subsequent 
correction of a flaw in the software that was used for linkage analysis are outlined, as 
well as the implications for analysis and interpretation of eQTLs that were detected 
using this software. The assessment of a methodology for the detection of potentially 
spurious cis-eQTLs in the eQTL dataset using newly available SHR genome 
sequence data is described. 
 
Chapter 4 contains the details of a co-expression analysis that was performed in cis- 
and trans-eQTLs following quality control and filtering. Statistically significantly 
correlated pairs of eQTLs were studied in all four tissues. The genetic basis of co-
expression in trans-eQTL clusters was investigated, including testing for functional 
enrichment and reassessment of co-expression after taking into account the effects of 
genotype. 
 
Chapter 5 describes the QTT analysis that was performed using physiological traits 
for which measurements were obtained in each of the RI strains. This entails the 
correlation of expression traits with physiological traits. The process and outcome of 
the QTT analysis of one trait, augmented by the incorporation of related analyses, that 
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contributed to the results of a major publication are described. The outcomes of the 
application of the described methods to other traits are summarised. A QTT analysis 
performed in a human dataset is described. 
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Chapter 2:  Materials and Methods 
 
2.1 The eQTL Dataset 
The eQTL dataset that formed the basis for this computational and statistical study 
was generated prior to the commencement of this thesis by Tim Aitman (MRC 
Clinical Sciences Centre, London; fat tissue) Norbert Hubner (Max-Delbruck-Center, 
Berlin; kidney and adrenal tissues) and Stuart Cook (MRC Clinical Sciences Centre, 
London; left ventricle) The process that was undertaken in each case is outlined 
below.  
 
2.1.1 Generation of the Recombinant Inbred Strains 
The derivation of the RI strains is as described in (Hubner et al., 2005; Pravenec et 
al., 1989). Thirty-six RI strains were bred by systematic inbreeding and sibling 
mating for at least 20 generations (Pravenec, 1996) from the initial cross of 
BN.Lx/Cub and SHR/Ola inbred parental strains by Michal Pravenec and Vladimir 
Kren at the Czech Academy of Sciences in Prague. Of these 36 strains, four went 
extinct, two were not available for generation of eQTL data, and one was 
subsequently removed from the analysis due to loss of homozygosity, possibly due to 
breeding error. The remaining 29 were used in downstream analysis.   
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2.1.2 Generation of the eQTL Dataset 
The eQTL dataset consists of thousands of expression traits that have been measured 
in the RI strains and mapped to the genome by linkage analysis and been found to be 
statistically significant following correction for multiple testing. The procedures that 
were undertaken to generate the dataset were undertaken prior to the commencement 
of this thesis, and are described in detail in (Hubner et al., 2005) and (Petretto et al., 
2006a). They are summarized in 2.1.2.1-2.1.2.3.  
 
2.1.2.1 Microarray Expression Profiling 
Measurements of mRNA abundance were obtained in four tissues (fat, kidney, 
adrenal and left ventricle), as described in (Hubner et al., 2005) from four biological 
replicates in each of the original 30 RI strains by microarray (as discussed above, one 
strain was subsequently removed from the analysis). Each of the 120 microarrays 
used for each tissue experiment (4 replicates × 30 RI strains) was processed and 
normalized separately (Petretto et al., 2006a). Outliers were removed using the 
Nalimov outlier test (p < 0.001), and the raw values averaged across the four 
biological replicates in each strain using the Robust Multichip Average (RMA) 
algorithm to give expression summary values. The expression value used in 
downstream analysis is the anti-log of the RMA output values (Hubner et al., 2005). 
For the fat, kidney and adrenal tissues RAE 230A Affymetrix GeneChips, which 
assess the expression levels of 15,923 transcripts across the genome, were used. For 
left ventricle Rat230_2 Affymetrix GeneChips, which assess the expression levels of 
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31,099 transcripts, were used.  
 
2.1.2.2 Marker Genotyping 
1,011 autosomal microsatellite markers were used in the construction of the genetic 
linkage map used in the subsequent generation of the eQTL dataset. The construction 
of the linkage map in the BXH/HXB RI strain panel was as described in (Jirout et al., 
2003; Pravenec, 1996). To summarize, DNA was obtained from each strain, and 
genotyping was achieved by PCR analysis and/or Southern blotting (Pravenec, 1996).     
 
2.1.2.3 Linkage Analysis 
eQTLs represent regions of the genome that are linked to an expression trait. The 
marker map was constructed using MapMaker (Lincoln et al., 1993), incorporating 
input from Ensembl (Hubbard et al., 2002) and BLASTN alignment in order to 
position the genotyped markers as accurately as possible on the genetic map. 
Following the construction of the map, the genome-wide linkage analysis of 
expression traits was performed using QTL Reaper (Manly, 2006). This software, 
whose analysis is based on that implemented in the earlier Map Manager QTX 
system, also by Ken Manly (Manly et al., 2001) assesses linkage between each 
expression trait and each marker by regression, finding a likelihood ratio statistic 
(LRS) for each probeset-marker combination. The genome-wide statistical 
significance was found empirically by permutation as described in (Hubner et al., 
2005). Quoted p-values of eQTL significance are empirical p-values obtained by 
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comparing the LRS score with the distribution of at least 1,000 null (permuted) LRS 
scores for that probeset-marker combination. 
 
2.1.3 The eQTL Database 
The eQTL data, including probeset and linkage mapping information, eQTL statistics 
(e.g. LOD score and heritability), probeset expression, and marker genotype data was 
stored in a MySQL database, held on the Codon server maintained by the Imperial 
College Centre for Bioinformatics. eQTL Explorer (Mueller et al., 2006) was used to 
produce visual representations of the cis- and trans-eQTL data held in the MySQL 
database. 
 
2.1.4 Interpretation of eQTL Data 
A variety of data indirectly related to the eQTL mapping process summarized in 2.1 
was recorded in the eQTL database and is used to inform downstream analysis of the 
data therein: 
 
2.1.4.1 Fold Change 
The term ‘fold change’ refers to a ratio in transcript abundance (such as measured by 
a microarray) between two populations. Fold change between the parental strains was 
found for each probeset by dividing the average expression across the biological 
replicates in SHR with that in BN. The fold change can be used as an indicator of the 
size of the eQTL effect (Petretto et al., 2006a). 
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2.1.4.2 Heritability Analysis 
Heritability (h
2
) refers to the proportion of the total variance in a population that can 
be attributed to genetic factors, as opposed to environmental factors (Visscher et al., 
2008). In the RI strains, the measure of heritability (h
2
trait) was found for each 
probeset as described in (Petretto et al., 2006a) using the following formula: 
 
Where VA represents the variance of the mean expression levels across the strains, 
and VR represents the mean of the variances within each strain. 
 
 
2.2 Validation of Data 
A wide variety of factors must be taken into consideration in order to achieve 
meaningful outcomes from the downstream analysis of an eQTL dataset (Kendziorski 
and Wang, 2006). Some validation of the biological and computational components 
of the dataset and its construction, including quality control of the microarray gene 
expression data (described in (Hubner et al., 2005)) and accounting for multiple 
testing of the eQTLs by calculating the False Discovery Rate (described in (Petretto 
et al., 2006a)), was carried out prior to the commencement of this thesis. Methods 
used in the computational validation and filtering of the eQTL dataset discussed in 
Chapter 3 (3.1) are described in more detail in this section. 
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2.2.1 Validation of the eQTL Mapping 
The methods described below were used to validate the eQTL mapping through 
comparison of the output of QTL Reaper with those of other methods. The structure 
of the data is described in more detail in order that the methods used and the 
motivations for doing so can be explained as clearly as possible. 
 
2.2.1.1 Statistical Methods of Comparative Linkage Analysis 
The validation of the QTL Reaper output was carried out by comparison with two 
other methods of linkage analysis: Map Manager QTXb – a software package by the 
same authors as QTL Reaper (Manly et al., 2001), and an implementation of the 
Mann-Whitney-Wilcoxon two-sample test. 
 
Map Manager QTXb is used to map gene expression to a marker map. It enables a 
wide variety of analysis methods and assessments of statistical significance to be used 
to map QTLs. However it lacks the functionality to perform a batch analysis, meaning 
that full-scale validation of QTL Reaper findings using this software was impractical. 
 
A pointwise linkage analysis method was developed using Perl and R. This enabled a 
measures of linkage for each probeset-marker combination to be quickly and 
efficiently obtained, with minimal complications. This method applies the Mann-
Whitney-Wilcoxon test and provides a nominal, indicative p-value for each 
combination.  
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2.2.1.2 The Mann-Whitney-Wilcoxon Test 
The Mann-Whitney-Wilcoxon test, sometimes referred to as the Mann-Whitney U 
test or Wilcoxon rank-sum test, is a non-parametric equivalent of the two-sample t-
test. It is an established independent test of linkage of transcript expression levels to 
genetic markers (e.g. (Yvert et al., 2003)). A test statistic (U) is found by ordering the 
expression levels, then comparing their rank sums corresponding to each of the two 
groups n1 and n2 where R1 is the sum of the ranks of the expression levels in group 1. 
The formula used to obtain U is given below: 
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In the analysis described in 3.1, the Mann-Whitney-Wilcoxon test is used to compare 
the expression levels for each of the two groups corresponding to the SHR and BN 
genotype across the 29 RI strains. The R implementation wilcox.test was used for this 
analysis. 
 
2.2.2 Validation of Probeset Annotations 
The accuracy of the mapping of microarray probesets to the genome is critical to the 
analysis of the eQTL dataset that is described in chapters 4 and 5. The annotations 
provided by Affymetrix were compared to the alignment of the sequence with the 
EnsEMBL (Hubbard et al., 2002) assembly. The software used to do this was 
developed in-house, led by Nicholas Dickens and Jonathan Mangion (then of MRC 
Clinical Sciences Centre), and is called SCAMPA (Systematic Categorisation of 
Affymetrix Microarray Probeset Annotations) (Dickens, 2006). 
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2.2.2.1 SCAMPA 
SCAMPA is a Perl pipeline that categorises probesets on the basis of two criteria: 
The consistency of the alignment of the probeset sequence provided by Affymetrix to 
the genome in EnsEMBL, and the consistency of the gene annotation of the probeset 
between the Affymetrix and EnsEMBL. The probesetes were categorised by 
alignment into tiers:  
1) All probes map to the same region of the genome 
2) A minority of the probes map to a different region of the genome to the rest 
3) Probes map to multiple genomic locations 
4) The majority of the probes do not map to the genome at all 
 
The annotation categories, from A to E, indicate the degree of agreement between the 
Affymetrix and EnsEMBL annotations.   
 
2.2.3 Filtering of the eQTL Dataset 
Only probesets found to map consistently to the genome (i.e. those in SCAMPA tiers 
1 and 2) were used in the analyses described in chapters 4 and 5. Probesets that did 
not meet this criterion, had missing expression data or for which the SDP of the 
marker at the peak of linkage had more than 10 missing genotypes were removed 
from the analysis (Table 3.2). Reannotation of these probesets was not attempted for 
reasons of time. 
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2.3 Detecting Polymorphisms in Probe Binding Regions 
The measurements provided by using a microarray such as an Affymetrix GeneChip 
to study gene expression are produced by quantifying the hybridisation of 
oligonucleotide probes on the chip with mRNA in samples of each tissue. The 
underlying assumption is that the level of hybridisation is representative of the 
quantity of mRNA present. However, it has been shown that probe signals can vary 
as a consequence of polymorphisms (e.g. SNPs) in the regions of the transcribed 
target gene that bind to the probe, resulting in a misleading indication of differential 
expression between the sample populations (Alberts et al., 2007a). Methods used in 
the study of polymorphisms in probe binding regions discussed in Chapter 3 (3.2 and 
3.3) are described in more detail in this section. It should be noted that the findings of 
this study were not used to filter the sets of eQTLs used in chapters 4 and 5. 
 
2.3.1 Sequencing of SHR Genome 
The SHR genome was sequenced by Santosh Atanur and collaborators (the SHR 
Genome Sequencing Consortium) using massively parallel sequencing technology 
from Illumina/Solexa (Atanur et al., 2010); the sequencing methodology is as applied 
in (Bentley et al., 2008). At the time of commencement of the analysis described in 
this thesis, sequencing provided 4.5X coverage of the SHR genome. 
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2.3.2 Identification of SNPs in Regions of Interest 
SHR sequence data was related to the EnsEMBL (Flicek et al., 2008) BN reference 
sequence by Santosh Atanur using MAQ, a freely available software package for 
building mapping assemblies (http://maq.sourceforge.net/). 2.3 million SNPs were 
identified between SHR and BN in this way. On validation by capillary sequencing, 
96% of a sample of predicted SNPs were confirmed and the false positive rate of SNP 
prediction was found to be less than 1%.   
 
Affymetrix probes were mapped to the SHR genome in collaboration with Santosh 
Atanur and Liqun He using RMAP v0.2 (http://rulai.cshl.edu/rmap/), an R package 
which maps sequencing reads to their genomic location. Probesets in which all of the 
probes mapped consecutively to the same chromosome were used in the analysis 
described in 3.3. Probesets whose probes mapped to the genome with more than 2 
mismatches or mapped to multiple locations on the genome were not used in this 
analysis. 
 
2.3.3 AffyGG 
AffyGG is a computational method of predicting cis-eQTLs that occur due to 
polymorphisms in the probe binding region and are therefore not indicative of 
variation in gene expression (Gilad et al., 2005), sometimes referred to as potential 
false cis-eQTLs (Alberts et al., 2007b). It was developed by Rudi Alberts, Gonzalo 
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Vera and Ritsert Jansen. The method, implemented in an R package, is based on 
comparing the signals from individual probes with those across the whole probeset 
(Alberts et al., 2008).  
 
AffyGG’s probeElimination procedure works by combining individual probe signals 
and genotype data in an ANOVA-based statistical ‘multiprobe’ model (Alberts et al., 
2005) to identify probes within the probeset having a disproportionate effect on the 
QTL linkage. The probe having the greatest such effect (referred to as the ‘probe by 
QTL’ effect) is eliminated from the probeset (‘dropped’) in an iterative fashion. 
AffyGG repeats this process until 9 of the 11 probes have been ‘dropped’. 
 
The principle underlying the AffyGG methodology is that because ‘false cis-eQTLs’ 
are caused by polymorphisms in the probe binding regions of one or more of the 
probes in the probeset, the discounting of these probes will cause the QTL effect to 
evaporate. However, it has not previously been possible to objectively assess whether 
or not the probes that are eliminated by AffyGG do in fact have polymorphisms in 
their probe binding regions, and the outputs produced by the AffyGG 
probeElimination procedure are therefore subject to interpretation. 
 
2.3.4 Support Vector Machine (SVM) 
The Support Vector Machine is a flexible binary classification method that applies a 
‘support vector’, which is not necessarily linear, to achieve optimal categorisation 
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(Cortes and Vapnik, 1995). The R implementation svm contained within package 
e1071 (Karatzoglou et al., 2006) was used with the linear kernel in the analysis 
described in 3.3.2, in order to discriminate between two groups of cis-eQTL 
transcripts that had previously been identified (Figure 3.6) as displaying an 
approximately linear relationship with respect to two variables.  
 
 
2.4  Co-expression Analysis 
Methods used in the co-expression analysis of eQTLs that was performed in the sets 
of cis-eQTLs, trans-eQTLs and in trans-eQTL clusters in all four tissues in the eQTL 
dataset and is described in Chapter 4 are described in more detail in this section..  
 
2.4.1 Correlation Methods 
Correlation analysis provides a means of quantifying the strength of the linear 
relationship between two variables. In statistical genetics, correlation-based methods 
are widely applied to investigate possible relationships between genetic and 
phenotypic traits.  
 
2.4.1.1 Pearson Correlation 
The Pearson correlation coefficient (r) – sometimes referred to as the product 
moment correlation coefficient – is calculated in order to quantify the linear 
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relationship between two sets of paired variables x and y, such as a pair of expression 
profiles obtained from the same panel of RI strains, by the formula:  
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The Pearson correlation coefficient can range from -1 to 1, where -1 indicates the 
maximum possible negative linear relationship between the variables, 0 indicates no 
linear relationship, and 1 indicates the maximum possible positive linear relationship. 
The significance of this relationship can be assessed by application of a z-test to the 
coefficient given the sample size, or (as was done in the work described here) 
empirically by permutation. The implementation of Pearson correlation contained 
within MatLab function corrcoef was used in the co-expression and QTT analyses 
described in chapters 4 and 5 of this thesis. 
 
2.4.1.2 Point Biserial Correlation 
Point biserial correlation is a method of quantifying the linear relationship between a 
continuous and a dichotomous (binary) variable, such as an expression profile and a 
set of homozygous genotypes. The point biserial correlation coefficient rpb is a special 
case of the Pearson correlation coefficient (Kline, 2004), and is found by applying the 
following formula, where X is the continuous variable, Y is the dichotomous variable, 
and π is the proportion of values where Y=1: 
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The implementation of point biserial correlation biserial.cor contained within the R 
package ltm was used to obtain coefficients for use in the partial correlation analysis 
(2.4.5) described in 4.2.3. 
 
2.4.2 Genome-wide Correlation of Gene Expression Levels 
The application of Pearson correlation to test for linear relationships between the 
transcript expression profiles of all pairs of distinct cis-eQTL and trans-eQTL 
transcripts was carried out using a pipeline developed in Perl and MatLab. The Perl 
elements of the pipeline utilise the standard DBI module to obtain data from the 
eQTL database, and filter for SCAMPA mapping tier as described in 2.2.3.  
 
MatLab was used to carry out the pairwise Pearson correlation of probeset expression 
levels and perform the permutation analysis required to generate the empirical p-
value for the correlation of each pair. The methodology used for the permutation 
analysis is outlined in 2.5.3.  
 
2.4.3 Assessment of the Similarity of Genotypes 
It was considered that the relationships between eQTLs identified through co-
expression analysis are at least in part a consequence of relationships between the 
underlying genotypes. To assess this, correlation of the genotype data was performed 
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for each pair of co-expressed eQTLs. This was carried out using a simple matching 
coefficient method implemented in Perl. For a pair of SDPs, a ‘match’ (i.e. a given 
strain having the same genotype in SDP 1 as in SDP 2) was scored as 1, a ‘mis-
match’ was scored as 0, and the total across the 29 strains was output as the matching 
coefficient. Missing genotypes were disregarded, since it would not be possible to 
differentiate a ‘match’ from a ‘mismatch’ in strains in which one of the two 
genotypes being compared was not available. The empirical p-value for the observed 
number of matches, given the number of genotypes in the SDPs being compared 
(excluding any strain in which there was a missing genotype in either SDP) is 
assessed as described in 2.5.4. 
 
2.4.4 Distance Analysis of Candidate Regulators of trans-eQTL clusters 
The trans-eQTL clusters observed in the eQTL dataset were found to be co-expressed 
and predicted to arise as a result of co-regulation by a regulatory gene at or near the 
peak of linkage of the cluster. 
 
The cis-eQTLs in the ‘window region’ of the peak of linkage, conservatively defined 
as 50Mb either side of the peak in order to account for inaccuracies in mapping due to 
linkage disequilibrium, were tested for correlation with the cluster using the same 
method as was used for the global co-expression analysis. 
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Genetic distance (cM) was incorporated into this analysis as a covariate. For each 
cluster, the genetic distance between the peak of linkage and each of the cis-eQTLs in 
the window region was found. This distance was plotted against the averaged 
absolute correlation coefficients of the expression profile of each of the cis-eQTL 
transcripts with each of the eQTLs making up the trans-eQTL cluster. Simple linear 
regression of the distance against the averaged absolute correlation coefficient was 
then performed on the data in SPSS. An R
2
 value, which gives the proportion of the 
total variance between the two variables that is explained by the regression model, 
was found: 
squares of sum total
squares of sum regression2 R  
The analysis as described was also performed using all probesets mapping to the 
conservative window region (as opposed to just cis-eQTLs). 
 
2.4.5 Partial Correlation Analysis 
First order partial correlation analysis is used to find the correlation of two variables x 
and y after the effect of a third variable z has been taken into account. The method 
implemented is as described in (Mozhui et al., 2008) and was performed by finding 
the partial correlation coefficient rxy.z in the formula given below: 
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In the above partial correlation formula, as applied to a pair of expression profiles 
within a trans-eQTL cluster,  rxy is the Pearson correlation coefficient (2.4.1.1) of the 
expression profiles and rxz & ryz are the point biserial correlation coefficients (2.4.1.2) 
of each expression profile with the SDP of the marker at the cluster’s peak of linkage. 
 
A two-tailed t-test was used to assess the significance of each pairwise partial 
correlation coefficient conditioned on the genotype at the peak of linkage of the 
trans-eQTL cluster. t, with n-2-k degrees of freedom was found using the following 
formula.  
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In this formula, r is the partial correlation coefficient, k is the number of conditioning 
variables (in first order partial correlation analysis, k = 1), and n is the number of data 
points (here, n is the number of RI strains with genotype data in the SDP of the 
marker at the trans-eQTL cluster’s peak of linkage). Where n = 29 (i.e. no missing 
genotypes in the SDP), the two-tailed t-test is performed with 26 degrees of freedom. 
The significance threshold corresponding to the relevant number of degrees of 
freedom was then found using a lookup table. 
 
 
 2.5  Assessment of Statistical Significance 
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The methods used to assess the statistical significance of the findings of the co-
expression and genotype correlation analyses described in the previous section, 
including methods used to correct for multiple testing, are outlined in this section. 
Their application to the datasets produced by the correlation analyses is described. 
 
 
2.5.1 Permutation Testing 
Permutation testing is a method of finding a threshold of statistical significance of 
QTL linkage by randomly shuffling the trait values a large number of times and 
comparing the observed data to the null data (Churchill and Doerge, 1994). It enables 
an empirical p-value for the significance of an observation that inherently takes into 
account the distribution of the traits to be found, rather than a p-value, subject to 
assumptions, being estimated on the basis of a statistical model. The method by 
which permutation testing was applied in the co-expression analysis is outlined in 
2.5.3. 
 
2.5.2 Multiple Testing Correction Methods 
The genome-wide analyses described here involve the simultaneous testing of 
hundreds of thousands of hypotheses. The application of standard tests, such as 
Pearson correlation, in such a way results in the prediction of large numbers of false 
positive findings (Manly et al., 2004). This is accounted for in statistically sound 
studies by the application of a multiple testing correction method. 
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Multiple testing correction methods used in genome-wide studies typically control 
either the familywise error rate (FWER) – using methods such as the Bonferroni 
correction – or the false discovery rate (FDR). The FWER-controlling methods, 
which control for the probability of making one or more false discoveries for a given 
trait, have been found to be overly conservative for genome-wide studies, causing 
variants having all but the most extreme effect sizes to go undetected (Benjamini and 
Yekutieli, 2005; Kendziorski and Wang, 2006), so FDR-controlling methods are 
generally preferred (Manly et al., 2004). 
 
2.5.2.1 The False Discovery Rate (FDR) 
The FDR was originally described in (Benjamini and Hochberg, 1995) as “the 
proportion of the rejected null hypotheses that are erroneously rejected”, i.e. the 
proportion of false positives among all features called significant.  
 
The Benjamini-Hochberg procedure, a step-down method described in the 1995 
paper, was the first devised to control for FDR. An empirical Bayesian equivalent to 
the Benjamini-Hochberg was described by (Efron and Tibshirani, 2002). 
 
An adjustment to the approach to controlling for FDR described by Benjamini & 
Hochberg was proposed by John Storey (Storey, 2002). This method, along with 
others proposed around the same time (Manly et al., 2004), differ from that of 
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Benjamini & Hochberg in that they make use of a method of estimating the 
proportion of true null hypotheses (often referred to  as π0 or m0).  
 
The method described in full in (Storey, 2003a) and implemented in the Q-value 
procedure makes use of a concept called the positive False Discovery Rate (pFDR), 
which is conditioned on at least one positive finding having occurred. This procedure 
for controlling the FDR, which estimates π0 from the distribution of the p-values has 
been shown to give substantially greater power to reject the null hypothesis when it is 
false when the proportion of true alternative hypotheses is high (Manly et al., 2004). 
 
2.5.2.2 The Q-value Method 
The q-value procedure provides a significance threshold that corresponds to the 
proportion of significant features that turn out to be false positives (Storey and 
Tibshirani, 2003). If the assumptions implicit to the methodology, e.g. that p-values 
will be approximately evenly distributed from 0 to 1 (Xiao, 2004), are taken into 
account then Q-value is a robust and straightforward approach to multiple testing 
correction. It is particularly suited to genome-wide studies as, although all FDR-
based methods use a working assumption of independence of the underlying variables 
(Storey, 2002), it been shown to be conservative under ‘weak dependence’ of the 
considered features (Petretto et al., 2006b). ‘Weak dependence’ occurs when the 
number of correlated features is small relative to the total number of queried features 
(Pounds, 2006). Small groups of genes that behave nonrandomly (e.g. trans-eQTL 
clusters) can be considered to fit into this category (Petretto et al., 2006b). Software 
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used to implement this method, QVALUE, is available as a stand-alone package 
(Storey, 2003b) or as an R package from CRAN (Comprehensive R Archive 
Network) (Dabney and Storey, 2008) 
 
 
 
2.5.3 Assessment of statistical significance in co-expression analysis 
An implementation of the permutation method described by (Churchill and Doerge, 
1994) was used to determine the significance of all Pearson correlation coefficients of 
pairs of expression profiles in co-expression analysis, and also in QTT analysis (2.7). 
The MatLab script used to implement this method, along with sample input files, are 
provided in Appendix I.  
 
Briefly: Pearson correlation was performed, within a matrix, of all pairs of interest 
(e.g. all cis-eQTLs in a tissue), using MatLab’s corrcoef function. Following this, for 
each of the pairs, 10,000 ‘null’ co-expression matrices were generated by repeatedly 
performing Pearson correlation, again using corrcoef, after the expression traits were 
randomly shuffled across the RI strains. Following this, for each pair the observed 
correlation coefficient was ranked among the null correlation coefficients. A matrix 
of actual correlation coefficients, referred to henceforth as the ‘observed matrix’ is 
constructed, whose dimensions correspond to the number of eQTLs under analysis. A 
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matrix of nominal p-values is also created by the MatLab script, but these were not 
used in further analysis.  
 
Following the construction of the ‘observed matrix’ of correlation coefficients, the 
correlation analysis is repeated many times with the expression measurements having 
been shuffled across the strains, to generate a set of ‘null’ matrices of correlation 
coefficients.The empirical pairwise p-value corresponding to a Pearson correlation 
coefficient corresponds to the ranking of the observed correlation coefficient as 
follows: 
 
Thus, a ranking of 500
th
 among the 10,000 (actually 10,001, but for simplicity’s sake 
10,000 was used in calculating the empirical p-values by this method) would 
correspond to an empirical p-value of 0.05.  
 
In order to correct for multiple testing across the genome and threshold the p-values 
obtained as above in a manner that takes into account the multiple testing across the 
genome, an FDR-based multiple testing correction, the QVALUE method (2.5.2.2) 
(Storey and Tibshirani, 2003), was applied to these empirical p-values. A q-value 
threshold of q = 0.05 was used in this analysis.  
 
2.5.4 Assessment of statistical significance in correlation of genotypes 
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Significant correlation or anti-correlation of genotypes was defined on the basis of a 
probability table (Appendix II), in the construction of which the probability of each 
possible coefficient occurring by chance was calculated. The significance of a 
matching coefficient is dependent on the number of matches that have been tested 
(i.e. the greater of the two numbers of missing genotypes in the two SDPs being 
correlated). Significance of correlation and/or anti-correlation was defined as a two-
tailed empirical probability of p<0.1. 
 
2.5.5 Assessment of statistical power of co-expression analysis 
The statistical power and precision of the co-expression analysis were assessed for 
cis- and trans-eQTLs in the four tissues using the tests for power and confidence 
interval (CI) of correlation implemented in PASS (Power And Sample Size) 2008. 
Full descriptions of the test procedures used are given in 
http://www.ncss.com/pdf/manuals/PASSUG3.pdf, chapters 800 and 801 respectively; 
the methods are summarised below: 
 
2.5.5.1 Power Calculations for Co-expression Analysis 
The statistical power (1.8.3) of a correlation analysis can be found by the formula 
given below, where r is the sample correlation coefficient; R(r|n,ρ) is the area under 
the correlation density curve to the left of r, N is the sample size, ρ is the population 
correlation, and α is the significance level for one correlation.  
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The power of the significance test ρ1 > ρ0 is given by first solving: 
  ),|(1 0NrR  
Followed by computing the power (1-β): 
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In the analysis using this method that is presented in 4.2.1, the sample correlation 
coefficient used for the power and CI analyses was chosen to be approximately 
equivalent to the threshold q = 0.05 for each co-expression analysis. The significance 
level for one correlation α = 0.05 was used. 
 
The confidence interval (CI) is an interval defined, based on a specified probability α, 
sample size and sample correlation coefficient, such that the population correlation 
coefficient will occur within the interval 1-α% of the time. Where α=0.05, the 
proportion of intervals that will include the true population coefficient is 95%. 
 
 
2.6 Functional Analysis of Co-expressed or Co-incident Genes 
Computational analyses were performed on sets of transcripts that the co-expression 
analysis described in chapter 4 found to be related by expression correlation and 
colocalisation, in order to investigate the possibility of functional relatedness among 
these transcripts.  
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2.6.1 Gene Ontology (GO) 
The Gene Ontology is a system of annotation, which facilitates the analysis of genes 
by providing a controlled vocabulary, meaning that related genes can easily be 
identified by a computer program through the presence of shared ‘GO terms’ 
(Ashburner et al., 2000).  
 
The GO is divided into three categories: Biological Process, which describes the 
biological objective to which the gene contributes (e.g. ‘transport’); Molecular 
Function, which describes the biochemical activity to which the gene contributes (e.g. 
‘aminomethyltransferase activity’; and Cellular Component, which describes the 
cellular location in which the gene is active (e.g. ‘nuclear membrane’). Not all GO 
annotated genes have annotations for all three categories. 
 
The ontology takes the form of a directed acyclic graph (DAG), which relates terms 
of different degrees of specificity, linking ‘low-level’ (more general) to high-level 
(more specific) terms. Annotation to a specific term implies annotation to all of the 
‘parent’, more general terms (Lewin and Grieve, 2006).   
 
2.6.2 DAVID 
DAVID (Database for Annotation, Visualization and Integrated Discovery) is a web-
based tool for functional annotation of gene/protein sets that makes use of Gene 
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Ontology annotations as well as providing options of taking into account other forms 
of functional information such as protein and pathway annotation (Dennis et al., 
2003).  
 
In this project, DAVID was used to assess functional enrichment in trans-eQTL 
clusters by testing for statistically over-represented GO terms, using the DAVID 
Gene Functional Classification Tool (Huang et al., 2007). This tool tests for 
functional enrichment of a list of gene identifiers (Affymetrix probeset identifiers 
were used in the analysis presented in 4.2.4) relative to a background gene set (the 
DAVID Rattus norvegicus population background set was used in the analysis). 
Enrichment is quantified by the Expression Analysis Systematic Explorer (EASE) 
score (Hosack et al., 2003). This is found by the Functional Classification Tool by 
applying a conservative modification to the Fisher’s Exact Test score following the 
comparison, within a 2x2 contingency table, of the proportion of genes in the 
supplied list annotated with a given GO term against the population background set 
(http://david.abcc.ncifcrf.gov/helps/functional_annotation.html#E3).  
 
2.6.3 The Kolmogorov-Smirnov (K-S) Test 
The two-sample Kolmogorov-Smirnov (K-S) test is a non-parametric test of the 
hypothesis that two samples are drawn from the same distribution. The K-S test 
statistic D is found by computing the difference between the two sample distribution 
functions Fn2(x) and Fn2(x) as per the below formula (Young, 1977): 
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In 4.2.4, this method was used to compare levels of functional enrichment found in 
15 large trans-eQTL clusters with those found in random groups of trans-eQTL 
genes. The SPSS v14 implementation of the two-sample Kolmogorov-Smirnov test, 
which computes an exact p-value, was used for this analysis. 
 
2.7  Quantitative Trait Transcript (QTT) analysis 
As described in chapter 5, QTT analysis was performed in order to test for 
correlations between physiological trait measurements in the RI strains and 
expression traits that have been mapped to the genome. This can be carried out by 
genome-wide correlation analysis, similarly to that performed for pairs of eQTLs and 
described in 2.4.2. Specifically, for each physiological trait of interest, the 
measurements of the expression of genes underlying each cis-eQTL were correlated 
with the set of trait measurements by Pearson correlation, and p-values for each 
combination of trait and cis-eQTL transcript expression profile were found using the 
permutation method used for co-expression analysis described in 2.5.3 and 
implemented in MatLab (Petretto et al., 2008). 
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Chapter 3: Validation and Exploration of a Large Biological 
Dataset 
The analyses described in Chapters 4 and 5 are dependent on the integrity of the 
BXH/HXB eQTL dataset. The validation and filtering of the dataset described in 3.1 
was carried out prior to the commencement of the genome-wide co-expression and 
quantitative trait transcript studies described in chapters 4 and 5. The work described 
in 3.2 and 3.3 was exploratory and not used to filter the eQTL dataset. 
 
 
3.1 Validation of eQTL Data 
 
3.1.1 Introduction  
The eQTL dataset was generated in each of the four tissues using 1,011 microsatellite 
markers. In fat, kidney and adrenal, 15,923 probesets were analysed. In left ventricle, 
31,099 probesets were analysed through the use of a more advanced GeneChip 
(2.1.2.1). The set of eQTLs used in downstream analysis is delineated in Table 3.1. 
These, totalling 8,269 eQTLs across all four tissues, were identified at a genome-wide 
significance of p < 0.05 from a total of 16,098,153 possible significant linkages 
(eQTL) in fat, kidney and adrenal and 31,441,089 in left ventricle. At this level of 
significance, the tissue-specific expected FDR for cis-eQTLs is 4–8%, and the tissue-
specific expected FDR for trans-eQTLs is 26-35% (Petretto et al., 2006a). 
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Table 3.1: Expression QTLs identified in each of the 4 rat tissues at genome-wide p<0.05 
 
The size and nature of this dataset makes its analysis statistically challenging. Manual 
curation of a dataset this large is impossible, which means that computational 
analysis is essential not only to interpret and analyse the dataset, but also to ensure 
that the quality of the data is robust enough to enable hypothesis generation. This was 
achieved through the application of a series of filters and verification procedures to 
the gene expression and linkage data. 
 
The linkage analysis was carried out using QTL Reaper, a software package 
developed by Ken Manly of the University of Tennessee (Manly, 2006). Michelle 
Johnson, a colleague in the Physiological Genomics & Medicine group, observed that 
some of the linkages identified by QTL Reaper could not be replicated by 
MapManager QTX, a software program that uses a similar method to perform linkage 
analysis.  
 
A sample outcome from the initial comparative linkage analysis using QTL Reaper 
and MapManager QTX, is provided in Figure 3.1. Some probesets showed good 
Tissue No. of cis-eQTLs No. of trans-eQTLs 
Fat 558 923 
Kidney 718 1,033 
Adrenal 602 933 
Left Ventricle (LV) 1,362 2,140 
Total 3,240 5,029 
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concordance in LOD scores between the outputs of the two methods, as in a), while 
others showed poor concordance; specifically, a high LOD score was generated by 
QTL Reaper but no such linkage was predicted by MapManager. An example of such 
a probeset is shown in b). This probeset 1375894_at, along with several others like it, 
was included in the dataset at that time as a significant eQTL because of this spurious 
QTL Reaper finding of ‘linkage’.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
95 
 
a) 
 
b) 
 
Figure 3.1: Corroboration of eQTL Reaper and MapManager QTX LOD scores on 
Chromosome 1 for a) an eQTL linked to a marker with no missing genotype data in its SDP 
and b) an eQTL linked to a marker with missing genotype data in its SDP. 
The data for this figure was provided by Michelle Johnson, and it is included for illustrative purposes 
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I followed up the observation illustrated in Figure 3.1 by commencing a full-scale 
review of the eQTL data and the generation of a new dataset, the current set, which is 
used in all of the statistical analyses described in Chapters 4 & 5.   
 
Separately from the verification of linkage analysis outcomes, study has been 
undertaken of the accuracy of the probeset annotations. This involved the application 
of a technique, SCAMPA (2.2.2.1) developed by a colleague, Nicholas Dickens, to 
test the concordance of the mapping of the probesets against EnsEMBL annotations. 
This was used after linkage analysis, to filter the eQTLs identified by the re-run 
linkage analysis. The results of this filtering are shown in Table 3.2. 
 
Table 3.2: Outcome of filtering of eQTLs by SCAMPA ‘tier’ classification based on EnsEMBL 
mapping. 
SCAMPA tiers 3 and 4 were excluded from downstream analysis. 
 
 
3.1.2 Results 
Probesets whose linkage data failed to corroborate between the two software 
packages used were observed to correspond to those in which the SDP of the marker 
at the peak of linkage (peak marker) contained one or more missing genotypes; that 
TISSUE CIS TRANS 
 No. before Filtering No. after Filtering No. before Filtering No. after Filtering 
Fat 785 558 1149 923 
Kidney 961 718 1320 1033 
Adrenal 860 602 1201 933 
Left Ventricle (LV) 1927 1362 2735 2140 
TOTAL 4533 3240 6405 5029 
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is, where at least one of the then 30 RI strains could not be genotyped at that marker 
locus, and therefore no genotype information was provided for this strain. This led to 
the formulation of the hypothesis that the presence of missing data in the SDP 
underlies the non-corroboration of these QTL Reaper-identified linkages, and the 
prediction that these linkages may be spurious. 
 
The ‘missing genotypes hypothesis’ was tested across the whole dataset by direct 
comparison of the p-value of linkage output by QTL Reaper with that produced by 
performing a Mann-Whitney-Wilcoxon test – a non-parametric equivalent of the two-
sample t-test, between each eQTL probeset and peak marker. This method was used 
because MapManager is unsuited to large-scale ‘batch’ analysis. 
 
The results of this analysis, illustrated in Figure 3.2, were clear. These scatterplots 
show in a) the outcome of this comparative analysis in eQTLs whose peak marker 
SDPs contained at least one missing genotype, and in b) the outcome of comparative 
analysis for those eQTLs whose peak marker SDPs contained no missing genotypes. 
Log p-values are given in order that the relationship between Wilcoxon and QTL 
Reaper p-values may be observed. 
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a) 
 b) 
 
Figure 3.2: QTL Reaper p-values plotted against Wilcoxon Test p-values for all eQTLs 
linked to markers a) with missing genotype data and b) without any missing genotype data   
A cumulative total of 3,765 eQTLs across the four tissues had at least one missing genotype and are 
shown in a). Of these, 254 (6.7%) had Wilcoxon p < 0.05, and 62 (1.6%) had Wilcoxon p < 0.01. 
A cumulative total of 10,813 eQTLs across the four tissues had no missing genotypes and are shown in 
b). Of these, 10,813 (100%) had Wilcoxon p < 0.05, and 10,812 (99.99%) had Wilcoxon p < 0.01. All 
totals are prior to any other filtering of eQTLs e.g. tiering filter. 
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All eQTLs have a QTL Reaper p-value of p<0.05 (
-
log10 p > 1.3). As is apparent in 
a), the eQTLs linked to markers with missing genotypes are irreproducible by Mann-
Whitney-Wilcoxon test just as they were by MapManager; the distribution of 
Wilcoxon p-values is clearly indicative of a serious problem with the linkage data 
being output by QTL Reaper. In b), it is similarly clear that this is not a universal 
problem with the QTL Reaper linkage data, but can indeed be explained by the 
presence of missing genotypes.  
 
The ‘missing genotypes hypothesis’ was also tested with regard to ‘groups’ of 
eQTLs. These were defined differently to the trans-eQTL clusters that were 
introduced in 1.8.2.1 and will be discussed in depth in Chapter 4 – all sets of 10 or 
more probesets linked to a marker (regardless of whether they were cis or trans) were 
included in the analysis. There were 711 such sets, (termed ‘groups’ to avoid 
confusion with trans-eQTL clusters) in the dataset across the four tissues. The 
Wilcoxon p-value of linkage of each of the eQTLs in each group was found, and the 
percentage of corroborating (i.e. significant by Wilcoxon test) eQTLs was found for 
each group. The outcome of this analysis was similarly conclusive to those described 
previously. Of the 711 groups, 614 had 100% corroboration between QTL Reaper 
and Wilcoxon p-values, defined as a significant eQTL (all eQTLs by definition have 
QTL Reaper p≤ 0.05) with nominal Wilcoxon p<0.05. The other 97 had 40% 
corroboration or less. This fully corresponded to the set of groups whose peak 
markers contain missing genotypes, as illustrated in Figure 3.3. 
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a)
 b) 
 
Figure 3.3: QTL Reaper p-values vs Wilcoxon p-values for eQTLs forming groups for  
which the marker at the peak of linkage has missing genotype data in a) one or more strains 
and b) none of the strains 
The group shown in a) is linked to marker D1Cebr103s1, b) is linked to marker D17Rat144. Note the 
differing y-axis scales in a) and b). The maximal Wilcoxon p-value for any eQTL shown in b) is 0.001.  
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Figure 3.3 shows the data used in the previous figure for two specific ‘groups’. One 
of these, shown in a), had 2 missing genotypes in its peak marker’s SDP. The other, 
shown in b), had no missing genotypes in its peak marker’s SDP. Again, Log p-
values are used for clarity of the scatterplots. 
 
The combined outcomes of these statistical analyses provided conclusive evidence for 
the ‘missing genotypes hypothesis’, showing that the presence of any number of 
missing genotypes in marker SDPs led to the indication of spurious linkages by QTL 
Reaper which were incorporated into the eQTL dataset. 
 
Upon investigation of the QTL Reaper software, these spurious linkages were found 
to have arisen as a consequence of a flaw in an algorithm handling missing 
genotypes, which was a discarded part of the MapManager software from which QTL 
was derived but became important when the software was adapted into iterative form 
(as in QTL Reaper). The symptions of this flaw, which caused SDPs with missing 
genotypes to be interpreted incorrectly and had previously gone un-noticed, were 
communicated to Ken Manly, the author of the software, and resolved. A patched 
version of QTL Reaper was made available to the host group and to other software 
users.  
 
Following re-analysis of the linkage data using the new, patched version of QTL 
Reaper, the comparative analysis shown in Figure 3.2 was repeated on the new 
dataset. The outcome of this, shown in Figure 3.4, demonstrated full corroboration 
102 
 
between QTL Reaper and the Wilcoxon-Mann-Whitney results, indicating that 
spurious linkages were no longer present in the dataset following the correction of the 
problem with the linkage analysis software.  
 
 
Figure 3.4: QTL Reaper vs Wilcoxon p-values for all eQTLs, including those with missing 
genotype data for one or more strains, in the eQTL dataset following the repair of the bug in 
QTL Reaper and the re-running of the analysis. 
 
 
The outcomes of the process of data validation outlined here exemplify the crucial 
role that the undertaking of systematic computational quality control has played in the 
eQTL analysis project. The discrepancies in linkage analysis output between the 
original (un-patched) version of QTL Reaper and other methods concerned a 
substantial proportion of the eQTL dataset (25.8% of cumulative total eQTLs across 
the four tissues).  
103 
 
3.1.3 Discussion 
The discoveries about the dataset made in the course of the missing genotypes 
analysis exemplify the importance of systematic validation of large, multifactorial 
datasets. The flaw in QTL Reaper that produced the spurious linkage p-values was 
identified only because the initial observation of discrepancy between the QTL 
Reaper linkages and those given by other methods of analysis.  
 
Without these discrepancies having been observed and their cause identified through 
a combination of critical assessment of the dataset and large-scale statistical analysis, 
these spurious eQTLs may have gone un-noticed. Needless to say, this would have 
had a serious impact on the work described in the next two chapters and on that of 
others using the QTL Reaper software or this particular eQTL dataset. 
 
Following these observations of the mishandling of missing data by the original 
version of QTL Reaper, the fully corroborated dataset generated using the patched 
version of QTL Reaper was used to produce the set of eQTLs used in all studies 
described in this thesis – the dataset delineated in Table 3.1. 
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3.2 Comparative Sequence Analysis of cis-eQTL Probesets 
 
3.2.1 Introduction 
Cis- and trans-eQTLs are classified in such a way as to reflect local and distant 
regulation of gene expression respectively. Gene expression is measured, as described 
in 1.6.1, by assaying transcript abundance through the hybridization of 
complementary mRNAs to probes on a microarray, followed by the measurement of 
signal intensity. While this methodology is well-established and has led to many 
novel discoveries, it is not flawless. One potential pitfall in the interpretation of the 
output of DNA microarray experiments was described in (Alberts et al., 2007b). 
 
Alberts et al found that it is possible for differences in probe signal intensity to be 
produced as a result of polymorphisms (e.g. SNPs) in the region targeted by the 
probe, even in the absence of differential gene expression between the two sample 
populations (i.e. those with SHR or BN genotype at the linkage region). These 
spurious linkages show up in the dataset as cis-eQTLs, and because they are not 
actually indicative of differentially expressed genes they are referred to as ‘false cis-
eQTLs’. Validation in mouse datasets has found around a third of the cis-eQTLs to be 
irreproducible by qRT-PCR (Doss et al., 2005).  
 
We sought to analyse our eQTL dataset in order to identify potential false cis-eQTLs. 
To this end, we investigated cis-eQTLs whose target regions had been sequenced in 
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SHR and BN and identified those which may have been caused by polymorphisms in 
one or more probe binding regions. Later, work on the sequencing of the SHR 
genome (Atanur et al., 2010) enabled a much more thorough assessment of the levels 
of polymorphism in probe binding regions and therefore of the potential proportion of 
spurious linkages in the cis-eQTL dataset. 
 
3.2.2 Results  
25 cis-eQTLs probesets had been sequenced in BN and SHR, in order that the SNPs 
in the probe binding regions could be observed and quantified. These are listed in 
Table 3.3. Just under half of this (admittedly small) sample – many of which were 
originally sequenced for other reasons – were found to contain a SNP in at least one 
of the probes’ target regions. 
 
The findings from this preliminary analysis suggested that, as in the mouse datasets 
discussed in (Doss et al., 2005) and the datasets discussed in (Alberts et al., 2007b), a 
substantial proportion of the cis-eQTLs in the rat BXH/HXB dataset contain SNPs in 
at least one of their probes’ binding regions. 
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   Probeset Tissue No. Polymorphisms Polymorphic 
Probes 
1368225_at Adrenal 2 4, 7 
1373592_at Adrenal 1 3 
1374583_at Fat 2 4, 8 
1374713_at Left Ventricle 2 1, 3 
1374915_at Fat 1 3 
1376732_at Kidney 1 4 & 5 (overlap) 
1383303_at Kidney 1 6 
1384309_at Left Ventricle 2 8, 9 
1388909_at Adrenal 2 1, 9 
1392961_at Left Ventricle 1 11 
1393902_at Kidney 1 3 
1398387_at Kidney 1 6 
1370065_at Adrenal 0 -- 
1370269_at Adrenal 0 -- 
1370401_at Kidney 0 -- 
1371137_at Kidney 0 -- 
1375343_at Kidney 0 -- 
1377329_at Left Ventricle 0 -- 
1379398_at Left Ventricle 0 -- 
1385205_at Left Ventricle 0 -- 
1387376_at Fat 0 -- 
1387819_at Kidney 0 -- 
1388617_at Adrenal 0 -- 
1392074_at Left Ventricle 0 -- 
1392972_at Left Ventricle 0 -- 
Table 3.3: Cis-eQTL probesets whose target regions were sequenced in BN and SHR, 
showing probes whose target regions were found to contain SNP(s). 
 
 
The SHR genome was sequenced in 2008 by Solexa paired-end sequencing 
technology, as described in (Atanur et al., 2010). The availability of this data enabled 
us to systematically identify cis-eQTL probesets with polymorphisms in one or more 
of the probe binding regions.  
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Around half (52.2%) of the total number of cis-eQTL probesets in our dataset were 
tested – the rest were filtered according to the following criteria: a) all 11 probes in 
the probeset were required to map consistently to the same region of the genome; b) 
genetic marker data at the site of the eQTL was required to be complete across the 29 
strains in the panel; and c) complete sequence information was required to be 
available in BN and SHR.   
 
The results of this analysis are shown in Table 3.4, below: 
 
Tissue 
No.  
cis-eQTLs 
Tested 
% with  
≥1 BN SNP 
% with  
≥1 SHR SNP 
% with  
≥1 SNP 
(BN and/or SHR) 
Fat 298 27.2 38.3 49.7 
Kidney 377 27.1 35.0 47.5 
Adrenal 316 27.5 37.0 50.0 
Left Ventricle 703 27.0 35.8 48.6 
TOTAL 1694 
Table 3.4: Findings of SNP analysis of cis-eQTLs using EnsEMBL BN and Solexa SHR 
sequence data 
 
The findings of the SNP analysis were consistent across the four tissues. Around 27% 
of the cis-eQTLs contained at least one polymorphism with respect to the BN 
sequence, and 35-38% contained at least one SNP in SHR. In total (because some 
eQTLs had SNPs in both BN and SHR when compared to the Affymetrix probe 
sequence) just under half of the cis-eQTLs across the four tissues were found to 
contain a polymorphism in at least one of the probes’ binding regions.  
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3.2.3 Discussion 
Preliminary sequence analysis of probe binding regions suggested that around half of 
the cis-eQTLs in the dataset may have SNP(s) in at least one of the probes’ target 
sequences. This ‘prediction’ was borne out by the much more thorough analysis of 
SNPs that was possible once the SHR sequence became available. 
 
The number of SNPs found in BN may appear surprising, since the GeneChips used 
here are ostensibly based on this inbred strain. However Affymetrix probesets are 
designed on the basis of EST (expressed sequence tag) sequences as well as from the 
rat genome assembly. ESTs are typically somewhat more prone to sequencing errors 
(Jain et al., 2007), and their use in the development of probes may explain many of 
these discrepancies. 
 
Although the proportion of cis-eQTL probesets with probe-binding region 
polymorphisms may appear large, it is important to note that not all SNPs affect 
hybridization -  not all probesets with SNP(s) in their probe binding regions are ‘false 
cis-eQTLs’ (Alberts et al., 2007b). At the same time, it does suggest that levels of 
irreproducible cis-eQTLs in the BXH/HXB dataset may be similar to those found in 
other eQTL datasets generated using Affymetrix GeneChips, e.g. (Doss et al., 2005).  
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3.3 Relating predictions of  software for predicting potential ‘false 
cis-eQTLs’ to Solexa sequence data 
 
3.3.1 Introduction 
The ANOVA-based method of predicting ‘false cis-eQTLs’ implemented in AffyGG 
(2.4.3) and described in (Alberts et al., 2008) has the potential to provide a means of 
filtering eQTL datasets to identify potential ‘false cis-eQTLs’ which are due to 
SNP(s) in probe binding regions rather than differential expression. However, despite 
this potential, it has not been adopted as a means of validating cis-eQTLs prior to 
functional or integrative analysis such as quantitative trait transcript (QTT) analysis.  
 
One reason for this may be that the algorithm has not previously been objectively 
validated on a dataset in which the SNPs have been fully characterised, meaning that 
the predictions made by AffyGG are taken somewhat on faith. Another is that the 
interpretation of the numerical output (a series of p-values) produced by AffyGG is 
not straightforward and again somewhat subjective.  
 
Here is described an attempt to address both of these issues, by making use of the  
SHR sequencing work carried out by the SHR Genome Sequencing Consortium 
(Atanur et al., 2010). The sequencing of the SHR genome (2.3.1) and the subsequent 
mapping of the Affymetrix GeneChip probes to the new sequence and to the 
EnsEMBL BN reference sequence (2.3.2) have enabled the polymorphisms in the 
probe binding regions of the cis-eQTL probesets that passed initial filtering to be 
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fully characterised. This data was used to assess the ability of AffyGG to identify 
probes within cis-eQTL probesets that contain SNPs, as indicated by the order in 
which probes are ‘dropped’ (eliminated from the probeset) by the iterative 
probeElimination process (2.3.3).  
 
3.3.2 Results 
The analysis described here was performed in the 1,694 cis-eQTLs across four tissues 
from the BXH/HXB RI panel listed in Table 3.4, following the same filtering as 
described in 3.2.2.  
 
 The effect on the ‘QTL by probe’ effect of the elimination of the first probe in the 
probeset was quantified. The ‘QTL by probe’ p-value output by AffyGG prior to the 
elimination of any probes is referred to as the ‘startint’ p-value, and the p-value 
following the elimination of the first probe is referred to as the ‘first pinteraction’ p-
value. For example, for the cis-eQTL whose probe intensity data are shown in Figure 
3.5 a) and which contains a polymorphism in probe #5, the ‘startint’ p-value given by 
AffyGG is p = 1.87 × 10
-62
. Once this probe is eliminated, the QTL effect evaporates: 
the ‘first pinteraction’ p-value is p = 0.36. 
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Figure 3.5 a): Probe signals plot for a cis-eQTL probeset containing a polymorphism in 
probe #5, and not displaying differential expression 
 
 
Figure 3.5 b): Probe signals plot for a cis-eQTL probeset containing no polymorphisms 
across the 11 probes and displaying differential expression across the majority of the probes 
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By way of contrast, the cis-eQTL shown in Figure 3.5 b) has no polymorphisms in 
any of its 11 probes’ binding regions. Note also that the log (intensity) for the SHR 
samples is lower than that for the BN samples in most of the 11 probes. This indicates 
that this cis-eQTL is probably due to differential gene expression. In other words, it is 
likely to be a true cis-eQTL.  
 
The ‘startint’ p-value for the likely ‘true’ cis-eQTL shown in Figure 3.5 b) is p = 
1.033021e-26, and the ‘first pinteraction’ p-value is p = 2.986986e-20. The ratio 
between these two is far lower than for the likely ‘false’ cis-eQTL shown in Figure 
3.5 a). Through the interpretation of these p-values, AffyGG can be used to identify 
probes that deviate substantially from the probeset average and potentially give a 
misleading indication of linkage. Trans-eQTLs can not be ‘false’ in this way because 
the genomic location of the transcript is not the same as that the probeset maps to, 
therefore any probe interactions that AffyGG might ‘find’ are due to chance. The 
trans-eQTL datasets in each tissue therefore make ideal, tissue-specific, controls.   
Thresholding of the cis-eQTLs in each tissue as described in (Alberts et al., 2007b), 
based on the 99th percentile of ‘startint’ and ‘first pinteraction’ following the 
application of AffyGG to the trans-eQTLs in our dataset (Table 3.5) was applied to 
the cis-eQTLs in each tissue (Table 3.6).  
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Table 3.5: 99
th
 percentile threshold ‘startint’ and ‘firstpinteraction’ AffyGG p-values 
obtained by applying AffyGG algorithm to trans-eQTLs in each of the four tissues. 
 
 
Table 3.6: Numbers of cis-eQTLs in each of the four tissues with ‘startint’ and ‘first 
pinteraction’ p-values exceeding the threshold 
These cis-eQTLs were predicted as potential ‘false cis-eQTLs’ at the specified threshold of 
significance 
 
As shown in Table 3.6, using the threshold of significance suggested, the 99
th
 
percentile of the probe by QTL effect before any probes have been dropped (i.e. 
‘startint’), almost 18% of cis-eQTLs were flagged as potential ‘false’ cis-eQTLs. 
Using the 99
th
 percentile of the ‘first pinteraction’ effect instead, almost 17% of cis-
eQTLs were so flagged.  
Trans StartInt Percentiles 
 No.  
Trans-
eQTLs 
StartInt 99
th
 
Percentile 
FirstInt 99
th
 
Percentile 
FAT 882 2.60E-20 2.86E-12 
KIDNEY 945 1.29E-24 2.14E-15 
ADRENAL 1039 6.35E-24 2.00E-15 
LV 1972 1.32E-29 2.65E-10 
Total/Average 4838 6.50E-21 6.70E-11 
No. Cis Above 
Threshold 
 No.  
cis-eQTLs 
No. (%) StartInt  
> 99
th
 Percentile 
No. (%) FirstInt  
> 99
th
 Percentile 
FAT 298 81 (27.2%) 66 (22.1%) 
KIDNEY 377 60 (15.9%) 46 (12.2%) 
ADRENAL 316 62 (19.6%) 41 (13.0%) 
LV 703 101 (14.4%) 133 (18.9%) 
Total 1694 304 (17.9%) 286 (16.9%) 
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However, this analysis was uninformed by sequence data. With knowledge of the 
SNP content of each probeset’s probes’ binding regions, it was possible to consider 
just how meaningful these thresholds are in terms of identifying potential ‘false’ cis-
eQTLs.  
 
We found that, of the 14.4-27.2% (across the four tissues) of cis-eQTLs flagged up 
by applying the thresholds given in Table 3.5, 73.3-80.2% contained at least one 
polymorphism between BN, SHR or both and the reference sequence (Data Not 
Shown). However, 39.1-43.4% of probesets that were not flagged up also contained 
at least one polymorphism. It was subsequently observed that the ratio of the QTL by 
probe p-value prior to the dropping of any probes and following the dropping of the 
first probe may be a more consistent indicator of potentially false cis-eQTLs. This is 
shown in Figure 3.6, upon which the ratio between ‘startint’ and ‘first pinteraction’ 
p-value is plotted for each of the 703 cis-eQTLs in the left ventricle.  
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Figure 3.6: Cis-eQTL probesets in left ventricle by AffyGG ‘startint’:‘first pinteraction’  
ratio  
All cis-eQTLs in left ventricle are plotted according to AffyGG output; specifically the ratio between 
startint (x-axis, the interaction p-value prior to elimination of the first probe) and first pinteraction (y-
axis, the interaction p-value following the elimination of the first probe). 
 
It can clearly be seen in this figure that the probesets shown in red (those in which a 
probe with a polymorphism in its probe binding region was dropped first by AffyGG) 
are substantially different in terms of this ratio to the other two sets. As such, the 
probesets with polymorphisms that were not identified by AffyGG (perhaps because 
the probeset is actually a true (i.e. differentially expressed) cis-eQTL) were combined 
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with those containing no SNPs (and therefore assumed to be a true cis-eQTL) in the 
next stage of this exploration of AffyGG’s predictive model (Figures 3.7-8). 
 
This ratio between ‘startint’ and ‘first pinteraction’ was systematically related to 
findings from comparative sequence analysis in the SHR and BN, by means of a 
Support Vector Machine (SVM) classification method (Cortes and Vapnik, 1995), 
implemented in R as described in 2.3.4. The outcome of the initial SVM analysis is 
shown in Figure 3.7, below. 
 
Figure 3.7: Classification of cis-eQTL probesets according to AffyGG prediction of probes 
with polymorphisms in probe binding regions 
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The accuracy of the SVM’s discrimination between those probesets for which 
AffyGG dropped a SNP-containing probe first and those for which it did not 
(including those probesets with no SNPs) was assessed by 10-fold cross-validation. 
The overall accuracy was found to be 86%. The Type I error rate of the SVM was 
very low – only 35 of 1293 probesets predicted not to have a SNP containing probe 
dropped first were misclassified. However, the rate of correct identification of 
probesets in which a SNP probe was dropped first was somewhat poorer – 197 of 401 
(49%) were correctly classified by the SVM. 
 
It was noted that as the startint or first pinteraction p-values approach 1 (log p ~ 0), 
classification becomes highly challenging. In Figure 3.8 a) and b), probesets for 
which log ‘startint’ < -10 and log ‘startint’ < -20 respectively were removed from the 
analysis. Following this, the rate of correct prediction of ‘SNP probe dropped first’ 
probesets increased to 67% (of 293) and 76% (of 212) respectively.  
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Figure 3.8 a): SVM classification of cis-eQTL probesets according to AffyGG prediction of 
probes with polymorphisms in probe binding regions, excluding those with log ‘startint’ < 10. 
 
 
 
 
 
 
Figure 3.8 b): SVM classification of cis-eQTL probesets according to AffyGG prediction of 
probes with polymorphisms in probe binding regions, excluding those with log ‘startint’ < 20.  
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Details of the SVM’s classification of probesets by ratio of ‘startint’ to ‘first 
pinteraction’ are provided in Table 3.7. As can be seen from the table; as a general 
rule, the higher this ratio the more likely the probeset is to have a SNP-containing 
probe. These probes are identified by AffyGG in 87.7% of cases where the ratio is 
greater than 3. 
 
Ratio 
(Greater than) 
Cumulative Total 
Probesets 
No. (%) predicted to 
have a SNP-containing 
probe dropped first by 
AffyGG 
No. (%) of overall correct 
SVM predictions 
11.369 68 68 (100%) 67 (98.5%) 
4 136 128 (94.1%) 117 (86%) 
3 179 157 (87.7%) 147 (82.1%) 
2 260 195 (75%) 199 (76.5%) 
1.5 474 229 (48.3%) 368 (77.6%) 
1.124 789 231 (29.3%) 637 (80.7%) 
Table 3.7: SVM classification of 789 probesets by ratio of ‘startint’ to ‘first pinteraction’. 
Probesets for which the sum of ‘startint’ and ‘first pinteraction’ is less than 10 were removed.  
 
 
3.3.3 Discussion 
The combining of newly-available SHR sequence data, Affymetrix probe sequence 
information and the EnsEMBL BN reference sequence enabled a comprehensive 
assessment of the prevalence of SNPs in probe binding regions and their effect on cis 
linkage to eQTLs to be made. This could then be related to the outputs of the AffyGG 
ANOVA model, enabling a more objective interpretation of the statistics produced by 
the software than has previously been possible to be made. 
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It was found by assessing the thresholding method discussed in (Alberts et al., 
2007b), which considers only the ‘startint’ p-value, against the sequence findings that 
the rate of identification of SNP containing probes of the suggested threshold was 
low. It was observed following the production of a scatterplot like that shown in 
Figure 3.6 that a ratio of ‘startint’ to ‘first pinteraction’ is a somewhat better 
predictor of SNP-containing probes identified by AffyGG, and this was explored 
further through the application of the SVM. 
 
It is important to note that the methodology used in this exploration of the 
interpretation of the AffyGG model’s output evaluates AffyGG’s rate of 
identification of SNP-containing probes, not the raw numbers of probesets with 
polymorphisms in their probe binding regions. This is because a probeset with a SNP 
in one or more of its probes’ binding regions is not necessarily a ‘false’ cis-eQTL – it 
is anticipated that many truly differentially expressed probesets will also have 
polymorphisms in one or more probe binding regions. Therefore, the observation that 
the AffyGG model has not eliminated a SNP-containing probe first does not indicate 
a Type II error on the part of AffyGG. (That is, SNP-containing probes are not always 
influential as regards the QTL effect). This complicates the interpretation of the 
AffyGG output, since it means that sequence cannot be used to ‘judge the accuracy’ 
of predictions, only to contribute to improving our understanding of those 
predictions. 
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Another factor that complicates the interpretation of the output is that the numbers of 
SNPs in a probeset vary. It is relatively straightforward to view the change in QTL 
effect upon dropping a probe (the change in ratio of ‘startint’ to ‘first pinteraction’) as 
an indicator of the likelihood of an eQTL being due to polymorphism rather than 
differential expression. However, some cis-eQTLs were found to have as many as 7 
probes with SNPs in their binding regions, making it very difficult to determine 
whether or not they are potentially ‘false’ by analysing this ratio. Unfortunately, it is 
impossible to know (unless full sequence data is available) how many polymorphisms 
there are across a probeset, so the interpretation of the AffyGG output cannot be so 
informed. 
 
The use of SHR sequence data to inform statistical analysis of the predictions of 
AffyGG has the potential to make this software much more useful. However, new 
angles on this analysis may be required to tackle the problem of uninformative cis-
eQTLs. 
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Chapter 4: Genome-wide Co-expression Analysis 
Incorporating Investigation of the Effect of Genotypic 
Variation 
 
4.1 Introduction 
Each eQTL in the dataset is described as either cis or trans, as defined in 1.8. These 
classes are anticipated to represent biological differences in the modes of regulation 
represented by the two types of eQTLs. Specifically, cis-eQTLs are defined as they 
are (1.8.1) so as to identify local gene effects on expression across the strains; 
conversely, trans-eQTLs are expected to identify remote gene effects, i.e. genes 
whose expression is affected by a polymorphism at a different locus. 
 
The only forms of data about regulation actually contained within the eQTL dataset 
are a) the microarray-measured expression levels of the probesets in each of the RI 
strains and b) the genotype information contained within the genetic markers’ SDPs. 
These can be combined in computational analysis with other information to enable 
informed biological hypotheses about the regulation of gene expression to be 
formulated.  
 
This eQTL dataset and others can and have been studied with a view to isolating the 
genes underlying specific eQTLs or groups of eQTLs (Hubner et al., 2005), an 
approach that has facilitated gene discovery in several model organisms (e.g. (Meng 
123 
 
et al., 2007)) and in humans (Goring et al., 2007). However, while it has been 
possible to identify and characterise the genes underlying cis-eQTLs, the study of 
trans-regulation using eQTL data has proven more challenging, undoubtedly at least 
in part due to the relatively smaller effect size of trans-eQTLs (Petretto et al., 2006a). 
 
Genome-wide, or ‘global’ investigations into the eQTL dataset have the potential to 
improve our understanding of the structure of the data, and therefore the quality of the 
predictions made using it. Several genome-wide analyses of eQTL data have been 
carried out, however the data is generally not fully explored before progression to the 
application of functional enrichment, pathway prediction and/or network construction 
algorithms. In some studies, such as (Cowley et al., 2008; Yvert et al., 2003), co-
expression analysis is carried out in a set of transcripts without making use of the cis-
trans delineation.  
 
The application of network construction methods to cis-eQTLs has not met with 
significant success in identifying functional sets (Lum et al., 2006). One possible 
explanation for this, noted by (Doss et al., 2005), is the confounding effect of linkage 
disequilibrium. The ambiguity as to whether the correlation of closely linked 
transcripts is due to pleiotropy (one gene affecting the expression of both of the 
correlated transcripts) or linkage makes the inference of biological significance of 
such relationships difficult (Chen et al., 2007).  
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Another possible factor affecting the interpretation of cis-eQTL co-expression 
analysis is long-range allelic association among un-linked markers. In (Cervino et al., 
2005) it was suggested that this allelic association may lead to false linkages in QTL 
mapping studies, and it is possible that this may apply also to co-expression analysis. 
 
The systematic co-expression analysis of the sets of cis-eQTLs and trans-eQTLs in 
each of the four tissues, combined with the testing for correlation of the SDPs of their 
associated markers, was intended to enable the structures of all of these datasets to be 
compared and contrasted, including class of eQTL and tissue.  
 
It has been shown that genes show highly tissue-specific patterns of regulation (Yang 
et al., 2006) and eQTL detection rates show tissue-specificity across the genome 
(Petretto et al., 2006a). The latter analysis is extended here through the investigation 
of the tissue-specificity of the statistical significance of co-expression relationships 
between eQTLs in the same dataset. In particular, the trans-eQTL clusters in the 
study dataset are highly tissue-specific – a large cluster identified in one tissue is 
completely absent in the next (Table 4.4, Appendix III).  
 
The 81 (Table 4.4) trans-eQTL clusters, defined as a group of 10 or more expression 
traits linked to the same genetic locus in trans, were identified purely through linkage 
analysis. They consist of transcripts with highly correlated expression levels, however 
the significance of this correlation in informing about biological relationships 
between the transcripts is not clear from genome-wide co-expression analysis alone, 
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because of the confounding effect of the genotype at the common peak of linkage. 
This can be accounted for by the use of partial correlation, conditioned on the 
genotype (4.2.3). 
 
Trans-eQTL clusters have been hypothesised (Yvert et al., 2003) to represent co-
ordinated regulation of the transcripts comprising the cluster (1.8.2.1), and previous 
attempts to identify the ‘master regulator’ (Morley et al., 2004) explaining the linkage 
of the cluster genes to the same locus have utilised co-expression methods but with 
little success (Keurentjes et al., 2007; Tu et al., 2006). The possibility of functional 
enrichment within trans-eQTL clusters has been explored in other datasets (e.g. (Lan 
et al., 2006; Wu et al., 2008)), with some studies having outcomes suggesting that 
such clusters are predictive of biological relationships. 
 
In (Fuller et al., 2007), coexpression network construction is performed prior to 
categorisation to identify ‘modules’ (1.9.5), hypothesised to consist of highly 
interconnected genes. This approach to ‘module’ identification is used by (Lan et al., 
2006) to identify highly correlated gene sets from a set of 5,293 trans-mapping 
mouse transcripts. These gene sets, like the trans-eQTL clusters, map to the same 
genomic location. Such ‘modules’ were also observed by (Emilsson et al., 2008) 
following analysis of a large human expression dataset, however these did not map to 
the genome by linkage-analysis. It is disputed whether the trans-eQTL clusters 
identified by linkage analysis and described in e.g. (Hubner et al., 2005) represent 
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truly biologically meaningful groupings of transcripts (Breitling et al., 2008). It has 
been suggested that these clusters may instead indicate genes with highly correlated 
expression (Pérez-Enciso et al., 2003), perhaps due to inter-sample technical variation 
(Kang et al., 2008), that link to the genome by chance because of the relatively small 
number of strains in the panel (1.8.3). 
 
The genetics and gene expression of eQTLs forming trans-eQTL clusters were 
studied in detail, and the previously hypothesised relationship between correlation of 
co-localising cis-eQTLs and the cluster trans-eQTLs was explored. Additionally, the 
hypothesis that the correlation in expression levels observed in trans-eQTL clusters 
ceases to be significant after the effect of genotype has been taken into account, and 
the prediction of functional enrichment of trans-eQTL clusters, were assessed in all 
large (≥30 trans-eQTLs) clusters in the BXH/HXB dataset through the application of 
partial correlation and Gene Ontology (GO) analysis respectively. 
 
 
4.2 Results 
 
4.2.1 Co-expression analysis of cis- and trans-eQTLs 
The methods used to carry out co-expression analysis and assess statistical 
significance are described in 2.4.2 and 2.5.3. The methods used to test for correlation 
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of marker genotypes are described in 2.4.3 and 2.5.4. Methods used in the assessment 
of the statistical power of co-expression analysis are described in 2.5.5. 
 
Figure 4.1 and Table 4.1 display the results of the co-expression analysis of cis-
eQTLs. They show that over 80% of the pairs of cis-eQTLs found to have 
significantly correlated expression profiles could potentially be explained by either 
genetic linkage (i.e. the eQTLs are less than 50cM apart) or long-range allelic 
association. In either case, testing for correlation of their peak marker’s SDPs 
identifies a statistically significant effect.  
 
In Figure 4.1, all significantly correlated pairs of cis-eQTLs in each tissue are shown, 
plotted by their positions on the genetic map.  
 
In Table 4.1, the percentage of all pairs of cis-eQTLs in each of the datasets found to 
be significantly correlated is given. This ranged from 0.6% to 0.9% of pairs tested. Of 
these, 67.9-81.6% could potentially be explained by linkage disequilibrium. These 
findings indicate that significant correlation of unlinked cis-eQTLs is very rare. 
 
In order to give context to these findings, Figure 4.2 shows the pattern of allelic 
association for all markers with no missing genotype data (n = 671) markers. 
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Figure 4.1: Scatterplots showing pairs of cis-eQTLs with significantly correlated gene 
expression by genetic map location in A) Fat, B) Kidney, C) Adrenal and D) Left Ventricle 
tissues. 
Those with significantly correlated SDPs are plotted in red; those with significantly anti-correlated 
SDPs in green; and those whose SDPs were not found to be correlated are shown in blue. 
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Tissue 
Total 
Number of 
Pairs 
No. 
Significant 
Correlated 
Pairs 
(q = 0.05) 
% Significant 
Correlated 
Pairs 
No. (%) 
Significantly 
Correlated Pairs 
located less than 
50cM apart 
No. (%) 
Significantly 
Correlated Pairs 
with  
Correlated 
Genotypes at Peaks 
of Linkage 
Fat 155,403 1,386 0.9 941 (67.9%) 1,114 (80.4%) 
Kidney 257,403 2,284 0.9 1,654 (72.4%) 1,979 (86.6%) 
Adrenal 180,901 1,443 0.8 1,123 (77.8%) 1,294 (89.7%) 
LV 926,841 5,371 0.6 4,382 (81.6%) 4,912 (91.5%) 
Table 4.1: Summary of cis-eQTL co-expression statistics in each of the four tissues. 
 
 
 
Figure 4.2: Scatterplot showing numbers of matches in SDP of all pairs of markers 
(excluding those with missing genotype data), genome-wide. 
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The data shown in Figure 4.1 and Table 4.1 can be considered in view of the 
genome-wide view of genotypic correlation of marker SDPs given in Figure 4.2, and 
contrasted with the outcome of the correlation of trans-acting eQTLs. This was 
performed using the same methods as was the cis-eQTL co-expression analysis.  
 
Because trans-eQTL probesets, by definition, do not map to the same genetic location 
as their peaks of linkage, two sets of genotype correlation statistics were produced for 
each significantly correlated pair of trans-eQTLs. These provide information on the 
genotypes of the markers at the eQTLs’ peaks of linkage, and of the nearest marker to 
the genetic map position of the probeset. 
 
Figure 4.3 shows all significantly correlated pairs of trans-eQTLs, plotted by the 
genetic map position of the probesets. Figure 4.4 shows the same correlated pairs, 
but plotted by the genetic map position of the peaks of linkage rather than the 
probesets. A summary of the findings of the genome-wide correlation of the trans-
eQTL dataset in each of the four tissues is given in Table 4.2.  
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Figure 4.3: Scatterplots showing pairs of trans-eQTLs with significantly correlated gene 
expression by genetic map location of transcript in A) Fat, B) Kidney, C) Adrenal and D) Left 
Ventricle tissues. 
Colour-coding as in Figure 4.1 
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Figure 4.4: Scatterplots showing pairs of trans-eQTLs with significantly correlated gene 
expression by genetic map location of peak of linkage in A) Fat, B) Kidney, C) Adrenal and 
D) Left Ventricle tissues. 
Colour-coding as in Figure 4.1 
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Table 4.2: Summary of trans-eQTL co-expression statistics in each of the four tissues. 
 
It is clear that there are many more significantly correlated pairs of trans-eQTLs than 
there are pairs of cis-eQTLs. One explanation for this finding is the fact that there are 
somewhat more trans-eQTLs in the eQTL dataset than there are cis-eQTLs (see 
Table 3.1).  
 
However, as well as there being a greater number of significantly correlated pairs of 
trans-eQTLs, a much greater proportion (2.9 – 14.9%) of possible pairs of trans-
eQTLs were found to be significantly correlated, relative to cis-eQTLs (0.6 – 0.9%). 
Unlike trans-eQTLs, the search-space for cis-eQTL transcripts is limited to the 
defined window region (1.8.1), meaning that many more probesets can form a trans-
eQTL in a given region of the genome than can form a cis-eQTL. Additionally, the 
fact that trans-eQTL genes can be located anywhere in the genome and be linked to 
the same region means that highly correlated groups of trans-eQTLs (trans-eQTL 
clusters) can occur, as was observed here. This explains the contrasting patterns of 
correlation observed in Figures 4.3 and 4.4. 
Tissue 
Total 
Number of 
Pairs 
No. 
Significant 
Correlated 
Pairs 
(q = 0.05) 
% 
Significant 
Correlated 
Pairs 
No. (%) 
Significantly 
Correlated Pairs 
with Significantly 
Correlated 
Genotypes at Peaks 
of Linkage 
No. (%) 
Significantly 
Correlated Pairs 
with Significantly 
Correlated 
Genotypes at 
Probeset Locations 
Fat 425,503 63,477 14.9 31,288 (49.3%) 6,375 (10.0%) 
Kidney 533,028 39,257 7.4 18,628 (47.5%) 4,601 (11.7%) 
Adrenal 434,778 12,482 2.9 7,945 (63.7%) 1,370 (11.0%) 
LV 2,288,730 78,826 3.4 44,110 (56.0%) 8,450 (10.7%) 
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Across the four tissues, 47.5-63.7% of significantly correlated pairs of trans-eQTLs 
were found by the matching coefficient analysis of SDPs to have significantly 
correlated genotypes at the peak of linkage. Less than 12% of the transcripts, 
however, were co-located. This is indicative of correlation of transcript expression 
profiles located in different regions of the genome, perhaps suggesting that – for these 
transcripts - gene expression (as quantitified by probeset hybridization) is influenced 
to a much greater degree by the segregation of a region of the genome that is at least 
20Mb away from the gene and is often on a different chromosome than by the 
segregation of the gene itself. Alternatively, it could be indicative – as suggested by 
(Breitling et al., 2008) – of chance linkage of the co-expressed trans-eQTLs. If one of 
a group of highly correlated trans-eQTL genes is linked to a given region, it is very 
likely that the others will be too, giving rise to a trans-eQTL cluster. 
 
The power and precision of the Pearson correlation analysis itself, given the sample 
size (n = 29), was assessed by finding the statistical power (estimated probability of 
rejecting the null hypothesis of no significant correlation given that it is false) and 
confidence intervals (range in which the true correlation coefficient will occur with 
95% probability) as described in 2.5.5. In each tissue, a Pearson correlation 
coefficient for this analysis was chosen to be approximately equivalent (due to the use 
of empirical p-values, there is not an exact, consistent correspondence) to the 
threshold q = 0.05. The confidence interval and statistical power for each co-
expression analysis are given in Table 4.3. 
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Tissue 
Approx. 
Threshold 
Pearson 
95% C.I. 
Lower Bound 
95% C.I. 
Upper Bound 
Statistical 
Power 
Cis-eQTLs 
Fat 0.61 0.314 0.798 96% 
Kidney 0.61 0.314 0.798 96% 
Adrenal 0.62 0.328 0.804 96% 
Left Ventricle 0.63 0.343 0.810 97% 
     
Trans-eQTLs 
Fat 0.47 0.125 0.714 75% 
Kidney 0.58 0.271 0.781 93% 
Adrenal 0.55 0.230 0.763 89% 
Left Ventricle 0.54 0.216 0.757 88% 
Table 4.3: 95% confidence intervals and statistical power for the identification of 
significantly correlated pairs of cis- and trans-eQTLs 
Significant Pearson correlation coefficient defined as coefficient approximately equivalent to threshold 
q = 0.05 
 
The results given in Table 4.3 show that the statistical power and precision of co-
expression analysis is, like that of the eQTL mapping itself (1.8.3), both greater and 
more variable across the tissues in cis-eQTLs than in trans-eQTLs. This is a 
consequence of a combination of the small size of the RI panel used for the analysis, 
and the relatively low threshold correlation coefficients defined by the q-value 
procedure as significant in trans-eQTLs.  
 
 4.2.2 Co-expression analysis within trans-eQTL clusters 
The pairwise correlation structure within trans-eQTL clusters was analysed, and the 
results are shown in Figure 4.5 and Table 4.4. As expected, there was found to be a 
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much greater degree of co-expression within the clusters than in the set of trans-
eQTLs as a whole.  
 
Figure 4.5 shows the outcome of this analysis, indicating the percentage of 
significantly correlated pairs (as defined in 2.6) in trans-eQTL clusters, grouped by 
tissue. The boxplots show the mean, interquartile range and range of this percentage 
in each of the four tissues. The horizontal lines give the percentage of significant 
pairwise correlation of expression profiles across the tissue as a whole. Table 4.4 
summarises the underlying data.  
 
 
Figure 4.5: Boxplots showing percentage within-cluster significant correlation of genes 
underlying trans-eQTLs forming trans-eQTL clusters relative to percentage significant 
correlation across tissue (indicated by horizontal lines). 
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Tissue 
% Trans-eQTL 
Significant Correlation 
(overall) 
No. Trans-eQTL Clusters 
(≥10 co-linked eQTLs) 
% Significant 
Correlation Within 
Clusters (average) 
Fat 14.9 11 90.2 
Kidney 7.4 23 84.2 
Adrenal 2.9 9 82.4 
LV 3.4 38 77.2 
Table 4.4: Significant co-expression of trans-eQTLs within trans-eQTL clusters and 
globally, by tissue 
 
Much of the statistically significant co-expression observed in the genome-wide 
analysis of trans-eQTLs is due to the presence in the dataset of these highly 
correlated groups of cluster-forming transcripts. The variability in levels of 
statistically significant correlation of trans-eQTLs between tissues can also largely be 
explained by the presence in the data of these groups. In fat, a large trans-eQTL 
cluster contains 146 trans-eQTLs with 96.8% significant pairwise correlation (see 
Appendix III), for a total of 10,250 significantly correlated pairs. This means that just 
under a third (32.7%) of the total number of significantly correlated trans-eQTLs in 
fat can be explained by the presence of this one trans-eQTL cluster. 
 
Kidney and adrenal do not contain such large trans-eQTL clusters (the largest cluster 
across these two tissues occurs in kidney and consists of 57 trans-eQTLs). The 
number of clusters observed in left ventricle is much higher than in any of the other 
three tissues – this is not surprising since the expression of almost twice as many 
transcripts was profiled and double the number of trans-eQTLs were detected (Table 
3.1) 
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As discussed in 1.8.3, an analysis of the statistical power to detect trans-eQTLs in 
each of the four tissues was carried out by others working on the dataset and 
published (Petretto et al., 2006a). The power to detect trans-eQTLs was found to be 
substantially higher in fat and left ventricle than in kidney and adrenal. One possible 
reason for this relates to the greater heterogeneity of cell types in the kidney and 
adrenal tissues relative to the other two; as many eQTLs have been found to be cell-
type specific (Gerrits et al., 2009), the signals in these tissues may be noisier.  
 
Because the effect size of trans-eQTLs is generally small (Hubner et al., 2005), 
relative to cis-eQTLs they are difficult to detect and the false positive rate is much 
higher. The trans-eQTLs in the 81 clusters listed in Appendix III were identified at 
genome-wide p < 0.05, at which the median expected FDR ranges from 26-35% 
across the tissues. This means that genome-wide, around one third of all trans-eQTLs 
are false positives, particularly as most (>75% across the four tissues) trans-eQTLs 
are not significant at p < 0.01. In Table 4.5, the numbers of trans-eQTL clusters in 
each tissue at more stringent levels of genome-wide significance are provided. 
 
 
 
 
 
139 
 
Tissue 
No. trans-eQTL clusters at: 
p < 0.05 p < 0.01 p < 0.001 
Fat 11 1 0 
Kidney 23 1 0 
Adrenal 9 1 0 
Left Ventricle 38 3 0 
Table 4.5: Numbers of trans-eQTL clusters at different genome-wide significance thresholds 
for mapping of trans-eQTLs. 
Trans-eQTL cluster is defined as a group of 10 or more trans-eQTLs that map to the same region of 
the genome 
 
Of 81 trans-eQTL clusters, six remain in the dataset when only the set of trans-
eQTLs that are significant at p < 0.01 is considered. These are bolded in Appendix 
III, which also lists the numbers of trans-eQTLs in all clusters found at p < 0.05 
remaining in the dataset at the more stringent genome-wide significance threshold. 
 
4.2.3 Partial correlation analysis of large trans-eQTL clusters 
The trans-eQTL clusters, by definition, consist of groups of genes linked to the same 
region of the genome. As such, it is logically implied that there will be some 
correlation of the transcripts’ expression profiles across the 29 RI strains, as these 
transcripts would not otherwise associate with the SDP of the marker at a common 
peak of linkage. Partial correlation analysis of the expression profiles, conditioned on 
the genotype of the marker, is a means of assessing the degree to which the effect of 
genotype gives rise to the observed correlation. 
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Partial correlation analysis was carried out on the fifteen clusters, across the four 
tissues, consisting of 30 or more trans-eQTLs (Table 4.6). Significance of the partial 
correlations was assessed using a two-tailed t-test. A t-statistic was found for each 
pair as described in 2.4.5 and significance at n-3 degrees of freedom (where n is the 
number of genotypes in the SDP of the marker at the cluster peak of linkage, 
excluding missing genotypes) was found. For each cluster, the percentage of pairs of 
expression traits whose partial correlation coefficients were found to be significant by 
this method is given. 
Tissue 
Marker at 
Cluster Peak 
of Linkage 
No.  
trans-
eQTLs in 
cluster 
No. pairs with 
significant 
partial 
correlation 
% pairs with 
significant 
partial 
correlation 
% 
significant 
Pearson 
correlation 
LV D15Rat29 54 2664 93.1 99.0 
Fat D17Rat1 146 17700 83.6 96.8 
LV D15Ucsf1 46 1508 72.9 92.9 
Fat Cacna1s 33 646 61.2 96.8 
LV D15Rat98 30 488 56.1 88.0 
LV D15Utr2 51 1416 55.5 85.5 
Kidney D15Rat69 57 1554 48.7 91.2 
LV Cyp45c 35 564 47.4 87.9 
Fat D4Rat240 31 372 40.0 84.7 
Kidney Igk@ 49 924 39.3 89.6 
Adrenal D11Rat16 31 312 33.5 75.5 
Adrenal D17Rat144 47 656 30.3 88.6 
LV Crabp1 165 7870 29.1 77.1 
LV D8Mit12 77 1492 25.5 68.8 
LV Ckb 43 328 18.2 79.2 
Table 4.6: Outcome of partial correlation analysis of the trans-eQTL genes forming clusters 
consisting of 30 or more eQTLs. 
Nominal significance of partial correlations defined by applying a two-tailed t-test to the coefficient 
with n-3 degrees of freedom. The clusters are ordered by % significance of the partial correlations. 
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The trans-eQTL clusters were found to vary substantially in levels of significant 
partial correlation. As expected, there is a positive relationship between the 
proportion of pairs of transcripts found to be significantly correlated by uninformed 
Pearson correlation, and those found to be significantly correlated once the potential 
confounding effect of genotype is taken into account through the application of 
partial correlation. These percentages are however not statistically equivalent, as the 
threshold used to assess significance of the partial correlation coefficients is not 
corrected for multiple testing across the genome-wide set of trans-eQTLs. 
 
4.2.4 Functional enrichment analysis of large trans-eQTL clusters 
One hypothesis for the explanation of the presence of these cluster-forming groups of 
co-expressed genes in eQTL datasets such as that described here is that they represent 
co-ordinated regulation of multiple genes perhaps by a ‘master regulator’ close to the 
peak of linkage of the trans-eQTL cluster (Yvert et al., 2003). It was considered that 
these genes may well share functional characteristics that would explain the 
occurrence of such co-regulation in a wider biological context. This hypothesis was 
tested by assessing the levels of functional enrichment within the sets of co-expressed 
transcripts by comparison of the gene ontology (GO) annotations of the probesets 
using DAVID functional classification tool (Huang et al., 2007). The biological 
process and molecular function ontologies were used. As with the partial correlation 
analysis, only those clusters consisting of 30 or more trans-eQTLs were used in the 
analysis.  The outcome of this analysis is shown in Table 4.7. For each GO term 
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found to be significant at p<0.01 by the DAVID functional enrichment tool, the term 
and the number of genes annotated for that term are provided in Appendix IV. 
 
Tissue 
Marker at 
Cluster Peak of 
Linkage 
No. Cluster 
trans-eQTLs 
Significant GO 
terms at  p<0.001 
Significant GO 
terms at  p<0.01 
Significant GO 
terms at p<0.05 
LV D15Rat98 30 0 0 1 
Adrenal D11Rat16 31 0 2 7 
Fat D4Rat240 31 2 4 8 
Fat Cacna1s 33 0 1 4 
LV Cyp45c 35 0 0 0 
LV Ckb 43 3 4 12 
LV D15Ucsf1 46 0 2 12 
Adrenal D17Rat144 47 0 1 8 
Kidney Igk@ 49 1 3 14 
LV D15Utr2 51 2 13 20 
LV D15Rat29 54 8 15 28 
Kidney D15Rat69 57 8 12 19 
LV D8Mit12 77 0 0 3 
Fat D17Rat1 146 3 20 52 
LV Crabp1 165 0 4 14 
Table 4.7: Outcome of GO analysis of trans-eQTL clusters consisting of 30 or more eQTLs using 
DAVID, a functional annotation software tool.  
 
 
Twelve (80%) of the large trans-eQTL clusters were found to be significantly 
enriched for at least one GO term at p<0.01, and 7 at p<0.001.  
 
To make it possible to assess the significance of these findings in the context of the 
trans-eQTL dataset as a whole, simulation studies were performed. As the median 
size of the 15 large trans-eQTL clusters is 47 eQTLs, 200 random sets of 47 trans-
143 
 
eQTL genes were selected and tested for functional enrichment using DAVID in the 
same way as were the large trans-eQTL clusters.  
 
At all p-value thresholds, fewer significant GO terms were found in random groups 
than in the trans-eQTL clusters. Kolmogorov-Smirnov (K-S) tests (2.6.3) were used 
to assess the statistical significance of these tests. At all three DAVID p-value 
thresholds (p<0.001, p<0.01, p<0.05) tested, the degree of functional enrichment 
found in the trans-eQTL clusters was found to be significantly greater than in the 
random trans-eQTL sets (K-S Exact test p-values: p<0.001, p<0.002, p<0.004). 
 
4.2.5 Investigation of the Genetic Basis of Co-regulation in trans-eQTL 
Clusters 
The outcomes of the co-expression and functional investigations of the trans-eQTL 
clusters described in the previous sections suggest that at least some of these groups 
of transcripts may represent biologically significant sets of genes within the tissue in 
which they were identified. As the defining feature of a trans-eQTL cluster is that all 
of the eQTLs therein are linked to the same region of the genome, this region is 
intuitively the first place to look in the search for the genetic basis of this co-
regulation. 
 
The region of the genome 50Mb either side of the peak of linkage of each cluster was 
designated the cluster’s ‘window region’. A wide region was deliberately chosen in 
order that all possible ‘master regulators’ (1.8.2.1) were taken into consideration, 
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taking into account the possibility of mapping error and the effects of linkage 
disequilibrium. The expression profiles of the cis-eQTLs in this ‘window region’ 
were then tested for co-expression with those of the trans-eQTLs in the cluster. It was 
anticipated that this would enable the prioritisation of cis-eQTLs as master regulator 
candidates. 
 
This  analysis was carried out, and cis-eQTLs with expression profiles highly 
correlated to those of the cluster trans-eQTLs were identified for several clusters. 
However, when the outcomes of these analyses (Figure 4.6) were inspected, the 
confounding effect of linkage disequilibrium was found to produce a strong negative 
relationship between the average correlation coefficient (R
2
: 0.15-0.43) with the 
distance of the potential regulator from the peak of linkage of the trans-eQTL cluster.  
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Figure 4.6: Scatterplots showing correlation of genes underlying cluster trans-eQTLs and 
cis-eQTLs located in the 50Mb window-region by distance of the cis-eQTL from the cluster 
peak of linkage in A) Fat, B) Kidney, C) Adrenal and D) Left Ventricle tissues. 
 
The hypothesis that genetic linkage is the cause of this distance effect on correlation 
of cis- and trans-eQTLs linked to the same genetic region was tested by analysing the 
correlation of genes located in the region but not linked to it. Figure 4.7 shows the 
outcome of this analysis. 
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Figure 4.7: Scatter plots showing correlation of genes underlying cluster trans-eQTLs with 
all probesets (not just eQTLs) located in the 50Mb window-region by distance of the cis-
eQTL from the cluster peak of linkage in A) Fat, B) Kidney, C) Adrenal and D) Left 
Ventricle tissues. 
 
As predicted, the covariate effect of distance on correlation with the cluster 
disappears when unlinked genes are tested for correlation rather than cis-eQTLs (R
2
: 
0.00-0.01). 
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4.3 Discussion 
The application of systematic genome-wide co-expression analysis, making use of the 
dichotomous SDPs across the RI strain panel, has enabled the correlation structure of 
all cis- and trans-eQTLs in a large dataset to be presented.  
 
It is not practical to test regulatory hypotheses directly at a genome-wide level in the 
laboratory, but the application of in silico methods can provide valuable insight into 
underlying regulatory structure. These include gaining an improved understanding of 
the nature of the individual linkages observed, the relationships between expression 
traits, and the specific associations between the genetic inheritance at the eQTL loci 
and the expression signals of the linked transcripts. 
 
The availability of four tissues from the same panel of RI strains; specifically adipose 
tissue, kidney, adrenal and left ventricle; enabled the systematic analysis effectively 
to be replicated four times. Although the same probesets (with extra probesets in one 
tissue (2.1.2.1)) and genetic markers were used in each genome-wide analysis, 
because eQTLs are so tissue-specific a different set of cis- and trans-eQTLs was 
produced and analysed in each of the four tissues. The levels of significant co-
expression observed in cis-eQTLs was found to be very similar across the four tissues 
(0.6-0.9% significant correlation), but in trans-eQTLs it was found to differ 
substantially across the tissues (2.9-14.9%) (Table 4.2) 
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Correlations of expression profiles were considered in tandem with those of the SDPs 
at the genetic loci, in view of the prevailing understanding of the biological basis of 
eQTLs as outlined in (Yvert et al., 2003), specifically that cis-eQTLs indicate local 
and trans-eQTLs distant regulation of the linked transcripts (1.8.1-2). These 
assumptions underlie most published analyses of eQTL data, and while they appear to 
make sense, there has been little study of their validity so it is worthwhile to consider 
initially the consistency of the conventional explanation with actual data. 
 
This was achieved by assessing the degree of significant co-expression in each of the 
four tissue datasets of cis- and trans-eQTLs, using an empirical permutation-based 
method described in 2.5.3. This was combined with assessment of the similarity of 
genetic inheritance at the peak of linkage; the method used for doing this is described 
in 2.5.4. The results of these analyses were then interpreted with regard to the genetic 
location of the eQTL, and in trans-eQTLs also the location to which the transcript 
maps, culminating in the production of the scatterplots in (Figures 4.1, 4.3 & 4.4).  
 
These scatterplots make clear the degree to which the sets of cis-eQTLs differ from 
trans-eQTLs in terms of overall levels of significant correlation. They enable patterns 
of correlation to be visualised in a way that makes clear the extent to which 
significant correlation of cis-eQTL transcript expression levels can potentially be 
explained by non-biological factors, specifically genetic linkage and long-range 
allelic association. In all four tissues, less than 1% of all pairs of cis-eQTLs were 
significantly correlated, and of these 80-90% were found to have significantly 
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correlated SDPs at the peak of linkage (Table 4.1). In contrast, percentage significant 
correlation of trans-eQTLs ranged from 3% to 15% across the tissues, and 48-64% of 
these were found to have significantly correlated SDPs at the peak of linkage (Table 
4.2). 
 
The interpretation of correlation of cis-eQTLs is made challenging by the 
confounding effect of linkage disequilibrium among closely linked eQTLs (Doss et 
al., 2005). The potential for finding correlation of non-linked cis-eQTLs is minimal 
by definition, as the transcript displaying variation in expression must be located at 
the same locus it maps to. Only 459 such pairs were found in the richest tissue (left 
ventricle), from a possible 926,841 (Table 4.1).  
 
Because of the confounding effect of linkage disequilibrium (Drake et al., 2006), the 
application of uninformed co-expression analysis to cis-eQTLs’ expression profiles 
(e.g. in the construction of co-expression networks) is unlikely to be directly 
informative about biological relationships. It is possible to test for causal 
relationships in pairs of transcripts that are both linked to the same locus (e.g. (Chen 
et al., 2007)), however this was not attempted here, as the investigation of trans-
eQTLs, in which a greater degree, and more interesting patterns, of correlation was 
observed took priority. A set of pairwise correlated cis-eQTLs is not suitable for 
testing for functional enrichment, because the co-expressed pairs are discrete. A 
simple functional analysis of these pairs was attempted using Chilibot (Chen and 
Sharp, 2004), which mines MEDLINE abstracts for genetic relationships, however 
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the attempt to find significant functional relationships between co-expressed genes 
using this method was unsuccessful. The biological explanation of the derivation of 
cis-eQTLs suggests that the differential transcript abundance underlying the linkage 
is caused by a direct gene effect, perhaps a polymorphism in a promoter or 3’UTR 
region of the gene whose expression is measured by the probeset (Hubner et al., 
2005).  
 
Since the definition of a trans-eQTL does not require that the transcript be located in 
the same region of the genome that the eQTL maps to, hence there is a much larger 
search-space for significantly correlated transcripts than in cis-eQTLs, it was 
expected that significant correlation of trans-eQTLs would be much commoner than 
in cis-eQTLs. This was clearly shown to be the case. Since trans-eQTLs are thought 
to arise as a result of remote regulation producing differential expression - highly co-
expressed trans-eQTLs have been predicted to represent key components in 
transcriptional networks (Lum et al., 2006) - it was anticipated that relationships 
between them identified by co-expression would be more biologically significant than 
in the cis-eQTL datasets. This possibility was investigated by studying trans-eQTL 
clusters. 
 
The presence of trans-eQTL clusters in this and other eQTL datasets was already 
well-characterised when this study began, and others e.g. (Lan et al., 2006) had 
observed that significantly co-expressed genes often map in trans to the same 
genomic locations. These findings were replicated in this study – 81 trans-eQTL 
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clusters, defined as 10 or more trans-eQTLs mapping to the same region of the 
genome, were identified (listed in Appendix III) – accounting for a large proportion 
of the significant correlation observed across the trans-eQTL dataset. Across the four 
tissues, 47.5-63.7% of significantly correlated trans-eQTLs were found to have 
significantly correlated genotypes at their peaks of linkage (Table 4.2). Of these, 
23.1-39.1% have peaks of linkage that are ≤1cM apart ((Grieve et al., 2008), Table 
S2). Furthermore, when the other significantly correlated pairs were investigated, 
many of these were found to consist of the same eQTLs as in the trans-eQTL 
clusters. This can be observed on the scatterplots plotted by eQTL map location 
(Figure 4.4) as ‘bands’ of significant correlations which coincide with the loci of 
clusters’ peaks of linkage, such as D17Rat1 – the marker at the locus of the largest 
trans-eQTL cluster in the fat tissue. The band corresponding to this marker’s genetic 
map location can be seen just to the left of the 2500cM mark on Figure 4.4A. The 
genes forming the trans-eQTL cluster are correlated not only with each other, but in 
many cases with other trans-eQTL genes that are not linked to the region. 
 
The presence of tissue-specific cluster-forming groups of highly correlated transcripts 
of differing sizes goes some way to explaining the difference in levels of significant 
co-expression between the tissues. While it was evident from the data in Table 4.2 
that trans-eQTL clusters explained some of the difference between the percentage 
significant correlation in fat and that in the other tissues, it remained unclear why 
many more pairs without significantly correlated genotypes at the peak of linkage 
(i.e. not in the same trans-eQTL cluster) were found to be co-expressed in fat than in 
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the other tissues. The observation that so many cluster-forming trans-eQTLs are also 
co-expressed with genes in other clusters (whose peaks of linkage do not have 
correlated genotypes with that of the first cluster) suggests that tissues in which there 
are large trans-eQTL clusters are likely to have more of both types of significant co-
expression.  
 
However, the biological basis of this co-expression, if indeed there is any – it has 
been speculated that the co-expressed groups of genes that form trans-eQTL clusters 
may be artifacts of non-biological variation (Breitling et al., 2008) – is still to be fully 
elucidated. Addtionally, the statistical power and precision of both the detection of 
trans-eQTLs (median expected FDR for trans-eQTLs across the four tissues = 26-
35% (Petretto et al., 2006a)) and the co-expression analysis itself (Table 4.3) are low. 
This is mainly due to a combination of the generally small effect sizes of trans-
eQTLs (Hubner et al., 2005) and the size of the panel, which is much smaller than 
would be ideal for this type of analysis (Carlborg et al., 2005). 
 
The trans-eQTL clusters themselves were studied in more depth in order to 
investigate the possibility of biologically significant groups of genes within the trans-
eQTL dataset, and perhaps generate more specific hypotheses regarding their 
regulation. Partial correlation analysis was performed to investigate the effect on the 
levels of correlation of expression profiles observed in trans-eQTL clusters of 
conditioning on the SDP of the marker at the peak of linkage of the cluster, and 
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analysis of GO annotations was performed to test the clusters for functional 
enrichment.  
 
Partial correlation and functional analysis were performed on larger trans-eQTL 
clusters (those consisting of 30 or more trans-eQTLs), as those below this size were 
considered to provide insufficient statistical power for informative conclusions to be 
drawn from the output.  
 
The partial correlation analysis found the levels of significant correlation of 
expression levels within the 15 large trans-eQTL clusters to be very variable. The 
percentage significant pairwise partial correlation across these clusters, conditioned 
on their respective marker genotypes, was found to range from 18.2-93.1% (Table 
4.6).  
 
The tests of functional enrichment in large trans-eQTL clusters, performed using 
DAVID, found there to be significantly over-represented GO terms at p<0.01 in 80% 
of the clusters (Table 4.7, Appendix IV). The findings of functional enrichment 
concord with the observation made in (Ghazalpour et al., 2005) and elsewhere that 
trans-eQTL clusters correspond with hotspots of genes enriched for a specific 
biological function or forming part of a common pathway. The observation that 
groups of highly correlated genes are frequently functionally enriched (Emilsson et 
al., 2008) is reinforced through carrying out the reverse analysis, i.e. first identifying 
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the groups of genes linked to common genetic regions, then carrying out the co-
expression and functional analysis.  
 
The findings of the functional enrichment analysis, that some of the trans-eQTL 
cluster-forming groups of transcripts are significantly functionally enriched, can be 
considered in view of the outcome of the partial correlation analysis. The two groups 
of co-expressed genes that were found to be most significantly correlated once the 
effect of the genotypes at the peak of linkage had been taken into account (Table 4.6) 
were those with peak of linkage at D15Rat29 in LV (93.1% significant partial 
correlation) and that with peak of linkage at D17Rat1 in fat (83.6% significant partial 
correlation). These two groups were also found to be the most functionally enriched, 
at p < 0.01 and p < 0.05, of the 15 clusters tested by gene ontology analysis using 
DAVID (Table 4.7). 27 of 130 genes (20.8%, 16 of the probesets were not identified 
by DAVID) in the D17Rat1 cluster were annotated with metal ion binding molecular 
function. In the D15Rat29 cluster, 13 of 47 genes (27.7%, 7 of the probesets were not 
identified by DAVID) were annotated with response to biotic stimulus biological 
process, and 9 (19.2%) with DNA binding molecular function (see Appendix IV for 
full details of all functional enrichment found).  
 
The application of partial correlation analysis to the trans-eQTL cluster-forming 
groups of transcripts in this dataset found that most, but not all, become much less 
significantly co-expressed when the effect of the genotype at the peak of linkage is 
taken into account. Those clusters that retain significance were found also to be more 
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significantly enriched for biological function, suggesting that the application of this 
partial correlation method may be informative in differentiating those co-expressed 
groups that arise as a consequence of real co-expression from those that may instead 
be due to technical factors. 
 
Finally, having identified groups of genes that are highly co-expressed and 
functionally enriched, the next stage in the investigation was to try and elucidate the 
biological basis of their co-regulation. The ‘master regulator’ hypothesis (Yvert et al., 
2003) suggests that the cis-eQTLs colocalising with the peak of linkage of the trans-
eQTL cluster are the best candidates.  
 
In previous investigations of trans-eQTL cluster regulation, correlation has been 
carried out between the cis-eQTLs in the same region of the genome as the trans-
eQTL cluster, however - as shown in Figures 4.6 & 4.7, the confounding effect of 
linkage disequilbrium means that it is not so straightforward as this to prioritise 
candidate regulators. When co-expression analysis of trans-eQTLs and candidate 
regulator cis-eQTLs was performed, a strong negative relationship between distance 
of the candidate from the peak of linkage and correlation with the trans-eQTL cluster 
transcripts was identified. This systematic effect is due to linkage effects and does not 
occur when unlinked transcripts are correlated with the transcripts forming the 
cluster. This indicates that carrying out uninformed co-expression analysis of trans-
eQTL cluster transcripts and candidate regulators in the cluster linkage region is not a 
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suitable method for prioritising candidate ‘master regulators’ of highly correlated 
groups of cluster-forming transcripts. 
 
However, the ‘master regulator’ hypothesis and in particular the way it was 
investigated in 4.2.5 relise on the cluster-forming groups of trans-eQTLs actually 
representing co-ordinately regulated transcripts by a gene at or near the peak of 
linkage. As discussed, the work of others (e.g. (Kang et al., 2008)) as well as the 
findings of the partial correlation analysis described in 4.2.3 suggest that may not 
actually be the case in many instances of trans-eQTL clusters identified by linkage 
analysis and/or uninformed co-expression analysis. 
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Chapter 5: Quantitative Trait Transcript Analysis of 
Physiological and Expression Traits 
 
5.1 Introduction 
The analysis of microarray data together with conventional linkage and physiological 
trait measurements has facilitated the identification of genes underlying individual 
differences in several complex traits in a variety of species (Glazier et al., 2002). 
Before the innovation of genome wide eQTL analysis, most of the quantitative trait 
genes that were identified in this way were found by conventional genetic mapping of 
the quantitative trait by linkage or association analysis to a genetic interval, followed 
by fine-mapping of the interval (Flaherty et al., 2005). 
 
The first way in which the data produced by eQTL analysis can be of use in the 
identification of candidate genes underlying physiological QTLs (referred to 
henceforth in this chapter as pQTLs in order to avoid confusion) is by identifying 
drivers of localised regulation of gene expression in the form of cis-eQTLs (1.8.1). 
Since cis-eQTLs are indicative of genes that are differentially expressed as a 
consequence of genetic variation in or close to the transcribed gene, they may suggest 
biological roles for specific genes. Depending on the experimental design, it may be 
possible to then relate this differental expression to previously mapped phenotypic 
variation, aiding prioritisation of candidate genes for the pQTL in question (Drake et 
al., 2006). 
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The eQTL dataset upon which the analysis here described was generated in RI strains 
generated from an intercross between a spontaneously hypertensive and a 
normotensive inbred strain of rat (SHR x BN) as described in (2.1.1). The SHR is an 
established model of the metabolic syndrome, obesity, and cardiovascular disease. 
Over a hundred physiological traits have been mapped in this cross (Hubner et al., 
2005) and in the BXH/HXB panel itself (Pravenec et al., 2002). This means that cis-
eQTLs colocalising with several mapped traits of substantial medical research interest 
can be identified and the genes underlying them prioritised for further investigation as 
a potential contributor to the phenotypic variation between the BN and SHR.  
 
This outlined method of moving towards the identification of quantitative trait genes 
can be augmented by making use of strain-specific continuous physiological 
measurements (e.g. blood pressure) and expression data, in an approach called 
‘Quantitative Trait Transcript (QTT) analysis’. The underlying hypothesis of QTT 
analysis is that transcripts whose expression profiles are significantly correlated with 
the trait are promising candidate genes for the trait (Passador-Gurgel et al., 2007). 
 
Measurements were obtained for a wide variety of metabolic, biochemical and 
physiological traits relating to the metabolic syndrome, type 2 diabetes, hypertension 
and left ventricular hypertrophy (LVH) and linked to the four tissues of study (1.5). 
The QTT analysis of traits relating to LVH is described in 5.2.1, and the analysis of 
traits measured in the adipose tissue, kidney and adrenal, and other metabolic traits, is 
described in 5.2.2. 
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5.2 Results 
 
5.2.1 Quantitative Trait Transcript Analysis of Left Ventricular Mass 
and Related Traits 
Quantitative Trait Transcript analysis was performed as outlined in 2.7, using data 
from the left ventricle tissue. The expression profiles of 1,444 LV cis-eQTLs were 
correlated with profiles consisting of indexed measurements of Left Ventricular Mass 
(LVM) of four to six biological replicates in each RI strain (Petretto et al., 2008). 
Additionally, in order that QTLs potentially underlying blood-pressure dependent 
hypertrophy could be distinguished from genetic determinants of LVM acting 
independently of blood pressure, QTT analysis was carried out on measurements of 
Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) in the RI strains.  
 
Those cis-eQTLs significantly correlated with LVM (p < 0.01) are shown in Table 
5.1, and a graphical representation of the pattern of correlation across the genome is 
provided by the scatterplot Figure 5.1. 
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Cis-eQTL 
Marker at 
cis-eQTL 
Peak of 
Linkage 
Probeset 
Chromo-
some 
Probeset 
Map 
Position 
(Mb) 
Pearson 
Correlation 
Coefficient 
Empirical 
p-value 
1380127_at D17Ucsf2 17 11.011 0.66702 0.0001 
1390960_at D8Mit11 8 122.986 0.6094 0.0006 
1373378_at D17Ucsf2 17 11.156 0.60066 0.0006 
1382468_at D17Ucsf2 17 12.220 0.59515 0.0009 
1397727_at D17Ucsf2 17 10.821 -0.56226 0.0019 
1388603_a_at D8Cebr16s5 8 126.911 0.55541 0.0018 
1385456_at D8Cebr16s5 8 127.910 -0.5479 0.0024 
1386128_at D17Ucsf2 17 12.044 -0.53985 0.002 
1391776_at D8Mit11 8 123.017 0.53803 0.0024 
1383759_at Drd1a 17 11.106 0.53044 0.0026 
1384301_at D17Mit7 17 12.620 0.52931 0.0031 
1383413_at D8Cebr16s5 8 127.153 0.5253 0.0033 
1377452_at D10Rat73 10 31.282 -0.51764 0.005 
1388613_at D8Cebr16s5 8 127.910 0.51128 0.0051 
1369415_at D17Ucsf2 17 10.815 0.50104 0.0058 
1389151_at D4Rat240 4 144.142 0.50102 0.0042 
1389376_at D4Rat240 4 151.764 0.48886 0.0075 
1369932_a_at D10Rat30 10 66.609 0.48481 0.0071 
1370004_at Cacna1s 4 154.891 -0.48354 0.008 
1388812_at D17Ucsf2 17 14.489 -0.48012 0.0074 
1376749_at D17Utr1 17 20.987 -0.46367 0.011 
1380383_at Ppy 10 90.702 -0.46329 0.0112 
1385899_at D10Rat31 10 49.009 0.46224 0.0104 
1392077_at D3Cebr9s1 3 92.371 0.45966 0.0122 
1395073_at D2Mit18 2 114.886 -0.45901 0.0104 
1383263_at D17Utr1 17 20.992 -0.45549 0.0121 
1370044_at Rbp2 8 103.843 0.44906 0.0124 
1378802_at D1Rat235 1 248.162 0.44266 0.0151 
1387438_at D10Cebr1016 10 35.788 -0.44258 0.0173 
1383070_at D17Ucsf2 17 16.012 0.66702 0.0001 
Table 5.1: Quantitative Trait Transcript left ventricle cis-eQTLs highly correlated with Left 
Ventricular Mass across 29 RI strains  
Probesets shown in bold represent Ogn, the gene that was prioritised and subsequently shown to be a 
key regulator of LVM. 
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Figure 5.1: Quantitative Trait Transcript (QTT) analysis of left ventricle cis-eQTLs with 
indexed Left Ventricular Mass measured in BXH/HXB RI strains 
Each point on the plot represents one of 1,444 cis-eQTL transcripts. Approximate empirical p-value 
thresholds are given. 
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Two groups of cis-regulated transcripts were identified as significantly correlated 
with LVM, on chromosome 17 (most significant p=0.0001) and chromosome 8 (most 
significant p=0.0006). Correlation was not observed at either of this loci with systolic 
(Figure 5.2) or diastolic (Figure 5.3) blood pressure, suggesting the presence of 
candidate determinants of LVM in one or both of these regions that may be 
independent of blood pressure.  
 
The results of a separate statistical analysis not forming part of this thesis but 
discussed in (Petretto et al., 2008) suggest that the effect of blood pressure on LVM is 
small, and previous genetic analysis (Cerutti et al., 2006) of the relationship between 
blood pressure and gene expression in the rat LV has found the effect of blood 
pressure to be minimal – suggesting that blood pressure independent regulation of 
LVM plays an important role in genetic determination of variation. 
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Figure 5.2: QTT analysis of left ventricle cis-eQTLs with Systolic Blood Pressure measured 
in BXH/HXB RI strains.  
Symbols as Figure 5.1 
 
 
 
 
Figure 5.3: QTT analysis of left ventricle cis-eQTLs with Diastolic Blood Pressure measured 
in BXH/HXB RI strains. 
Symbols as Figure 5.1 
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Further statistical analysis was performed on one of the regions identified by this 
process as candidates for the genetic determination of LVM; chromosome 17p14, 
which contains a pQTL for LVM previously identified in the BXH/HXB panel 
(Pravenec et al., 1995). Candidate genes were prioritised on the basis of the 
significance of their cis linkage and their degree of differential expression between 
SHR and BN.  
 
Of the candidate genes in the QTL region 17p14 showing significant QTT with LVM, 
Ogn (Osteoglycin) was prioritised following fine-mapping using an additional 46 
SNP markers within the region of interest, carried out by Enrico Petretto (Petretto et 
al., 2008). Ogn was uncorrelated with blood pressure, and showed the strongest fold 
change of the candidates in the region. Another candidate – Hbld2 – was excluded, as 
discussed in (Petretto et al., 2008), due to its mapping outside the QTL region. Ogn, a 
gene previously known to researchers as an extracellular matrix (ECM) protein with a 
role in bone morphogenesis (Bentz et al., 1991), was prioritised, sequenced, and - 
following subsequent in vitro and in vivo analysis - implicated as a key regulator of 
LVM in rodents. 
 
To begin to establish whether the rodent findings of Ogn regulation of LVM translate 
to humans, a further QTT analysis was performed using microarray data generated 
from biopsy samples from 26 human subjects. Expression data was correlated with 
LVM data obtained through echocardiography. The genes found to be best-correlated 
with LVM by straightforward QTT analysis (illustrated in Figure 5.4)  in these 26 
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subjects are listed in Table 5.2. OGN, the human orthologue of Ogn, is included in 
this list with an empirical p-value of correation of p=0.0012. 
Probeset Chromosome 
Gene  
Symbol 
Correlation 
Coefficient 
Nominal  
p-value 
Empirical  
p-value 
205846_at 12 PTPRB 0.70871 0.00005 0.0003 
210848_at N/A N/A -0.69006 0.00010 0.0003 
219029_at 5 C5orf28 0.69001 0.00010 0.0002 
220719_at 12 FLJ13769 -0.68556 0.00011 0.0003 
206390_x_at 4 PF4 -0.68221 0.00012 0.0001 
208169_s_at 1 PTGER3 -0.68218 0.00012 0.0001 
214369_s_at 11 RASGRP2 -0.6772 0.00014 0.0002 
201995_at 8 EXT1 0.67261 0.00017 0.0002 
220698_at 20 MGC4294 -0.65907 0.00025 0.0004 
210772_at 19 FPRL1 -0.65757 0.00026 0.0006 
218184_at 6 TULP4 0.64803 0.00034 0.0001 
213096_at 1 TMCC2 -0.63705 0.00047 0.0004 
208476_s_at 10 FRMD4A -0.62746 0.00060 0.0009 
205453_at 17 HOXB2 -0.62711 0.00061 0.0004 
221912_s_at 1 CCDC28B -0.62697 0.00061 0.0004 
216112_at 1 PKN2 -0.62493 0.00064 0.0006 
219126_at 6 PHF10 0.62293 0.00068 0.0004 
214814_at 4 YTHDC1 0.62019 0.00073 0.0007 
204422_s_at 4 FGF2 0.61849 0.00076 0.0012 
206003_at 4 CEP135 0.61829 0.00076 0.0008 
210145_at 1 PLA2G4A 0.6179 0.00077 0.0011 
203944_x_at 6 BTN2A1 0.61786 0.00077 0.001 
216818_s_at N/A N/A -0.61553 0.00082 0.0009 
218730_s_at 9 OGN 0.61546 0.00082 0.0012 
214981_at 13 POSTN -0.61393 0.00085 0.001 
208370_s_at 21 DSCR1 0.61386 0.00085 0.0009 
209672_s_at 7 FLJ20323 0.60973 0.00094 0.0014 
213150_at 7 HOXA10 -0.60954 0.00095 0.0015 
216664_at N/A N/A -0.60903 0.00096 0.0009 
220979_s_at 1 ST6GALNAC5 -0.60848 0.00097 0.0014 
Table 5.2: Transcripts whose expression was found to be most highly correlated with LVM 
in 26 human individuals by Pearson correlation. 
OGN, which was subsequently implicated in the regulation of Left Ventricular Mass in rats and 
humans, is highlighted in bold. 
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Figure 5.4: Genome-wide correlation of expression data with LVM measurements in 26 
human subjects 
Each point on the plot represents one of 1,444 human gene transcripts. Approximate empirical p-value 
thresholds are given. OGN transcript is shown in red and is indicated by the arrow 
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Figure 5.5 shows the Pearson correlation of normalised OGN expression with LVM 
in each of the 26 subjects. Note that OGN was found to be positively correlated with 
LVM in humans, whereas in rats the correlation was negative. This inconsistency was 
investigated by RT-PCR, as discussed in (Petretto et al., 2008), and found to be a 
consequence of alternative splicing in the 3’UTR of rat Ogn. 
 
 
Figure 5.5: Correlation of OGN expression measured in 26 human individuals with Left 
Ventricular Mass measurements 
 
 
 
 
 
 
 
 
168 
 
5.2.2 Quantitative Trait Transcript Analysis of non LVM-related Traits 
 
As well as the blood pressure and LVM data discussed in 5.2.1, QTT analysis was 
carried out on many other quantitative traits that have been measured in the RI 
strains. Much of this analysis is preliminary, in that the findings described here have 
not been progressed into the laboratory, and as such no candidate genes have been 
prioritised for the traits discussed here. All QTT analysis was performed following 
assessment of data quality. Data cleansing of physiological traits was carried out by 
other members of the Aitman laboratory 
 
QTT analysis was typically carried out on traits with relevance both to the metabolic 
syndrome or associated disorders modelled by the SHR (e.g. genetic hypertension), 
and to the tissues of study. Although some of the physiological traits are known to be 
affected by variation in more than one tissue and in others not included in the study, 
they have been divided here for ease of explanation into three categories: Adrenal 
traits, kidney traits, and fat (adipose tissue) traits. 
 
5.2.2.1 Adrenal-related Physiological Traits 
QTT analysis was performed on 14 separate adrenal traits measured by Daniel 
O’Connor (UCSD) in 3-5 individuals from each of the RI strains. 
 
The factors secreted by the adrenal gland have a substantial influence on blood 
pressure through their influence on renal sodium reabsorption (Binder, 2007). The 
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catecholamines (the most significant of which are dopamine, epinephrine and 
norepinephrine) have also been associated with insulin resistance, dyslipidaemia and 
glucose intolerance (Landsberg, 1999; Reynisdottir et al., 1994).  
 
Levels of each of the three catecholamines listed above were measured in the RI 
strains. Additionally, catecholamine biosynthetic enzymes (Ciaranello et al., 1975) 
phenylethanolamine-N-methyltransferase (PNMT) and dopamine-β-hydroxylase 
(DBH) were quantified; as were three of the chromogranins – proteins that perform a 
variety of roles including regulation of catecholamine secretion (Zhang et al., 2006). 
 
As well as the catecholamines, other hormones produced by the adrenal gland are 
thought to play a role in the development of the metabolic syndrome. Corticosterone 
is a glucocorticoid hormone, the rodent equivalent of cortisol, which is known to 
contribute to the hypertensive response to stress (Andrews and Walker, 1999). The 
level of serum corticosterone was measured. 
 
Finally, the concentrations of sodium, potassium and chloride in the blood were 
quantified. High levels of sodium and chloride (Schmidlin et al., 2005) are associated 
with hypertension, as is deficiency in potassium (Channa et al., 2004). The balance of 
sodium and potassium ions is regulated by the renin-angiotensin-aldosterone system 
(Delles et al., 2008), in which the kidney and adrenal gland both play central roles. 
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As an example, the outcome of the QTT analysis of serum chloride concentration 
against cis-eQTLs in the adrenal gland is shown in Figure 5.6, and the 15 adrenal cis-
eQTLs found to be correlated with serum chloride at empirical p < 0.01 are listed in 
Table 5.3. The same analysis was carried out for each of the quantitative traits 
provided. 
 
The serum chloride QTT region on chromosome 1 coincides with two physiological 
QTLs for changes in body weight, Bw18 and Bw20, mapped in an SHR cross. 
 
 
Figure 5.6: QTT analysis of adrenal gland cis-eQTLs with serum chloride levels measured 
in BXH/HXB RI strains.  
Symbols as Figure 5.1 
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Cis-eQTL 
Probeset 
Chr 
Probeset Map 
Position (Mb) 
Gene 
Symbol 
Absolute 
Pearson 
Correlation 
Coefficient 
Empirical  
p-value 
1368585_at 2 30.890 Cart 0.59 0.0006 
1368267_at 3 11.366 Pomt1 0.58 0.0006 
1372068_at 17 71.418 
BS69 
protein 
0.58 0.0007 
1370665_at 8 47.356 Hyou1 0.58 0.0009 
1373672_at 17 37.799 
Similar to 
SPI6 
0.56 0.0011 
1377290_at 1 182.032 Tnrc6a 0.57 0.0013 
1388617_at 17 37.144 Bphl 0.55 0.0013 
1370929_at 14 81.306 Lrpap1 0.54 0.0017 
1367788_at 1 186.870 Phkg2 0.55 0.0023 
1368225_at 17 40.124 Rsec5 0.56 0.0027 
1393856_x_at N/A N/A -- 0.50 0.0054 
1373316_at 3 165.811 -- 0.51 0.0059 
1390625_at 4 76.093 RGD1304879 0.49 0.0077 
1368311_at 1 196.867 Mgmt 0.48 0.0078 
1374467_at 10 11.762 Trap1 0.48 0.009 
Table 5.3: Quantitative Trait Transcript candidates identified as significantly correlated to an 
exemplar adrenal gland-related trait (serum chloride level) 
15 adrenal cis-eQTLs were found to be correlated to this trait with empirical p<0.01. Numbers of cis-
eQTLs significantly correlated to 19 other adrenal gland traits ranged from 3 to 23 (median: 9.5). 
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5.2.2.2 Kidney-related Physiological Traits 
The kidney is known to play a key role in the development of genetic hypertension 
(Rettig and Grisk, 2005). The renin-angiotensin-aldosterone system involves both the 
kidneys and adrenal gland – renin is a hormone secreted by the kidneys – and 
regulated blood pressure by inducing blood vessel contraction and by modulating the 
balance of sodium and potassium ions (Binder, 2007). Additionally, mutations in 
several genes governing renal salt handling have been found to produce disorders of 
blood pressure regulation (Ji et al., 2008). 
 
Measurements of systolic (SBP) and diastolic blood pressure (DBP), pulse pressure 
(PP) and heart rate (HR) were tested against cis-eQTLs in the kidney by QTT 
analysis. The outcome of the QTT analysis of pulse pressure is shown in Figure 5.7, 
and the kidney cis-eQTLs found to be correlated with each of the four traits tested at 
empirical p < 0.01 are listed in Table 5.4.  
 
A pulse pressure QTT identified on chromosome 19 at empirical p < 0.001 coincides 
with a blood pressure QTL, Bp17, that had previously been mapped in the BXH/HXB 
cross, and a heart rate QTT region identified on chromosome 7 at empirical p < 0.005 
is colocalised with a pQTL for albuminuria (renal function), Uae23, that was mapped 
in an SHR/Fub backcross.  
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Figure 5.7: QTT analysis of Kidney cis-eQTLs with pulse pressure measured in BXH/HXB 
RI strains.  
Symbols as Figure 5.1. Potential QTT regions of interest were identified on chromosomes 10 and 19. 
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Cis-eQTL 
Probeset 
Chr 
Probeset 
Map Position 
(Mb) 
Gene 
Symbol 
Absolute 
Pearson 
Correlation 
Coefficient 
Empirical  
p-value 
1368891_at 19 55.047 Gnpat 0.61 0.0007 
1388151_at 10 11.067 Coro7 0.58 0.0008 
1371785_at 10 12.941 Tnfrsf12a 0.56 0.0014 
1370705_at 10 11.919 Znf597 0.56 0.0016 
1370830_at 14 97.703 Egfr 0.55 0.0016 
1387157_at 19 39.411 Pmfbp1 0.54 0.0027 
1371870_at 19 53.732 
Similar to 
FKSG26 
0.50 0.0048 
1373438_at 10 106.647 Ube2op 0.51 0.0054 
1375532_at 6 42.781 Id2 0.48 0.0079 
1376136_at 10 15.110 Rhot2 0.47 0.01 
Table 5.4 a): Kidney cis-eQTLs identified as significantly correlated (empirical p<0.01) to 
Pulse Pressure by QTT analysis  
 
 
 
Cis-eQTL 
Probeset 
Chr 
Probeset 
Map 
Position 
(Mb) 
Gene 
Symbol 
Absolute 
Pearson 
Correlation 
Coefficient 
Empirical  
p-value 
1386212_at 13 90.028 Spna1 0.72 0 
1387146_a_at 15 87.893 Ednrb 0.60 0.0006 
1374379_at 13 88.637 
Dusp23_ 
Predicted 
0.48 0.0076 
Table 5.4 b): Kidney cis-eQTLs identified as significantly correlated (empirical p<0.01) to 
Heart Rate by QTT analysis 
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Cis-eQTL 
Probeset 
Chr 
Probeset Map 
Position (Mb) 
Gene 
Symbol 
Absolute 
Pearson 
Correlation 
Coefficient 
Empirical  
p-value 
1371689_at N/A N/A -- 0.54 0.0019 
1375966_at 16 10.052 Mmrn2 0.52 0.0028 
1371749_at 7 123.813 
Celsr1_ 
Predicted 
0.53 0.0034 
1374782_at 7 113.676 
Rhpn1_ 
Predicted 
0.51 0.0041 
1376501_at 7 122.794 Arhgap8 0.50 0.0057 
1374608_at 4 149.617 -- 0.50 0.0058 
1389800_at 1 199.042 Pwwp2 0.48 0.0072 
1379783_at 7 113.394 -- 0.47 0.008 
Table 5.4 c): Kidney cis-eQTLs identified as significantly correlated (empirical p<0.01) to 
Diastolic Blood Pressure by QTT analysis 
 
 
Cis-eQTL 
Probeset 
Chr 
Probeset 
Map 
Position 
(Mb) 
Gene 
Symbol 
Absolute 
Pearson 
Correlation 
Coefficient 
Empirical  
p-value 
1370705_at 10 11.919 Znf597 0.57 0.0008 
1387157_at 19 39.411 Pmfbp1 0.58 0.001 
1371785_at 10 12.941 Tnfrsf12a 0.56 0.0014 
1377303_at 10 14.137 -- 0.55 0.0025 
1370269_at 8 61.468 Cyp1a1 0.50 0.0054 
1370830_at 14 97.703 Egfr 0.49 0.0058 
1388151_at 10 11.067 Coro7 0.50 0.0059 
1374782_at 7 113.676 
Rhpn1_ 
Predicted 
0.48 0.0086 
1377342_s_at 3 10.091 Fnbp1 0.47 0.0092 
Table 5.4 d): Kidney cis-eQTLs identified as significantly correlated (empirical p<0.01) to 
Systolic Blood Pressure by QTT analysis 
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5.2.2.3 Fat-related and Miscellaneous Physiological Traits 
The adipose tissue, along with muscle and liver, is central to the pathogenesis of the 
metabolic syndrome, insulin resistance and type II diabetes (Biddinger and Kahn, 
2006).  
 
QTT analysis was performed systematically on 75 metabolic traits, using cis-eQTLs 
from adipose tissue and also from the other three tissues. The measurements that were 
carried out to explain this physiological data are detailed in Appendix V. Full data on 
all QTT cis-eQTLs at p<0.01 by permutation in each of the four tissues are provided 
on the Data CD. Totals for each of the four tissues tested are given in Table 5.5 a) 
(fat), b) (kidney), c) (adrenal gland) and d) (left ventricle).  
 
Co-localisation analysis of the QTTs identified in this analysis and those described 
earlier in this thesis with physiological QTLs has not been carried out to date, but 
work on the development of testable functional hypotheses from these data is ongoing 
in the host laboratory, including the development of congenic strains (Morrissey, C., 
2010, personal communication). 
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ins=0/cell 8 MAP 11 totchol0 8 
absnefa/cell 9 RLVHWT 13 totphos0 4 
ins=50k-0/cell 17 kidneydif 13 totchol4 18 
fold 6 kidney5wk 29 totphos4 4 
ins50k/cell 23 kidney8wk 14 ins0/vol 5 
absnefa 11 livchol 4 ins50/vol 19 
ratwt 8 liver(g) 4 delins/vol 11 
cell vol 23 livpool 4 hematocrit 90 8 
ins0 7 offspring 3 platelet aggrega 4 
ins15 4 IDLch0 8 CORT-20 14 
glu0 1 IDLch4 12 CORT-40 5 
glu15 6 IDLph0 3 CORT-80 4 
ins/glu0 7 IDLph4 4 CORT-140 7 
ins/glu15 5 LDLch0 14 ACTH-20 21 
IPGTT0 5 LDLch4 9 NA/h/kg 11 
IPGTT30 1 LDLph0 9 A/h/kg 8 
IPGTT60 12 LDLph4 10 DOP/h/kg 7 
IPGTT120 6 HDL2ch0 9 CTA 14 
ch0 7 HDL2ch4 6 CUPOOL 6 
ch7 6 HDL2ph0 11 CUDW 5 
ch15 0 HDL2ph4 10 CUWW 2 
tg0 5 HDL3ch0 26 NO 7 
tg7 9 HDL3ch4 6 Padwt/BW 30 
tg15 1 HDL3ph0 2 AUC 7 
HDL15 4 HDL3ph4 5 log fold 6 
Table 5.5 a): Total numbers of fat cis-eQTLs identified as significantly correlated (empirical 
p<0.01) to 75 metabolic traits by QTT analysis 
10,000 permutations were used to find empirical p-values for each trait (definitions provided in 
Appendix V). A cumulative total of 665 QTT candidates were identified. Full data from this analysis is 
provided on the Data CD. 
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ins=0/cell 18 MAP 6 totchol0 7 
absnefa/cell 12 RLVHWT 18 totphos0 5 
ins=50k-0/cell 27 kidneydif 3 totchol4 10 
fold 8 kidney5wk 21 totphos4 4 
ins50k/cell 29 kidney8wk 16 ins0/vol 2 
absnefa 7 livchol 7 ins50/vol 10 
ratwt 14 liver(g) 8 delins/vol 6 
cell vol 12 livpool 5 hematocrit 90 9 
ins0 3 offspring 8 platelet aggrega 7 
ins15 7 IDLch0 4 CORT-20 16 
glu0 6 IDLch4 8 CORT-40 7 
glu15 11 IDLph0 7 CORT-80 9 
ins/glu0 5 IDLph4 3 CORT-140 7 
ins/glu15 6 LDLch0 13 ACTH-20 15 
IPGTT0 13 LDLch4 9 NA/h/kg 15 
IPGTT30 3 LDLph0 9 A/h/kg 13 
IPGTT60 18 LDLph4 7 DOP/h/kg 9 
IPGTT120 7 HDL2ch0 11 CTA 16 
ch0 10 HDL2ch4 8 CUPOOL 12 
ch7 2 HDL2ph0 12 CUDW 12 
ch15 3 HDL2ph4 9 CUWW 16 
tg0 2 HDL3ch0 25 NO 8 
tg7 10 HDL3ch4 4 Padwt/BW 18 
tg15 6 HDL3ph0 9 AUC 15 
HDL15 12 HDL3ph4 12 log fold 11 
Table 5.5 b): Total numbers of kidney cis-eQTLs identified as significantly correlated 
(empirical p<0.01) to 75 metabolic traits by QTT analysis 
1,000 permutations were used to find empirical p-values for each trait (definitions provided in 
Appendix V). A cumulative total of 752 QTT candidates were identified. Full data from this analysis is 
provided on the Data CD. 
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ins=0/cell 6 MAP 11 totchol0 4 
absnefa/cell 6 RLVHWT 7 totphos0 8 
ins=50k-0/cell 10 kidneydif 1 totchol4 5 
fold 9 kidney5wk 8 totphos4 4 
ins50k/cell 11 kidney8wk 8 ins0/vol 2 
absnefa 12 livchol 8 ins50/vol 6 
ratwt 7 liver(g) 7 delins/vol 6 
cell vol 9 livpool 7 hematocrit 90 7 
ins0 4 offspring 6 platelet aggrega 3 
ins15 8 IDLch0 2 CORT-20 6 
glu0 4 IDLch4 6 CORT-40 2 
glu15 3 IDLph0 9 CORT-80 8 
ins/glu0 3 IDLph4 11 CORT-140 5 
ins/glu15 8 LDLch0 7 ACTH-20 15 
IPGTT0 4 LDLch4 5 NA/h/kg 5 
IPGTT30 3 LDLph0 9 A/h/kg 12 
IPGTT60 3 LDLph4 17 DOP/h/kg 5 
IPGTT120 8 HDL2ch0 13 CTA 15 
ch0 4 HDL2ch4 3 CUPOOL 7 
ch7 2 HDL2ph0 12 CUDW 12 
ch15 2 HDL2ph4 5 CUWW 4 
tg0 5 HDL3ch0 14 NO 9 
tg7 10 HDL3ch4 6 Padwt/BW 12 
tg15 3 HDL3ph0 17 AUC 4 
HDL15 6 HDL3ph4 4 log fold 11 
Table 5.5 c): Total numbers of adrenal cis-eQTLs identified as significantly correlated 
(empirical p<0.01) to 75 metabolic traits by QTT analysis 
1,000 permutations were used to find empirical p-values for each trait (definitions provided in 
Appendix V). A cumulative total of 530 QTT candidates were identified. Full data from this analysis is 
provided on the Data CD. 
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ins=0/cell 26 MAP 30 totchol0 10 
absnefa/cell 34 RLVHWT 19 totphos0 18 
ins=50k-0/cell 27 kidneydif 12 totchol4 13 
fold 13 kidney5wk 45 totphos4 7 
ins50k/cell 33 kidney8wk 37 ins0/vol 13 
absnefa 27 livchol 21 ins50/vol 24 
ratwt 33 liver(g) 8 delins/vol 17 
cell vol 24 livpool 24 hematocrit 90 23 
ins0 13 offspring 16 platelet aggrega 26 
ins15 21 IDLch0 3 CORT-20 18 
glu0 12 IDLch4 22 CORT-40 8 
glu15 11 IDLph0 14 CORT-80 19 
ins/glu0 17 IDLph4 17 CORT-140 10 
ins/glu15 17 LDLch0 21 ACTH-20 13 
IPGTT0 25 LDLch4 16 NA/h/kg 29 
IPGTT30 8 LDLph0 11 A/h/kg 21 
IPGTT60 20 LDLph4 13 DOP/h/kg 9 
IPGTT120 11 HDL2ch0 22 CTA 25 
ch0 11 HDL2ch4 11 CUPOOL 7 
ch7 7 HDL2ph0 35 CUDW 22 
ch15 9 HDL2ph4 12 CUWW 5 
tg0 12 HDL3ch0 22 NO 19 
tg7 27 HDL3ch4 2 Padwt/BW 20 
tg15 8 HDL3ph0 12 AUC 17 
HDL15 18 HDL3ph4 13 log fold 20 
Table 5.5 d): Total numbers of left ventricle cis-eQTLs identified as significantly correlated 
(empirical p<0.01) to 75 metabolic traits by QTT analysis 
1,000 permutations were used to find empirical p-values for each trait (definitions provided in 
Appendix V). A cumulative total of 1335 QTT candidates were identified. Full data from this analysis 
is provided on the Data CD. 
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5.3 Discussion 
By improving our understanding of the relationships between genes underlying cis- 
and trans-eQTLs, it becomes possible to construct co-expression networks and make 
hypotheses regarding genetic modules. However, in order to achieve real insight into 
the genetics of complex traits such as the metabolic syndrome and left ventricular 
hypertrophy (LVH), it is necessary to integrate physiological trait data into this type 
of statistical genetic and computational analysis. 
 
The use of rodent models in research into the pathophysiology and genetics of the 
metabolic syndrome (Lusis et al., 2008) and LVH (Sarwar and Cook, 2009) has 
formed the basis of much of our understanding of the mechanisms underlying these 
pathologies. Although there are of course substantial differences in terms of biology 
between humans and rodents, homologues of genes first identified in rodents have in 
several cases been hypothesised to underlie aspects of human disease. Cd36 (Aitman 
et al., 1999), for instance, was the first complex trait gene identified through the use 
of DNA microarrays, in the SHR. Human CD36 protein is 86% identical to that found 
in the rat (Lepretre et al., 2004), and CD36 was subsequently implicated in human 
insulin resistance (Miyaoka et al., 2001), and has been associated with components of 
the metabolic syndrome (Love-Gregory et al., 2008) as well as type 2 diabetes 
(Lepretre et al., 2004).  
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Rodents have several inherent advantages over humans as sources of data for gene 
discovery (Guryev and Cuppen, 2009). The QTT analyses described here have two 
main components – the identification of cis-eQTLs in biologically relevant tissues, 
and the correlation of the expression of these with the quantitative traits measured in 
the same strains . Rodent RI strains are ideal for this purpose because they are 
renewable, meaning that the animals in which the traits are measured are genetically 
identical to those from which the tissue samples for microarray analysis were taken 
(1.4) (Pravenec, 2008). In addition, the range and depth of clinical research that can 
be carried out in humans, particularly healthy ‘control’ subjects, is limited for ethical 
and practical reasons. This often means that studies in humans are less specific than 
would be optimal for gene discovery (Delles et al., 2008). As discussed in Chapter 4 
and in (Petretto et al., 2006a), gene expression is highly tissue-specific.  
 
In rodents, obtaining tissues is not a problem and it was possible in the studies 
described here to perform full gene expression and QTT analysis on cis-eQTLs in 
four tissues that are highly relevant to the metabolic syndrome and/or LVH: Adipose 
tissue, kidney, adrenal gland and left ventricle. 
 
In 5.2.1, a QTT analysis that led to the implication of Ogn in blood pressure-
independent regulation of LVM in the RI strains, and subsequently of OGN in human 
LVM (Petretto et al., 2008), was described. It had previously been shown that blood 
pressure effects do not substantially correlate with LVM in both humans and rodents 
(Sarwar and Cook, 2009), even though hypertension and LVH are both risk factors 
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for heart failure (Schocken et al., 2008). The Ogn transcripts were not found by the 
QTT analysis to be correlated with either systolic or diastolic blood pressure. The 
cardiac role of Ogn, along with that of Ephx2 (Monti et al., 2008), was discovered 
following genome-wide expression profiling in a rat model – in the latter case, an F2 
cross derived from SHHF, the stroke-prone spontaneously hypertensive rat. Ephx2 
was subsequently found to be differentially regulated in human heart failure. 
 
In 5.2.2, analyses involving 103 measurements of a variety of quantitative traits in the 
other three tissues were summarised. The QTT data produced through correlation of 
cis-eQTL gene expression with these measurements across the RI strain panel 
potentially informs a wide range of hypotheses on the relationships between genome 
and phenome with regard to the components of the metabolic syndrome and related 
traits. 
 
Similar relationships between gene expression and trait measurements as were 
identified on chromosome 17 in the investigation of LVM regulation  in the left 
ventricle (Figure 5.1) were found in other traits. These included serum chloride, for 
which potential adrenal QTTs were found on chromosomes 1 and 17 (Figure 5.6), 
and pulse pressure, for which potential kidney QTTs were found on chromosomes 10 
and 19 (Figures 5.7). It was not possible for these analyses to be taken forward 
within the time-frame of this thesis. However, data is provided on the Data CD for 
the purpose of mining for other potential relationships between cis-eQTL genes and 
phenotypes, and investigations using these data are ongoing in the host laboratory. 
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The worth of QTT analysis in this dataset in precipitating gene discovery has been 
demonstrated here (5.2.1, (Petretto et al., 2008)) and elsewhere (Pravenec et al., 
2008). In the latter, Cd36 was identified as a significant QTT for diastolic blood 
pressure. A blood pressure pQTL had previous been identified in the vicinity of the 
Cd36 locus, and Cd36 transcript expression was found to be inversely correlated with 
radiotelemetric measurements of systolic and diastolic blood pressure at p < 0.01. 
 
Although the ‘genetical genomics’ (Jansen and Nap, 2001) methodology has been 
widely adopted by geneticists working in a variety of species, the integration of 
physiological trait data to such genome-wide expression analyses only began 
relatively recently. The term ‘quantitative trait transcript’ was coined in (Passador-
Gurgel et al., 2007), in which QTT analysis in Drosophila melanogaster was used to 
identify transcripts whose expression correlated with survival on exposure to 
nicotine, although the potential of approach of correlating clinical trait values with 
transcript levels had been discussed previously (Drake et al., 2006). An approach that 
with hindsight could be seen as a forerunner of QTT analysis was successfully 
applied to prioritise Insig2 as a gene influencing plasma cholesterol levels in mice 
(Cervino et al., 2005).  
 
Recent QTT analyses carried out in humans (Emilsson et al., 2008) and in mice 
(Chen et al., 2008) have identified genes expressed in adipose tissue and in liver that 
influence obesity-associated traits, such as plasma HDL cholesterol – many of which 
have also been measured and analysed in the rat RI strains (5.2.2). In addition to the 
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identification of three previously unknown obesity-related genes (Lpl, Lactb and 
Ppm1l), Chen et al described the use of their eQTL data to identify functional units in 
metabolic networks that are hypothesised to regulate the physiological traits found by 
QTT to be correlated with transcripts in the network. Some of the component genes 
of one of these networks were subsequently validated, in that genetic perturbation 
resulted in significant alterations to the metabolic traits under consideration, such as 
fat/muscle ratios (Yang et al., 2009). The same metabolic network, the macrophage-
enriched metabolic network (MEMN) was identified in humans (Emilsson et al., 
2008), showing that rodent research can lead to improved understanding of human 
systems at more than a single-gene level. 
 
There are some caveats associated with the use of QTT analysis to identify candidate 
genes for the regulation of physiological traits. As a method entailing direct 
correlation of transcript expression with quantitative trait measurements, it is not able 
to identify genetic regulation of traits by means other than transcriptional control, 
such as alternative splicing (Drake et al., 2006) or DNA methylation (Hansen et al., 
2008), nor is QTT suitable for identification of coding sequence variation which may 
impact upon phenotype, except where these may alter the amount of transcript 
produced (as in the case of Ogn). Additionally, QTT analysis cannot in and of itself 
provide information on complex traits, only on their quantifiable components 
(Wentzell et al., 2007).  
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More prosaically, it is required for gene identification that probes representing the 
transcript concerned be present on the microarray chip. The recent introduction of 
next generation sequencing (NGS) approaches to expression profiling, by direct RNA 
sequencing (RNA-Seq) may obviate some of these difficulties associated with 
microarrays by allowing transcript abundance to be determined without the need for 
pre-designed probes (Wang et al., 2009).  Either way, the integration of the methods 
such as this with other approaches, such as the network construction methods applied 
by (Chen et al., 2008), and the analysis of more diverse data types (Schadt, 2009) will 
be required in order to gain real insight into the complex genetics of traits like the 
metabolic syndrome. 
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Chapter 6: General Discussion 
The overall aims of this study were to make use of the combined linkage and gene 
expression data available in four tissues from the BXH/HXB panel to improve our 
understanding of the relationships between gene expression traits, eQTLs and 
physiological traits modelled by the SHR. This entailed the undertaking of a 
systematic analysis of the correlation structures of cis- and trans-eQTLs and the 
genetic basis of trans-eQTL clusters across all four tissues. Additionally, the control 
of transcript levels potentially underlying one physiological trait, LVM, was studied 
in depth, and QTT analysis was carried out on a further 103 traits using cis-eQTL 
data. 
 
 
6.1 Summary of Findings 
In Chapter 3, a full-scale comparative validation of the output of the linkage analysis 
software used to generate the eQTL dataset is described. The demonstration of the 
irreproducible nature of linkage data produced by QTL Reaper where there was 
missing genotype data at the peak of linkage motivated the repair of the software bug 
and the remapping of the eQTLs, excluding many spurious trans-eQTLs and clusters. 
Separately, an investigation of the possibility of false cis-eQTLs as a consequence of 
polymorphisms in the microarray probes’ binding regions is discussed. An 
exploratory study of a statistical model for predicting potential false cis-eQTLs, in 
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which newly available SHR sequence data was used to test the model’s predictions, is 
described. 
 
In Chapter 4, the application of an FDR-based method for determining statistical 
significance of pairwise correlations of gene expression across the 29 strains is 
described. This enabled the correlation structure of the sets of cis- and trans-eQTLs 
in all four tissues to be visualised and contrasted. Statistically significant correlation 
of cis-eQTLs is rare, and genetic linkage or long-range allelic association are 
potential explanations for it in almost all cases. Statistically significant correlation of 
trans-eQTLs is much commoner; however there is much more potential, given the 
definitions of cis- and trans-eQTLs, for correlated transcripts to be identified in the 
trans-eQTL dataset. Groups of co-expressed transcripts forming trans-eQTL clusters 
were identified in all four tissues; in most cases these were tissue-specific. Functional 
analysis of these trans-eQTL cluster-forming groups of co-expressed transcripts, 
carried out using DAVID (a Gene Ontology based tool) found several of the larger 
trans-eQTL clusters to be functionally enriched. Partial correlation analysis of these 
clusters found the two most functionally enriched also to be the most significantly co-
expressed once genotype at the peak of linkage was taken into account. The findings 
described in this chapter have several implications for the use of gene expression and 
eQTL data to predict functional relationships between genes and in the construction 
of networks. 
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In Chapter 5, a QTT analysis carried out using cis-eQTLs in the left ventricle and 
physiological trait measurements obtained in the RI strains is described. This QTT 
analysis led to the prioritisation of a region on chromosome 17 and in particular the 
gene Ogn as a candidate regulator of left ventricular mass in the rat, a function that 
was subsequently confirmed in rodents. An associated QTT analysis that was carried 
out using data from 26 human individuals, showing a clear positive correlation 
between OGN expression and left ventricular mass, is described. QTT analyses that 
were performed systematically using cis-eQTL data from all four tissues and 103 
physiological measurements (Table 5.5, Appendix V) are summarised – data 
produced by these analyses is provided on the Data CD. 
 
 
6.2 General Discussion 
The analysis described in this thesis was carried out on eQTL datasets derived from a 
panel of 29 rat RI strains. It has been possible to validate and generate testable 
hypothesis by applying statistical and computational methods to this dataset, and in 
the case of Ogn make use of it to precipitate the discovery of a complex trait gene. 
However, as discussed in 1.8.3, the statistical power to detect eQTL accorded by such 
a panel is suboptimal. This means that much significant genetic variation, particularly 
trans-acting variation, in transcript levels in these rats is likely to have been missed 
(Carlborg et al., 2005). In addition, the expected FDR at genome-wide significance  
p<0.05 for trans-eQTLs – whose effect sizes are typically small – is high (Petretto et 
190 
 
al., 2006a), and most trans-eQTL clusters are no longer present in the dataset when a 
more stringent threshold of p<0.01 is used. 
 
RI strains do provide a boost in statistical power relative to F2 populations (de Koning 
et al., 2005) because they offer a simpler genetic model (no heterozygotes); however 
the inbreeding process is laborious and takes a long time. A project is underway to 
produce a mouse RI panel consisting of 400 lines, the Collaborative Cross (Mott and 
Flint, 2008) that will, if successful, offer much greater statistical power to detect 
QTLs with small effects. In both rats and mice, the development of heterogeneous 
stock panels, in which QTLs can be directly mapped to a high resolution, by 
interbreeding inbred strains is ongoing (Aitman et al., 2008). By applying novel 
analytical methods to a rat heterogeneous stock panel derived from eight inbred 
strains, an anxiety trait was mapped to within a 95% confidence interval of 13Mb 
(Johannesson et al., 2009). The BXH/HXB RI panel does however offer benefits to 
researchers into the metabolic syndrome and associated traits that are not shared by 
the heterogeneous stock, thanks to its derivation from the SHR (1.3.3). The 
sequencing of the SHR genome (Atanur et al., 2010), which in combination with the 
BN sequence enabled the study described in 3.3 to be performed, also offers the 
potential to generate a marker map for use in genetic analysis of the RI strains of 
much greater resolution than is currently available, through the identification of novel 
SNPs, indels and copy number variants. 
 
191 
 
The work described in chapters 4 and 5 involves the application of correlation-based 
methods to genomic, transcriptomic and quantitative phenotypic trait data. Such 
methods are widely used in statistical genetics as they provide a straightforward and 
easily understood means of quantifying relationships within large datasets, and 
because correlation methods are amenable for use in the construction of models such 
as co-expression networks (Emilsson et al., 2008). Pairwise correlation methods such 
as Pearson correlation (2.4.1.1) are suitable for testing for linear relationships, which 
biological relationships – particularly across levels e.g. between transcript and 
phenotypic trait – may not be (Jansen et al., 2009). These methods do not directly 
provide information about causality (Wu et al., 2009). Measurements of pairwise 
correlation is influenced by confounding factors such as, in the case of co-expression 
analysis, linkage disequilibrium (Lusis et al., 2008) which typically means that an 
eQTL transcript is correlated with a wide region rather than a single marker. The 
interpretation of correlation of closely linked genes is further complicated by the fact 
that closely linked but separate genes may influence the same trait, and their effects 
may interact (Rockman and Kruglyak, 2006). 
 
Some such confounding factors can be taken into account through the use of partial 
correlation, which enables the correlation between two variables to be found taking 
into account the effect of others (2.4.5). This method was applied to groups of 30 or 
more transcripts linked in trans to the same genetic locus (large trans-eQTL clusters) 
in 4.2.3. It has been suggested that trans-eQTL clusters are mostly artefacts, resulting 
from the influence of unknown confounding factors – e.g. the method used to 
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standardise RNA abundance across samples (Kliebenstein, 2009) – and that they 
occur in eQTL datasets generated in relatively small populations, such as the 
BXH/HXB RI panel, because if one of a group of highly correlated transcripts is 
linked to a region of the genome, the others necessarily (as an effect of that 
correlation) will be also. It is therefore possible that a large cluster may by chance be 
linked to a specific locus, and that therefore no gene at this locus is involved in 
regulating the expression of cluster’s constituent transcripts. 
 
A model-based method of accounting for the inter-sample correlation and removing 
spurious trans-eQTL clusters has been proposed, and in a sample dataset applying 
this removed all such groups (Kang et al., 2008). Some studies, e.g. (Ghazalpour et 
al., 2008), have however found clusters that remain significant after correcting for 
such effects. The outcome of the investigations using partial correlation and 
functional enrichment described in 4.2.3 and 4.2.4 suggest that at least two clusters, 
one of which consists of 146 trans-eQTL genes, in the BXH/HXB dataset may be 
genuinely co-expressed, biologically interesting and worthy of further investigation, 
for instance through the application of pathway analysis methods (Kliebenstein, 
2009). However, the utility of such methods, as well as the GO-based functional 
enrichment analysis described in 4.2.4, is limited by the quality of the annotation 
available (Auffray et al., 2009).  
 
Another limitation associated with the eQTL study design has to do with the 
biological source of the RNA samples used in expression profiling. As shown by this 
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(4.2.2) and other (e.g. (Yang et al., 2006)) studies, gene expression is highly tissue-
specific. Furthermore, it has been found to be highly cell-type dependent (Gerrits et 
al., 2009). Tissue samples used in this and many other eQTL studies (e.g. (Chesler et 
al., 2005)) are heterogeneous in terms of cell-type – for instance, the adrenal gland 
samples used in this study includes both cortex and medulla. This means that inter-
sample variation can occur as a consequence of differing sample compositions 
(Gerrits et al., 2009), although this will be true across the four biological replicates as 
well as strains, so in many but not necessarily all cases will be taken into account. 
 
The linkage mapping of quantitative physiological traits such as blood pressure to the 
genome as physiological QTLs (pQTLs) is a well established methodology, and was 
carried out in the inbred strains used to generate the RI strain dataset prior to the 
commencement of the work described in this thesis (Hubner et al., 2005). These 
pQTLs are broad chromosomal regions as a consequence of linkage disequilibrium 
and contain many potential candidate genes. The information on expression variation 
provided by eQTLs can help to narrow down the list of candidate causative genes 
(Haley and de Koning, 2007).  
 
One way of doing this is to test for correlation between the phenotypic and expression 
traits (Drake et al., 2006) by carrying out QTT analysis, as was used to prioritise Ogn 
as a candidate gene underlying a cardiac mass pQTL in 5.2.1. Here, cis-eQTLs across 
the genome were tested for correlation with physiological measurements across the 
RI panel. It should be borne in mind that, in a GeneChip-generated eQTL dataset 
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such as this, some cis-eQTLs have been found (Alberts et al., 2007b) to arise as a 
consequence of differential hybridisation due to SNPs in probe binding regions, 
rather than genuine differential expression of the transcript(s) (3.2 & 3.3). For those 
cis-eQTLs that do represent differentially expressed transcripts, it is true that the cis-
eQTLs’ linkage to the QTL region implies a potential relationship between their 
expression and the physiological trait without the need for QTT analysis, and also 
that linkage disequilibrium means that fine mapping is required to identify the 
candidate gene from the significant QTTs. Although the presence of the QTL was 
taken into account, it was mapped in the parental strains not the RI panel. 
Additionally, the use of QTT in this instance enabled the relationship between the 
expression traits, LVM and blood pressure to be visualised and compared easily 
(Figures 5.1-5.3).  
 
The QTT method is however not limited to cis-eQTLs and has been used in other 
settings on transcripts not previously known to be linked to a region of interest 
(Emilsson et al., 2008). It has been suggested that the QTT approach could potentially 
be used in personalised medicine, combining data on the effect of a drug with 
expression analysis in a human clinical population (Ruden, 2007), although 
difficulties with such a study include the aforementioned tissue/cell-type specificity 
of variation in expression, the variation inherent in a human population, making 
achieving a suitable statistical power to achieve significance problematic. The latter 
two are also issues which arise where GWAS studies are considered (1.2.3), and 
difficulties in replication that have been reported in association with GWAS (Frayling 
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et al., 2007) would probably arise with this method also. Model organisms, and RI 
panels in particular, allow much more highly controlled and more reproducible 
experiments to be carried out than do humans (Guryev and Cuppen, 2009), and access 
to relevant tissues/cell types is much less of an issue.  
 
Other limitations associated with QTT analysis include the fact that not all regulation 
of biological processes takes place through control of gene expression (Drake et al., 
2006), that unaccounted-for confounding factors can produce uninformative findings 
of relationships (Yang et al., 2009), and that the effects of any one locus on a 
physiological phenotype may be too small to be detected by QTT analysis 
(Schliekelman, 2008). 
 
Like conventional QTL analysis, the QTT is a method of generating testable 
hypothesis regarding genes underlying trait variation – it does not prove anything in 
and of itself. The testing of specific causative hypotheses, as ever, takes place in the 
laboratory using methods, e.g. fine-mapping, in vitro models, RT-PCR and the 
generation of transgenics, such as were used to identify Ogn as a regulator of cardiac 
mass in (Petretto et al., 2008). Other QTT candidates identified as described in 5.2.2 
are currently being investigated in the host laboratory by methods including the 
generation of congenic strains (Morrissey C., 2010, personal communication). This 
method was used, following QTT analysis in the RI strains, along with transgenesis 
to identify Cd36 as a quantitative trait gene for blood pressure (Pravenec et al., 2008), 
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and also in the prioritisation of Acaa2 as a candidate for blood pressure regulation 
(Johnson et al., 2009).  
 
Computational approaches, including the integration of expression data into 
molecular networks (Chen et al., 2008), pathway analysis methods such as Ingenuity 
Pathways Analysis (Wang et al., 2007), and GSEA (functional analysis using curated 
gene sets (Subramanian et al., 2005))(Yang et al., 2009) have been used to assess the 
functional relevance of genes found to be correlated to a phenotypic trait.  
 
Because many genes contribute to phenotypic variation in complex traits, the 
consideration of expression variation within an integrative framework that takes into 
account this complexity may be more useful in understanding disease states (Schadt, 
2009). Data on the correlation between phenotypic and expression variation may 
contribute to the effort to construct models that incorporate interactions between 
different levels (e.g. genome, transcriptome, metabolome) within the cell and the 
organism as a whole (Hansen et al., 2008). The application of statistical procedures, 
such as the likelihood-based causal model selection (LCMS) probabilistic model 
described by (Schadt et al., 2005), can help differentiate between correlations that are 
causal to a clinical phenotype and those that are reactive to it (Yang et al., 2009), and 
also assess the joint probabilities of two closely linked loci influencing the phenotype 
independently of one another (Schadt, 2009). This method was used in the 
identification of the MEMN as a co-expression network having a causal relationship 
with obesity traits (Chen et al., 2008).  
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The methods of collecting biological data and of analysing it are continually 
developing. In the study of gene expression, RNA-Seq has been described as “a 
revolutionary tool for transcriptomics” (Sarwar and Cook, 2009) that some have 
speculated may represent the beginning of the end for microarrays (Auffray et al., 
2009). This recently-developed method is based on next-generation sequencing 
(NGS) technologies which enable tens of millions of DNA molecules to be sequenced 
in parallel (Simon et al., 2009). RNA is sequenced after being converted to cDNAs, 
or – in a still newer method – directly (Ozsolak et al., 2009). RNA-Seq has been 
shown by comparison with qRT-PCR able to quantify transcript abundance 
accurately and has been found to be reproducible across replicates (Wang et al., 
2009). Additionally, RNA-Seq has high dynamic range; it is able to detect transcripts 
that are expressed at both very low and very high levels (Mortazavi et al., 2008; 
Turner et al., 2009). It has also been shown to be well-suited to translational studies 
(Sugarbaker et al., 2008) and investigation of splice variants, chromatin modification 
sites and protein and transcription factor binding sites (Guryev and Cuppen, 2009).  
 
With RNA-Seq, the quantification of transcript abundance is not limited to those 
transcripts that are represented on a chip, and cross-hybridisation and spurious signals 
such as that discussed in 3.2 and 3.3 (Alberts et al., 2007b; Simon et al., 2009) do not 
impact data quality as with microarrays. Relative to microarrays, RNA-Seq is 
however very expensive at present, and poses computational and analytical 
challenges because of the massive quantities of data generated, the short reads, and 
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the identification of reads that span exon junctions or contain large polymorphisms 
(Wang et al., 2009). Because microarrays are relatively cheap and easy to use and 
analytical methodologies are now well-established, they are unlikely to be supplanted 
in the near future (Simon et al., 2009). Hence, improvements in our understanding of 
microarrays and their limitations remain of great research value. 
 
The extent of the complexity of the biological systems underlying traits such as the 
metabolic syndrome is just beginning to be appreciated (Schadt, 2009). The 
generation of ever-larger datasets using improving technologies with greater range 
and sensitivity is anticipated to provide the materials to investigate this complexity 
and build our understanding of the biology of complex traits. In order for these data 
to be exploited to the full and meaningful hypotheses to be generated from them, 
computational techniques and methods of statistical analysis must keep up with the 
pace.  
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6.3 Concluding Remarks 
The use of combined gene expression and linkage analysis to generate regulatory and 
functional hypotheses has been proven here and elsewhere to be a powerful 
technique. In this thesis, the utility of correlation analysis on such a dataset to 
prioritise cis-eQTLs as candidate genes for physiological traits has been demonstrated 
through the application of QTT analysis with left ventricular mass and blood pressure 
data to precipitate the identification of Ogn as a candidate regulator of left ventricular 
mass. Many other candidate regulatory genes underlying physiological traits have 
been generated through the systematic application of this technique, and data 
resulting from this is provided. The study of the correlation structure of groups of 
transcripts forming trans-eQTL clusters, combined with functional enrichment 
analysis, has suggested that some such groups may indeed be biologically interesting.  
 
Overall, the results described in this thesis demonstrate the strength of systematic, 
statistically sound approaches to the analysis of a large, consistent eQTL dataset. The 
importance of having a thorough understanding of both the biological and 
computational basis of such a dataset has been emphasised throughout.  
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Appendix I MATLAB script used to find empirical p-values of correlation  
  in QTT analysis 
 
 
This MatLab script was integrated into a Perl pipeline: 
 
% matlab script for cis vs trans correlation analysis 
clear; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%load data 
[cisdata, cistrait, cisline] = tblread('DBP_physiol_trait_dat', 
'\t');  
[transdata, transtrait, transline] = tblread('CIS_heart_dat','\t');  
ntrans = size(transdata,2); %ntrans was ntraits. 
ncis = size(cisdata,2); %new line. 
ntotal = ntrans*ncis; 
ntraits = sqrt(ntotal); %ntraits in single-type analyses is total 
trans. These are then correlated with each other for ntrans*ntrans 
correlations. Here ntrans*ncis correlations are carried out. 
[trans_r,trans_c] = size(transdata);     %%%%%% trans_r is no. of 
trans strains, trans_c is no. of trans traits. Was simply r and c. 
[cis_r,cis_c] = size(cisdata);  %%%%%% cis_r = cis 
strains, cis_c = cis traits. New line based on above. 
 
cc = zeros(trans_c,cis_c); % Initiate correlation results matrix. 
p = zeros(trans_c,cis_c); % Initiate correlation p-values matrix. 
p1t = zeros(trans_c,cis_c); % Initiate one-tailed correlation p-
values matrix. % p one t not p ell t! 
emp = zeros(trans_c,cis_c); % Initiate empirical p-values matrix. 
 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% correlations  
 
for i = [1:ntrans]; 
  corrtesttrans = transdata(:,i); 
  corrtesttemp(:,1) = corrtesttrans; 
 
  for j = [1:ncis]; 
    corrtestcis = cisdata(:,j); 
    corrtesttemp(:,2) = corrtestcis; 
    [cc1,pvals] = corrcoef(corrtesttemp); 
    currcorrcoef = cc1(1,2); 
    currp = pvals(1,2); 
    cc(i,j) = currcorrcoef; 
    p(i,j) = currp; 
    onetailed = currp / 2; 
    p1t(i,j) = onetailed; 
    clear corrtestcis currcorrcoef currp cc1 pvals; 
  end; 
  clear corrtesttemp corrtesttrans; 
end;  
clear i j; 
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%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% set up parameters for 
perms. 
nperms = 10000; 
combinations = ntrans; 
alpha = 0.05; 
combination_threshold = round(nperms - ((alpha/(combinations/2)) * 
nperms)); 
 
cctosort = zeros(trans_c,cis_c,nperms); % Initiatialise 3D 
correlation results matrix. 
for k = [1:nperms]; 
    for m = [1:trans_c]; 
     permdata(:,m) = transdata(randperm(trans_r),m); 
    end; 
    for i = [1:ntrans]; 
     nullcorrtesttrans = permdata(:,i); 
     nullcorrtesttemp(:,1) = nullcorrtesttrans; 
       
       for j = [1:ncis]; 
        nullcorrtestcis = cisdata(:,j); 
        nullcorrtesttemp(:,2) = nullcorrtestcis; 
        cc1 = corrcoef(nullcorrtesttemp); 
        nullcurrcorrcoef = cc1(1,2); 
        cctosort(i,j,k) = abs(nullcurrcorrcoef); 
       end; 
    end; 
  end; 
 
   ccsort = sort((cctosort),3); 
   thresh = squeeze(ccsort(:,:,combination_threshold)); 
   abstest = abs(cc); 
   signif = abs(cc) > thresh; 
 
[i j] = find(signif); 
 
ncorrcoef = size(cc,1); 
nullcorrcoeftosort = zeros(nperms,1); 
 
for i = [1:ncorrcoef]; 
  empi = 0; 
  nullcorrcoeftosort = ccsort(i,1,:); 
  nullcorrcoefsorted = sort(nullcorrcoeftosort,'descend'); 
  currcorrcoef = abs(cc(i,1)); 
  for j = [1:nperms]; 
    if nullcorrcoeftosort(:,:,j) >= currcorrcoef 
      empi = empi + 1;  
    end;  
 
    if empi == 0; 
      empi = 1; 
    end; 
 
    empp = empi / nperms; 
  end; 
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  emp(i,:) = empp; 
end; 
 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% output results 
 
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', transtrait, 
'delimiter', '','coffset', 0, 'roffset', 1) 
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', '***', '-append', 
'delimiter', '', 'coffset', 0, 'roffset', 1)  
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', cistrait, '-append', 
'delimiter', '', 'coffset', 0, 'roffset', 1) 
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', '***', '-append', 
'delimiter', '', 'coffset', 0, 'roffset', 1)  
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', cc, '-append', 
'delimiter', ' ', 'coffset', 0, 'roffset', 1) 
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', '***', '-append', 
'delimiter', '', 'coffset', 0, 'roffset', 1)  
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', printp, '-append', 
'delimiter', ' ', 'coffset', 0, 'roffset', 1) 
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', '***', '-append', 
'delimiter', '', 'coffset', 0, 'roffset', 1)  
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', thresh, '-append', 
'delimiter', ' ', 'coffset', 0, 'roffset', 1) 
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', '***', '-append', 
'delimiter', '', 'coffset', 0, 'roffset', 1)  
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', signif, '-append', 
'delimiter', ' ', 'coffset', 0, 'roffset', 1) 
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', '***', '-append', 
'delimiter', '', 'coffset', 0, 'roffset', 1)  
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', emp, '-append', 
'delimiter', ' ', 'coffset', 0, 'roffset', 1) 
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', '***', '-append', 
'delimiter', '', 'coffset', 0, 'roffset', 1)  
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', p1t, '-append', 
'delimiter', ' ', 'coffset', 0, 'roffset', 1) 
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', '***', '-append', 
'delimiter', '', 'coffset', 0, 'roffset', 1)  
dlmwrite('DBP_physiol_trait_dat_CIS_heart.out', 
combination_threshold, '-append', 'delimiter', ' ', 'coffset', 
0, 'roffset', 1) 
 
close all 
 
clear ans tick r c k tick i j k nperms  
 
quit 
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Contents of exemplar physiological trait data file provided as input to MatLab 
correlation script: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 DBP 
1H 84.79 
2H 88.47 
3H 96.34 
4H 83.25 
5H 87.09 
7H 84.23 
10H 94.64 
15H 84.92 
17H 100.34 
18H 88.36 
20H 80.65 
21H 88.75 
22H 89.37 
23H 86.19 
24H 77.13 
25H 81.34 
27H 84.7 
29H 83.54 
31H 83.47 
2B 83.18 
3B 79.87 
5B 84.86 
6B 90.77 
8B 86.08 
9B 79.22 
10B 89.81 
11B 89.02 
12B 84.91 
13B 86.84 
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Extract from contents of cis-eQTL expression data file provided as input to MatLab 
correlation script: 
 
 1367551_a_at 1367562_at 1367574_at 1367628_at 
"1H" 7.67973709 10.93780422 10.90817738 10.99627399 
"2H" 7.1980772 10.91172218 11.12731838 10.92982292 
"3H" 7.21639681 10.63175392 11.10826874 10.93883705 
"4H" 7.27095747 11.49904156 11.09344959 10.89237213 
"5H" 7.3797121 11.40389347 11.3356514 11.1481514 
"7H" 7.71912003 11.84435558 11.59171867 10.90641594 
"10H" 7.55096245 10.90875053 11.30874825 11.26289845 
"15H" 7.58139229 10.16538239 10.66611767 10.33894157 
"17H" 7.28413916 10.78122997 11.26590443 11.11721992 
"18H" 7.22759676 10.85401917 11.42521286 11.07767487 
"20H" 7.66844988 10.96870708 11.24119377 11.06907177 
"21H" 7.38165379 10.92046738 10.77867508 10.61616993 
"22H" 7.77224445 11.24554157 11.04502678 11.24810982 
"23H" 7.18954372 10.68624783 11.2198925 10.92363071 
"24H" 7.11914206 10.77099705 11.15253925 11.17246342 
"25H" 7.5004549 11.62852097 11.27778912 10.80047417 
"27H" 7.62077045 11.53417587 11.18069267 11.23991013 
"29H" 7.2272234 11.30589294 11.20408058 10.79101849 
"31H" 7.79323292 10.67498493 11.11670303 11.01991272 
"2B" 7.73587513 11.55472469 11.2713747 11.25311947 
"3B" 7.57724667 10.66844463 11.2103014 10.91379261 
"5B" 7.12386179 11.00831032 11.15570927 10.92574596 
"6B" 7.53646517 10.90838242 11.22941494 11.33149529 
"8B" 7.78968382 11.4825716 11.58284187 11.2701416 
"9B" 7.88862085 10.76527596 11.06812954 10.79598141 
"10B" 7.42299223 10.85657406 11.56780624 10.94619942 
"11B" 7.37523937 10.92200661 11.30420399 11.31643295 
"12B" 7.20876074 10.68705273 11.10902119 10.69730568 
"13B" 7.63697529 11.13474655 11.63410568 11.3121376 
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Appendix III Sizes of trans-eQTL clusters at p < 0.05 and p < 0.01, and 
percentage significant co-expression levels in all trans-eQTL 
clusters 
Tissue 
Marker at trans-
eQTL cluster 
peak of linkage 
No. 
Transcripts 
in Cluster 
(p < 0.05) 
No. trans-eQTLs 
in Cluster 
(p < 0.01) 
% Significant  
trans-trans 
expression 
correlation 
Fat Cacna1s 33 5 96.8 
Fat D11Rat7 11 0 85.5 
Fat D12Ntr2 19 2 94.7 
Fat D14Rat52 14 2 100 
Fat D16Cebr204s40 20 5 87.4 
Fat D16Mit1 12 5 87.9 
Fat D17Rat1 146 26 96.8 
Fat D1Rat27 19 5 87.7 
Fat D1Rat7 13 2 97.4 
Fat D4Rat240 31 8 84.7 
Fat D8Utr5 21 9 73.8 
Kidney Abpa 12 7 81.8 
Kidney Crabp1 18 4 96.1 
Kidney Cyp45c 23 3 83.6 
Kidney D10Cebrp1016s2 15 4 85.7 
Kidney D10Cebrp207s1 22 1 81.8 
Kidney D15Rat29 11 2 72.7 
Kidney D15Rat69 57 11 91.2 
Kidney D16Cebr204s40 16 7 67.5 
Kidney D16Mit2 14 2 79.1 
Kidney D2Cebr11s4 13 6 79.5 
Kidney D3Cebrp1038s1 14 5 74.7 
Kidney D4Mit11 13 2 88.5 
Kidney D4Rat35 24 7 87 
Kidney D4Utr4 12 4 81.8 
Kidney D5Rat174 27 3 90.6 
Kidney D5Rat38 10 3 95.6 
Kidney D8Rat_42 17 4 81.6 
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Kidney D8Rat150 11 1 89.1 
Kidney D8Rat21 12 6 90.9 
Kidney D8Utr5 16 6 72.5 
Kidney Igk@ 49 8 89.6 
Kidney Scnb2 20 2 90.5 
Kidney Slc12a1 22 4 86.1 
Adrenal Abpa 10 5 75.6 
Adrenal D11Rat16 31 9 75.5 
Adrenal D15Rat29 11 0 100 
Adrenal D17Rat144 47 16 88.6 
Adrenal D1Utr6 11 1 74.5 
Adrenal D20Mit1 11 4 78.2 
Adrenal D20Rat55 16 6 80.8 
Adrenal D8Rat56 14 3 83.5 
Adrenal D8Utr3 20 4 85.3 
LV Abpa 15 7 73.3 
LV Ckb 43 4 79.2 
LV Crabp1 165 47 77.1 
LV Cyp45c 35 8 87.9 
LV D11Cebr11s6 11 0 67.3 
LV D11Mit4 10 2 80 
LV D13Cebr9s2 27 7 86.9 
LV D13Cebr9s3 12 6 72.7 
LV D13Utr6 13 1 66.7 
LV D15Rat123 11 3 74.5 
LV D15Rat29 54 9 99 
LV D15Rat98 30 3 88 
LV D15Ucsf1 46 8 92.9 
LV D15Utr2 51 9 85.5 
LV D16Cebr204s40 15 2 74.3 
LV D16Mit3 13 2 82.1 
LV D16Rat46 28 7 92.1 
LV D16Rat67 26 4 72.9 
LV D17Mit6 20 8 78.9 
227 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LV D17Rat17 10 3 66.7 
LV D1Cebrp37s18 10 4 60 
LV D20Arb249 11 0 54.5 
LV D3Cebr37s29 10 3 80 
LV D3Mit16 14 2 67 
LV D4Rat140 10 2 82.2 
LV D6Mit10 14 3 93.4 
LV D6Rat79 20 3 77.9 
LV D6Rat80 15 1 84.8 
LV D8Cebr81s4 14 3 64.8 
LV D8Mgh4 10 2 68.9 
LV D8Mit12 77 27 68.8 
LV D8Rat219 21  3 83.3 
LV D8Rat49 11 4 63.6 
LV D8Utr2 10 1 82.2 
LV D8Utr5 22 11 72.3 
LV Edn3 10 0 68.9 
LV Kcnj1 18 2 82.4 
LV Tpm1 23 9 79.1 
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Appendix IV  Distinct DAVID significant (p < 0.01) Biological Process and 
Molecular Function GO terms, and numbers of genes annotated 
with each term, in large trans-eQTL clusters 
 
Trans-eQTL 
cluster peak 
of linkage 
Tissue 
Significantly enriched GO 
terms  (p < 0.01) 
No. (%) genes 
enriched for GO term 
 
D11Rat16 
 
Adrenal 
Carboxylic acid metabolism 6 (20.7%) 
Organic acid metabolism 6 (20.7%) 
D17Rat144 Adrenal Metabolism 20 (45.5%) 
Cacna1s Fat Cellular metabolism 16 (50%) 
D4Rat240 Fat 
Extracellular matrix structural 
constituent 
5 (17.9%) 
Skeletal development  5 (17.9%) 
Organ development 7 (25%) 
Structural molecule activity 5 (17.9%) 
D17Rat1 Fat 
Calcium ion binding 15 (11.5%) 
Alpha-type channel activity 11 (8.5%) 
Channel or pore class 
transporter activity 
11 (8.5%) 
Alkali metal ion binding 7 (5.4%) 
Morphogenesis 17 (13.1%) 
Ion binding 27 (20.8%) 
Metal ion binding 27 (20.8%) 
Metal ion transport 9 (6.9%) 
Sexual reproduction 8 (6.2%) 
Reproduction 9 (6.9%) 
Synaptic transmission 9 (6.9%) 
Cation transport 10 (7.7%) 
Transporter activity 22 (16.9%) 
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Ion transport 12 (9.2%) 
Gametogenesis 7 (5.4%) 
Enzyme inhibitor activity 7 (5.4%) 
Cell-cell signalling 12 (9.2%) 
Transport 28 (21.5%) 
Establishment of localization 31 (23.9%) 
Transmission of nerve impulse 9 (6.9%) 
D15Rat69 Kidney 
Establishment of localization 22 (39.3%) 
Localization 22 (39.3%) 
Transport 20 (35.7%) 
Intracellular transport 10 (17.9%) 
Establishment of cellular 
localization 
10 (17.9%) 
Cellular localization 10 (17.9%) 
Protein transport 8 (14.3%) 
Establishment of protein 
localization 
8 (14.3%) 
Intracellular protein transport 7 (12.5%) 
Protein localization 8 (14.3%) 
Vesicle-mediated transport 7 (12.5%) 
Secretion 6 (10.7%) 
Igk@ Kidney  
Synaptic transmission 6 (14%) 
Transmission of nerve impulse 6 (14%) 
Cell-cell signalling 7 (16.3%) 
Ckb 
Left 
Ventricle 
Establishment of localization 12 (34.3%) 
Localization 12 (34.3%) 
Cell organization & biogenesis 9 (25.7%) 
Transport 9 (25.7%) 
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Crabp1 
Left 
Ventricle 
Transporter activity 19 (14.2%) 
Establishment of localization 27 (20.2%) 
Localization 27 (20.2%) 
Transport 24 (17.9%) 
Cyp45c 
Left 
Ventricle 
None None 
D15Rat29 
Left 
Ventricle 
Response to biotic stimulus 13 (27.7%) 
Defense response 12 (25.5%) 
Immune response 11 (23.4%) 
Modification-dependent 
protein catabolism 
5 (10.6%) 
Proteolysis during cellular 
protein catabolism 
5 (10.6%) 
Cellular protein catabolism 5 (10.6%) 
Protein catabolism 5 (10.6%) 
Biopolymer catabolism 5 (10.6%) 
Cellular macromolecule 
catabolism 
5 (10.6%) 
Protein metabolism 13 (27.7%) 
Macromolecule catabolism 5 (10.6%) 
Proteolysis 6 (12.8%) 
Cellular protein metabolism 12 (25.5%) 
Cellular macromolecule 
catabolism 
12 (25.5%) 
DNA binding 9 (19.2%) 
D15Rat98 
Left 
Ventricle 
None None 
D15Ucsf1 
Left 
Ventricle 
Nucleotide binding 9 (22%) 
Regulation of biological 
process 
12 (29.3%) 
D15Utr2 
Left 
Ventricle 
Protein targeting 5 (12.8%) 
Cell organization and 
biogenesis 
10 (25.6%) 
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Protein transport 6 (15.4%) 
Establishment of protein 
localization 
6 (15.4%) 
Protein localization 6 (15.4%) 
Intracellular transport 6 (15.4%) 
Establishment of cellular 
localization 
6 (15.4%) 
Cellular localization 6 (15.4%) 
Intracellular protein transport 5 (12.8%) 
Protein import into nucleus 3 (7.7%) 
Nuclear import 3 (7.7%) 
Protein import 3 (7.7%) 
Organelle organization and 
biogenesis 
6 (15.4%) 
D8Mit12 
Left 
Ventricle 
None  
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Appendix V Description of metabolic traits on which systematic QTT analysis 
was carried out 
 
Physiological Trait Details 
ins=0/cell Basal glucose uptake by adipocytes 
absnefa/cell Non-essential fatty acids after isoproterenol induced lipolysis, 
corrected to cell number 
ins=50k-0/cell Difference of stimulated and basal glucose uptake 
fold Increase of glucose uptake by adipocytes 
ins50k/cell Insulin stimulated glucose uptake by adipocytes 
absnefa Non-essential fatty acids after isoproterenol induced lipolysis 
ratwt Rat weight 
cell vol Volume of adipocytes 
ins0 Serum insulin concentrations at the age of 8 weeks in male 
rats fed a normal diet 
ins15 Serum insulin concentrations at the age of 10 weeks in male 
rats fed a diet with 60% fructose for 15 days 
glu0 Serum glucose concentrations at the age of 8 weeks in male 
rats fed a normal diet 
glu15 Serum glucose concentrations at the age of 10 weeks in male 
rats fed a diet with 60% fructose for 15 days 
ins/glu0 Insulin/glucose ratio at the age of 8 weeks in male rats fed a 
normal diet 
ins/glu15 Insulin/glucose ratio at the age of 10 weeks in male rats fed a 
diet with 60% fructose for 15 days 
IPGTT0 Serum glucose concentrations during intraperitoneal glucose 
tolerance test at 0 min after glucose loading performed in male 
rats fed a diet with 60% fructose for 13 days 
IPGTT30 Serum glucose concentrations during intraperitoneal glucose 
tolerance test at 30 mins after glucose loading performed in 
male rats fed a diet with 60% fructose for 13 days 
IPGTT60 Serum glucose concentrations during intraperitoneal glucose 
tolerance test at 60 mins after glucose loading performed in 
male rats fed a diet with 60% fructose for 13 days 
IPGTT120 Serum glucose concentrations during intraperitoneal glucose 
tolerance test at 120 min after glucose loading performed in 
male rats fed a diet with 60% fructose for 13 days 
ch0 Serum cholesterol concentrations at the age of 8 weeks in 
male rats fed a normal diet 
ch7 Serum cholesterol concentrations in male rats fed a diet with 
60% fructose for 7 days 
ch15 Serum cholesterol concentrations in male rats fed a diet with 
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60% fructose for 15 days 
tg0 Serum triglyceride concentrations at the age of 8 weeks in 
male rats fed a normal diet 
tg7 Serum triglyceride concentrations in male rats fed a diet with 
60% fructose for 7 days 
tg15 Serum triglyceride concentrations in male rats fed a diet with 
60% fructose for 15 days 
HDL15 Serum HDL cholesterol concentrations in male rats fed a diet 
with 60% fructose for 15 days 
SBP Systolic Blood Pressure 
DBP Diastolic Blood Pressure 
PP Pulse Pressure 
MAP Mean Arterial Pressure 
RLVHWT Relative Left Ventricular Heart Weight 
kidneydif Difference between remnant kidney at the age of 8 weeks and 
a kidney at the age of 5 weeks (measure of compensatory 
renal hypertrophy) 
kidney5wk Relative weight of a kidney removed at the age of 5 weeks 
kidney8wk Relative weight of a remnant kidney removed at the age of 8 
weeks 
livchol Liver cholesterol concentrations in rats fed a high fat, high 
cholesterol diet from the age of 7-11 weeks 
liver(g) Liver weight 
livpool Cholesterol content of the liver 
offspring Number of young per litter 
IDLch0 IDL cholesterol in rats at the age of 7 weeks in rats fed a 
normal diet 
IDLch4 IDL cholesterol in rats at the age of 11 weeks in rats fed a 
high fat, high cholesterol diet for 4 weeks 
IDLph0 IDL phospholipids in rats at the age of 7 weeks in rats fed a 
normal diet 
IDLph4 IDL phospholipids in rats at the age of 11 weeks in rats fed a 
high fat, high cholesterol diet for 4 weeks 
LDLch0 LDL cholesterol in rats at the age of 7 weeks in rats fed a 
normal diet 
LDLch4 LDL cholesterol in rats at the age of 11 weeks in rats fed a 
high fat, high cholesterol diet for 4 weeks 
LDLph0 LDL phospholipids in rats at the age of 7 weeks in rats fed a 
normal diet 
LDLph4 LDL phospholipids in rats at the age of 11 weeks in rats fed a 
high fat, high cholesterol diet for 4 weeks 
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HDL2ch0 HDL2 cholesterol in rats at the age of 7 weeks in rats fed a 
normal diet 
 
HDL2ch4 HDL2 cholesterol in rats at the age of 11 weeks in rats fed a 
high fat, high cholesterol diet for 4 weeks 
HDL2ph0 HDL2 phospholipids in rats at the age of 7 weeks in rats fed a 
normal diet 
HDL2ph4 HDL2 phospholipids in rats at the age of 11 weeks in rats fed 
a high fat, high cholesterol diet for 4 weeks 
HDL3ch0 HDL3 cholesterol in rats at the age of 7 weeks in rats fed a 
normal diet 
HDL3ch4 HDL3 cholesterol in rats at the age of 11 weeks in rats fed a 
high fat, high cholesterol diet for 4 weeks 
HDL3ph0 HDL3 phospholipids in rats at the age of 7 weeks in rats fed a 
normal diet 
HDL3ph4 HDL3 phospholipids in rats at the age of 11 weeks in rats fed 
a high fat, high cholesterol diet for 4 weeks 
totchol0 Total serum cholesterol in rats at the age of 7 weeks in rats fed 
a normal diet 
totphos0 Total serum phospholipids in rats at the age of 7 weeks in rats 
fed a normal diet 
totchol4 Total serum cholesterol in rats at the age of 11 weeks in rats 
fed a high fat, high cholesterol diet for 4 weeks 
totphos4 Total serum phospholipids in rats at the age of 11 weeks in 
rats fed a high fat, high cholesterol diet for 4 weeks 
ins0/vol Basal glucose uptake by isolated adipocytes corrected to cell 
volume 
ins50/vol Insulin stimulated uptake of glucose by isolated adipocytes 
corrected to cell volume 
delins/vol Difference between ins50/vol and ins0/vol 
absnefa/vol Non-essential fatty acids after isoproterenol induced lipolysis, 
corrected to cell number 
hematocrit90 Hematocrit (proportion of blood volume occupied by red 
blood cells) at the age of 90 days 
platelet aggrega Platelet aggregation 
CORT-20 Serum corticosteron levels after 20mins of immobilization 
stress 
CORT-40 Serum corticosteron levels after 40mins of immobilization 
stress 
CORT-80 Serum corticosteron levels after 80mins of immobilization 
stress 
CORT-140 Serum corticosteron levels after 140mins of immobilization 
stress 
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ACTH20 Serum ACTH (corticotropin) levels after 20mins of 
immobilization stress 
NA/h/kg Urine noradrenaline, corrected for body weight 
A/h/kg Urine adrenaline, corrected for body weight 
DOP/h/kg Urine dopamine, corrected for body weight 
CTA Conditioned taste aversion 
CUPOOL Liver copper concentration after rats were fed a high fat, high 
cholesterol diet for 4 weeks 
CUDW Dry weight of liver copper 
CUWW Wet weight of liver copper 
NO Serum nitric oxide in male rats fed a normal diet 
Padwt/BW Weight of the fat pad relative to body weight 
AUC Area under the IPGTT curve 
log fold Log of the increase of glucose uptake by adipocytes 
 
